data_2lg6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lg6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.62 ' O ' ' N ' ' A' ' 5' ' ' GLY . 70.7 m . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.182 -0.673 . . . . 0.98999999999999999 109.182 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -42.82 80.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.582 0.551 . . . . 2.6600000000000001 111.789 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 132.46 -35.11 2.39 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 121.002 -0.618 . . . . 0.33000000000000002 113.022 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.34 -121.96 0.82 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.025 -0.607 . . . . 0.40000000000000002 112.497 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 m -141.56 162.19 36.08 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.479 -0.424 . . . . 0.94999999999999996 110.788 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.5 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -95.42 144.57 25.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.744 -0.662 . . . . 1.1699999999999999 110.847 -178.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.503 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.4 m-70 -142.09 128.7 20.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.49 -0.777 . . . . 0.26000000000000001 109.64 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.482 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 1.6 t80 -66.23 126.41 28.62 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.841 -0.429 . . . . 0.59999999999999998 109.841 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.44 -51.73 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.829 -0.7 . . . . 0.28000000000000003 112.826 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.62 -128.9 1.2 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.809 -0.71 . . . . 0.17000000000000001 111.994 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.1 m -148.8 136.72 11.3 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.81 0.338 . . . . 0.19 111.737 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.19 133.7 42.24 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.71 1.606 . . . . 0.28000000000000003 109.182 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 p -36.56 -36.29 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.822 0.344 . . . . 1.9199999999999999 111.665 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -48.3 77.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.158 -0.473 . . . . 0.51000000000000001 111.487 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.1 mt -74.47 177.3 6.07 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.144 1.165 . . . . 1.03 114.144 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 31' ' ' ALA . 1.6 pp -131.61 136.18 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 113.183 -1.826 . . . . 1.0700000000000001 109.237 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -66.9 102.42 0.96 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.776 0.322 . . . . 1.49 110.353 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.542 ' CG1' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.55 -33.47 15.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 1.0600000000000001 110.023 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.22 -163.4 34.18 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.55 -0.75 . . . . 0.20999999999999999 111.36 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.38 148.63 24.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.869 0.334 . . . . 1.3700000000000001 110.178 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.6 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 28.9 t . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 1.1599999999999999 108.847 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.6 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 80.9 mtm180 . . . . . 0 CA--C 1.515 -0.389 0 CA-C-O 121.184 0.516 . . . . 0.78000000000000003 112.337 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -111.12 137.17 49.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.186 -0.916 . . . . 1.25 109.679 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.13 126.57 38.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.695 -0.483 . . . . 0.71999999999999997 109.695 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.503 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 7.6 m -120.85 140.89 51.14 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.918 0.866 . . . . 0.16 111.942 -177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.542 ' HB1' ' CG1' ' A' ' 20' ' ' VAL . . . -129.5 173.53 10.48 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.123 -1.399 . . . . 0.98999999999999999 108.287 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.705 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 31.3 m95 -84.95 140.41 37.3 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-O 121.477 0.656 . . . . 0.52000000000000002 112.056 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.597 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 19.7 Cg_endo -58.35 -15.78 25.78 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 125.107 3.872 . . . . 0.34000000000000002 117.521 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.705 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -29.79 -33.41 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 119.228 0.922 . . . . 0.32000000000000001 113.176 -177.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.628 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -157.62 40.82 0.29 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.929 -0.767 . . . . 1.8999999999999999 108.929 -177.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.493 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.002 -0.999 . . . . 1.3200000000000001 110.649 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.66 ' O ' ' N ' ' A' ' 5' ' ' GLY . 62.4 m . . . . . 0 CA--C 1.512 -0.494 0 N-CA-C 108.339 -0.986 . . . . 0.98999999999999999 108.339 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.554 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 8.0 mtpm? -43.24 79.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 2.6600000000000001 111.278 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.66 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 138.47 -37.6 1.78 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.984 -0.627 . . . . 0.33000000000000002 112.509 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.7 -118.48 0.58 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.35 -0.453 . . . . 0.40000000000000002 112.108 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.0 m -149.4 165.04 33.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.127 0.489 . . . . 0.94999999999999996 111.098 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.454 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -96.69 140.54 31.13 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.499 -0.773 . . . . 1.1699999999999999 110.81 -178.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.427 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 27.4 m-70 -135.36 134.33 39.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.36 -0.837 . . . . 0.26000000000000001 108.865 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.527 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -69.11 123.91 22.36 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.804 -0.358 . . . . 0.59999999999999998 110.555 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.05 -48.88 0.9 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.127 -0.558 . . . . 0.28000000000000003 112.823 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.23 -128.29 1.18 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 121.096 -0.573 . . . . 0.17000000000000001 111.932 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.5 m -148.24 141.82 15.84 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.592 0.234 . . . . 0.19 111.53 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 17' ' ' LEU . 25.1 Cg_exo -55.84 132.27 51.02 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.543 1.496 . . . . 0.28000000000000003 108.979 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -36.22 -33.26 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 O-C-N 123.188 0.305 . . . . 1.9199999999999999 111.758 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.422 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -66.07 -48.32 71.37 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.561 -0.456 . . . . 0.51000000000000001 110.901 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 14' ' ' PRO . 22.5 mt -71.61 179.65 2.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.751 1.389 . . . . 1.03 114.751 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 31' ' ' ALA . 1.4 pp -135.48 136.6 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 113.14 -1.846 . . . . 1.0700000000000001 109.093 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -65.75 102.06 0.71 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.784 0.326 . . . . 1.49 110.6 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.54 ' CG1' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.9 -34.09 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.206 0.527 . . . . 1.0600000000000001 109.867 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.99 -169.69 42.85 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.188 -0.765 . . . . 0.20999999999999999 111.188 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.5 p -84.94 153.0 23.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.13 0.465 . . . . 1.3700000000000001 111.078 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 44.6 t . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.655 -0.702 . . . . 1.1599999999999999 109.912 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 86.5 mtm180 . . . . . 0 CA--C 1.515 -0.395 0 CA-C-O 120.642 0.258 . . . . 0.78000000000000003 110.901 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.3 m -103.1 138.14 40.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.078 -0.712 . . . . 1.25 109.078 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -92.32 126.72 37.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.863 -0.421 . . . . 0.71999999999999997 109.863 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 5.8 m -122.77 140.84 52.47 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.009 0.909 . . . . 0.16 112.737 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.54 ' HB1' ' CG1' ' A' ' 20' ' ' VAL . . . -127.97 173.12 10.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.064 -1.425 . . . . 0.98999999999999999 107.881 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.705 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 36.6 m95 -86.87 140.58 33.1 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-O 121.439 0.637 . . . . 0.52000000000000002 111.81 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 30.9 Cg_endo -61.32 -13.21 27.41 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 125.131 3.887 . . . . 0.34000000000000002 117.259 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.705 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -29.38 -34.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 119.13 0.877 . . . . 0.32000000000000001 112.399 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.606 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.4 OUTLIER -156.58 38.67 0.33 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.774 -0.825 . . . . 1.8999999999999999 108.774 -178.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.412 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.554 -0.748 . . . . 1.3200000000000001 109.88 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.601 ' O ' ' N ' ' A' ' 5' ' ' GLY . 46.5 m . . . . . 0 N--CA 1.445 -0.689 0 N-CA-C 108.197 -1.038 . . . . 0.98999999999999999 108.197 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -35.02 81.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.557 0.535 . . . . 2.6600000000000001 112.44 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 135.54 -44.44 1.17 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.043 -0.598 . . . . 0.33000000000000002 113.233 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.432 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.27 -140.49 3.05 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.703 -0.76 . . . . 0.40000000000000002 112.624 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 30' ' ' CYS . 4.8 m -116.42 160.71 20.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.065 0.459 . . . . 0.94999999999999996 111.675 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.11 149.47 21.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.599 -0.728 . . . . 1.1699999999999999 110.273 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.516 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 25.9 m-70 -144.59 133.5 22.56 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.627 -0.715 . . . . 0.26000000000000001 109.608 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.533 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 2.1 t80 -70.74 131.37 43.76 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 116.311 -0.404 . . . . 0.59999999999999998 110.398 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.09 -48.68 0.93 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.257 -0.497 . . . . 0.28000000000000003 112.686 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.87 -133.64 1.75 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.794 -0.717 . . . . 0.17000000000000001 111.983 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 88.3 m -152.4 139.9 12.94 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.643 0.259 . . . . 0.19 111.41 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' HIS . 51.1 Cg_exo -48.46 133.27 25.63 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.561 1.507 . . . . 0.28000000000000003 109.553 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.4 m -36.02 -33.02 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 O-C-N 123.367 0.417 . . . . 1.9199999999999999 111.54 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.478 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -71.96 -48.84 42.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.316 -0.402 . . . . 0.51000000000000001 111.737 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.459 HD22 ' NE1' ' A' ' 32' ' ' TRP . 24.9 mt -73.0 143.03 47.74 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.055 1.131 . . . . 1.03 114.055 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.413 HD11 ' O ' ' A' ' 18' ' ' ILE . 1.8 pp -95.55 137.0 24.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 113.047 -1.888 . . . . 1.0700000000000001 110.396 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 21' ' ' GLY . 24.4 tptm -67.82 100.65 0.96 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.333 -0.394 . . . . 1.49 110.089 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.513 ' CG1' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.49 -33.4 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 1.0600000000000001 110.942 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.404 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . 173.24 -155.79 23.21 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.774 -0.727 . . . . 0.20999999999999999 111.879 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.18 146.26 23.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.231 0.539 . . . . 1.3700000000000001 111.696 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.578 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 43.1 t . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.465 -0.789 . . . . 1.1599999999999999 109.412 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.578 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 75.0 mtm180 . . . . . 0 CA--C 1.513 -0.468 0 CA-C-O 121.276 0.56 . . . . 0.78000000000000003 112.444 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -110.33 138.7 46.36 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.036 -0.984 . . . . 1.25 109.576 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.53 125.6 37.24 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.111 -0.7 . . . . 0.71999999999999997 109.111 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.516 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 3.3 m -119.59 146.67 45.31 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.745 0.783 . . . . 0.16 110.955 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.513 ' HB1' ' CG1' ' A' ' 20' ' ' VAL . . . -138.85 173.5 11.51 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.244 -1.344 . . . . 0.98999999999999999 107.681 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.705 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 33.7 m95 -88.98 138.47 29.2 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-O 121.505 0.669 . . . . 0.52000000000000002 112.54 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.623 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 17.8 Cg_endo -57.36 -16.95 24.77 Favored 'Trans proline' 0 N--CA 1.487 1.114 1 C-N-CA 125.357 4.038 . . . . 0.34000000000000002 117.011 -177.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.705 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -27.27 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.435 0.902 . . . . 0.32000000000000001 113.435 -177.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 33' ' ' PRO . 15.1 p30 -159.28 29.35 0.2 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.915 0.865 . . . . 1.8999999999999999 109.735 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.411 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--N 1.313 -1.022 0 CA-C-N 114.68 -1.145 . . . . 1.3200000000000001 110.209 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.638 ' O ' ' N ' ' A' ' 5' ' ' GLY . 40.7 t . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 107.975 -1.12 . . . . 0.98999999999999999 107.975 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -45.58 81.58 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.21 0.529 . . . . 2.6600000000000001 111.23 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 127.18 -32.65 3.53 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.563 -0.744 . . . . 0.33000000000000002 112.772 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.481 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -153.25 -114.03 0.54 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.917 -0.659 . . . . 0.40000000000000002 113.05 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 30' ' ' CYS . 19.2 m -150.31 171.35 17.12 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.484 -0.421 . . . . 0.94999999999999996 111.589 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.1 m -95.59 144.01 26.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 1.1699999999999999 111.45 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.54 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 50.7 m-70 -150.5 123.13 8.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.852 -0.613 . . . . 0.26000000000000001 109.656 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.528 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 2.0 t80 -67.32 127.92 34.48 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.71 -0.396 . . . . 0.59999999999999998 110.152 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.14 -55.83 0.49 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.189 -0.529 . . . . 0.28000000000000003 113.113 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.88 -129.66 1.11 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.547 -0.835 . . . . 0.17000000000000001 112.497 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 93.6 m -151.14 143.91 16.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.723 0.297 . . . . 0.19 111.549 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -56.66 134.06 61.98 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.789 1.659 . . . . 0.28000000000000003 109.526 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.6 p -36.11 -33.88 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.396 0.435 . . . . 1.9199999999999999 111.473 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.49 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -67.64 -47.29 70.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.028 -0.533 . . . . 0.51000000000000001 111.511 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.84 -176.64 2.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.699 1.0 . . . . 1.03 113.699 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 31' ' ' ALA . 1.4 pp -138.62 135.22 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 113.793 -1.549 . . . . 1.0700000000000001 108.662 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.484 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 21.0 tptm -64.87 95.29 0.15 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.416 -0.356 . . . . 1.49 110.842 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.542 HG23 ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -71.88 -31.5 41.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.142 0.496 . . . . 1.0600000000000001 109.769 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.75 -149.88 14.77 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.544 -0.753 . . . . 0.20999999999999999 111.323 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.1 p -109.4 143.76 38.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.781 0.324 . . . . 1.3700000000000001 110.132 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.738 ' SG ' ' HA ' ' A' ' 29' ' ' CYS . 84.3 m . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 116.217 -0.447 . . . . 1.1599999999999999 110.155 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.528 ' HG2' ' HB2' ' A' ' 10' ' ' PHE . 76.9 mtm180 . . . . . 0 CA--C 1.511 -0.535 0 N-CA-C 113.096 0.776 . . . . 0.78000000000000003 113.096 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.484 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 27.7 m -102.84 140.04 37.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.857 -1.065 . . . . 1.25 110.695 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.738 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -93.3 125.04 37.69 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.236 -1.024 . . . . 0.71999999999999997 108.236 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.54 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 13.2 m -121.72 138.26 54.42 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.789 0.804 . . . . 0.16 111.705 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.558 ' O ' HG13 ' A' ' 18' ' ' ILE . . . -129.9 174.66 9.54 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.276 -1.329 . . . . 0.98999999999999999 108.381 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.734 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 45.4 m95 -87.25 142.11 33.24 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-O 121.412 0.625 . . . . 0.52000000000000002 111.413 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.8 Cg_endo -58.38 -23.61 64.31 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 125.004 3.802 . . . . 0.34000000000000002 117.413 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.734 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -21.9 -37.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.264 1.209 . . . . 0.32000000000000001 114.264 -177.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -155.04 20.58 0.44 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.936 0.398 . . . . 1.8999999999999999 110.64 -177.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.39 -0.815 . . . . 1.3200000000000001 111.059 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.667 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 45.8 m . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 108.24 -1.022 . . . . 0.98999999999999999 108.24 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 6.9 mtpm? -40.66 80.58 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.422 0.451 . . . . 2.6600000000000001 111.765 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 136.78 -38.0 1.8 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.179 -0.534 . . . . 0.33000000000000002 112.931 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.79 -121.89 0.67 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.363 -0.446 . . . . 0.40000000000000002 112.071 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.0 m -145.41 163.55 34.27 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.488 -0.419 . . . . 0.94999999999999996 110.143 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.667 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -95.82 138.27 33.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.307 0.575 . . . . 1.1699999999999999 111.61 -177.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.619 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.5 m-70 -127.56 135.09 49.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.181 -0.918 . . . . 0.26000000000000001 109.198 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.477 ' CB ' ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -71.45 134.81 46.85 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.863 -0.421 . . . . 0.59999999999999998 109.863 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.39 -42.09 1.98 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.89 -0.671 . . . . 0.28000000000000003 112.411 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.86 -129.53 1.72 Allowed Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.699 -0.763 . . . . 0.17000000000000001 112.313 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.7 m -151.86 140.6 13.67 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.534 0.207 . . . . 0.19 111.335 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 16' ' ' HIS . 36.8 Cg_exo -52.64 134.61 53.93 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.573 1.515 . . . . 0.28000000000000003 109.548 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -35.61 -33.59 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.113 0.482 . . . . 1.9199999999999999 111.774 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -69.14 -49.16 59.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.74 -0.664 . . . . 0.51000000000000001 111.62 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.7 mt -75.04 147.53 40.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.312 1.227 . . . . 1.03 114.312 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.462 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 1.6 pp -98.25 138.39 23.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 112.876 -1.966 . . . . 1.0700000000000001 110.133 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 21' ' ' GLY . 21.2 tptm -72.45 105.4 4.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.531 -0.304 . . . . 1.49 110.259 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.505 ' CG1' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.74 -32.77 9.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.128 0.489 . . . . 1.0600000000000001 110.115 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.462 ' O ' ' CE ' ' A' ' 19' ' ' LYS . . . 175.83 -156.76 22.34 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 111.077 -0.809 . . . . 0.20999999999999999 111.077 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 18.4 t -95.58 -170.61 2.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.258 0.529 . . . . 1.3700000000000001 109.953 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' ARG . 51.2 t . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 120.664 0.268 . . . . 1.1599999999999999 110.932 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' CYS . 85.9 mtm180 . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 120.838 0.352 . . . . 0.78000000000000003 111.574 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.42 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 9.7 m -100.97 138.52 37.9 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.657 -0.702 . . . . 1.25 109.429 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.447 ' HB3' HG21 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -91.47 126.12 36.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.145 0.498 . . . . 0.71999999999999997 109.795 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.619 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 4.5 m -117.75 143.76 45.94 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.893 0.854 . . . . 0.16 111.183 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB1' ' CG1' ' A' ' 20' ' ' VAL . . . -134.81 173.16 12.01 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.049 -1.432 . . . . 0.98999999999999999 107.236 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.744 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 42.6 m95 -89.31 140.56 28.65 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-O 121.577 0.703 . . . . 0.52000000000000002 112.157 -178.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 35' ' ' ASN . 29.8 Cg_endo -60.44 -16.75 43.77 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 125.078 3.852 . . . . 0.34000000000000002 116.781 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.744 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.4 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.605 0.965 . . . . 0.32000000000000001 113.605 -177.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.595 ' ND2' ' CE3' ' A' ' 34' ' ' TRP . 12.1 p30 -158.59 20.59 0.22 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.167 0.508 . . . . 1.8999999999999999 110.482 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.402 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--N 1.316 -0.869 0 CA-C-O 118.435 -0.793 . . . . 1.3200000000000001 110.827 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 5' ' ' GLY . 92.5 m . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 108.489 -0.93 . . . . 0.98999999999999999 108.489 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -40.91 83.29 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.533 0.52 . . . . 2.6600000000000001 111.449 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 131.44 -41.59 1.49 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.647 -0.706 . . . . 0.33000000000000002 112.357 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . -149.4 -126.01 1.43 Allowed Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.957 -0.457 . . . . 0.40000000000000002 111.957 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 m -135.24 167.09 21.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.129 0.49 . . . . 0.94999999999999996 110.899 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.59 ' SG ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -95.84 134.2 39.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.76 -0.655 . . . . 1.1699999999999999 110.407 -179.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.609 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 38.0 m-70 -130.6 135.35 47.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.36 -0.836 . . . . 0.26000000000000001 109.461 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.476 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -74.54 135.47 42.15 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.738 -0.385 . . . . 0.59999999999999998 110.203 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.36 -43.99 1.59 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.016 -0.612 . . . . 0.28000000000000003 112.896 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.93 -129.8 1.59 Allowed Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.728 -0.748 . . . . 0.17000000000000001 111.989 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.2 m -152.35 144.47 16.64 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.493 0.187 . . . . 0.19 111.037 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 16' ' ' HIS . 29.1 Cg_exo -55.63 134.08 61.84 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.557 1.504 . . . . 0.28000000000000003 109.235 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.5 m -34.76 -32.67 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.277 0.473 . . . . 1.9199999999999999 112.277 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -69.51 -48.92 59.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.958 0.409 . . . . 0.51000000000000001 111.58 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.8 mt -73.47 149.22 42.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.623 1.342 . . . . 1.03 114.623 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 2.0 pp -99.91 138.56 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 112.94 -1.937 . . . . 1.0700000000000001 110.257 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 22.2 tptm -69.97 97.09 1.1 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.442 -0.344 . . . . 1.49 110.599 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -73.81 -31.12 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.016 0.436 . . . . 1.0600000000000001 110.297 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.71 -151.19 16.49 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.941 -0.647 . . . . 0.20999999999999999 111.912 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.5 p -96.68 178.11 5.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.71 0.291 . . . . 1.3700000000000001 110.986 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.622 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 43.7 t . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 116.226 -0.443 . . . . 1.1599999999999999 109.844 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.622 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 80.4 mtm180 . . . . . 0 CA--C 1.514 -0.436 0 CA-C-O 121.055 0.455 . . . . 0.78000000000000003 111.569 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.428 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 50.8 m -102.54 138.85 38.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.272 -0.876 . . . . 1.25 109.144 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.453 ' HB3' HG21 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -91.97 126.21 36.97 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.357 -0.608 . . . . 0.71999999999999997 109.357 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.609 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 5.1 m -118.58 139.34 51.63 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.917 0.865 . . . . 0.16 111.47 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.501 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -135.04 173.17 12.03 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.963 -1.471 . . . . 0.98999999999999999 107.331 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.729 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 45.6 m95 -86.34 139.58 34.08 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-O 121.485 0.66 . . . . 0.52000000000000002 112.076 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 35' ' ' ASN . 10.3 Cg_endo -54.04 -25.81 38.38 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 125.204 3.936 . . . . 0.34000000000000002 117.448 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.729 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -23.14 -38.16 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.012 1.116 . . . . 0.32000000000000001 114.012 -177.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.615 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.3 OUTLIER -158.54 40.75 0.25 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.621 -0.511 . . . . 1.8999999999999999 109.621 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.18 -0.914 . . . . 1.3200000000000001 110.825 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 5' ' ' GLY . 76.8 m . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 107.745 -1.205 . . . . 0.98999999999999999 107.745 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -34.02 78.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.927 0.714 . . . . 2.6600000000000001 112.927 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 134.55 -43.29 1.27 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.712 -0.756 . . . . 0.33000000000000002 113.394 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.56 -136.71 2.51 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.662 -0.78 . . . . 0.40000000000000002 112.772 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -116.26 162.23 17.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.243 0.544 . . . . 0.94999999999999996 111.344 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -96.08 139.09 32.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.631 -0.713 . . . . 1.1699999999999999 109.888 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.62 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 27.1 m-70 -134.02 132.77 40.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.26000000000000001 109.81 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.518 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -73.01 132.94 44.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.303 -0.408 . . . . 0.59999999999999998 110.226 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.02 -48.16 0.98 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.129 -0.558 . . . . 0.28000000000000003 112.631 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.4 -139.74 4.02 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 111.423 -0.671 . . . . 0.17000000000000001 111.423 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.4 m -147.13 137.41 12.35 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.675 0.238 . . . . 0.19 111.158 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 17' ' ' LEU . 32.8 Cg_exo -52.54 133.22 48.57 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.833 1.689 . . . . 0.28000000000000003 109.602 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.5 t -35.91 -34.19 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.328 0.393 . . . . 1.9199999999999999 111.779 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.476 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -62.55 -48.62 78.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.235 0.54 . . . . 0.51000000000000001 110.386 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 14' ' ' PRO . 37.1 mt -77.32 155.32 32.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.637 1.208 . . . . 1.03 114.088 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 33' ' ' PRO . 1.8 pp -108.42 134.21 51.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 112.704 -2.043 . . . . 1.0700000000000001 110.005 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' HE3' ' HB3' ' A' ' 28' ' ' SER . 22.4 tptm -68.71 93.47 0.53 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.809 0.337 . . . . 1.49 110.211 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.412 ' CG1' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -71.46 -28.67 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.41 0.624 . . . . 1.0600000000000001 109.863 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.31 -156.55 27.76 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.611 -0.996 . . . . 0.20999999999999999 110.611 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.47 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 14.1 t -94.47 -179.94 5.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 117.213 0.506 . . . . 1.3700000000000001 109.692 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.599 ' HB3' ' C ' ' A' ' 27' ' ' ARG . 42.4 t . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 116.197 -0.456 . . . . 1.1599999999999999 110.355 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.599 ' C ' ' HB3' ' A' ' 23' ' ' CYS . 79.8 mtm180 . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 110.072 -0.344 . . . . 0.78000000000000003 110.072 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.443 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . 58.8 m -105.58 141.24 37.38 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.911 -0.774 . . . . 1.25 108.911 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 22' ' ' SER . 0.9 OUTLIER -91.65 125.65 36.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.183 0.516 . . . . 0.71999999999999997 109.803 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.62 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 4.4 m -120.03 138.6 53.42 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.934 0.873 . . . . 0.16 110.728 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.441 ' O ' HG13 ' A' ' 18' ' ' ILE . . . -136.25 173.66 11.46 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.119 -1.401 . . . . 0.98999999999999999 107.455 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.746 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 52.1 m95 -87.45 141.81 32.65 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-O 121.443 0.64 . . . . 0.52000000000000002 111.996 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' ASN . 16.8 Cg_endo -57.56 -21.15 44.95 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 125.179 3.919 . . . . 0.34000000000000002 117.565 -176.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.746 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.16 -35.91 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.65 0.981 . . . . 0.32000000000000001 113.65 -177.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.629 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -155.28 31.83 0.38 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.401 -0.592 . . . . 1.8999999999999999 109.401 -177.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.408 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 119.051 -0.5 . . . . 1.3200000000000001 110.121 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.835 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 94.8 m . . . . . 0 CA--C 1.511 -0.52 0 N-CA-C 109.027 -0.731 . . . . 0.98999999999999999 109.027 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -48.67 79.33 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.747 0.308 . . . . 2.6600000000000001 110.745 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 131.76 -28.34 3.56 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.626 -0.797 . . . . 0.33000000000000002 112.857 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.17 -121.33 0.64 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.923 -0.656 . . . . 0.40000000000000002 112.699 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -148.79 173.14 13.58 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.58 -0.365 . . . . 0.94999999999999996 110.844 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' SG ' ' A' ' 3' ' ' CYS . 86.8 m -93.53 143.16 26.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.974 -0.557 . . . . 1.1699999999999999 111.027 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.655 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 37.3 m-70 -144.44 122.12 11.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.605 -0.725 . . . . 0.26000000000000001 109.401 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.473 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 2.7 t80 -69.14 136.61 52.43 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 120.268 -0.573 . . . . 0.59999999999999998 109.863 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.42 -45.71 1.27 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.028 -0.606 . . . . 0.28000000000000003 112.037 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.74 -134.89 3.12 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.987 -0.845 . . . . 0.17000000000000001 110.987 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.4 m -148.05 142.77 16.85 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 120.572 0.225 . . . . 0.19 110.933 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 16' ' ' HIS . 51.8 Cg_exo -50.6 132.91 37.19 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.659 1.572 . . . . 0.28000000000000003 109.804 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 p -36.16 -26.82 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.598 0.592 . . . . 1.9199999999999999 112.598 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -78.85 -45.51 20.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.085 0.469 . . . . 0.51000000000000001 111.526 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 14' ' ' PRO . 32.8 mt -74.29 143.2 45.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.341 1.067 . . . . 1.03 113.861 -177.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.447 HD11 ' CB ' ' A' ' 31' ' ' ALA . 1.9 pp -95.96 138.72 20.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.182 -1.826 . . . . 1.0700000000000001 110.504 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -72.43 100.38 2.68 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.178 -0.465 . . . . 1.49 110.84 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.489 ' CG1' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -74.2 -36.41 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.169 -0.308 . . . . 1.0600000000000001 110.169 179.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.39 -161.3 28.64 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.062 -0.589 . . . . 0.20999999999999999 112.178 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.55 138.91 34.25 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.494 0.318 . . . . 1.3700000000000001 110.721 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 98.5 m . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.498 -0.319 . . . . 1.1599999999999999 110.857 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.473 ' HG2' ' HB2' ' A' ' 10' ' ' PHE . 68.7 mtm180 . . . . . 0 CA--C 1.509 -0.611 0 N-CA-C 113.34 0.867 . . . . 0.78000000000000003 113.34 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 m -105.43 140.81 37.98 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.669 -1.15 . . . . 1.25 110.506 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -92.88 125.75 37.63 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.557 -0.905 . . . . 0.71999999999999997 108.557 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.655 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 4.3 m -118.27 137.38 53.09 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.804 0.811 . . . . 0.16 111.291 -177.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.489 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . . . -133.98 171.92 13.54 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.398 -1.274 . . . . 0.98999999999999999 108.014 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.711 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 37.1 m95 -88.74 139.31 29.43 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-O 121.446 0.641 . . . . 0.52000000000000002 112.073 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.602 ' O ' ' N ' ' A' ' 35' ' ' ASN . 12.3 Cg_endo -54.54 -20.95 22.55 Favored 'Trans proline' 0 N--CA 1.486 1.086 1 C-N-CA 125.339 4.026 . . . . 0.34000000000000002 117.663 -177.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.711 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.16 -34.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.614 0.968 . . . . 0.32000000000000001 113.614 -177.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.638 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -158.23 37.76 0.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.848 -0.797 . . . . 1.8999999999999999 108.848 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.416 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.081 -0.962 . . . . 1.3200000000000001 110.191 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.632 ' O ' ' N ' ' A' ' 5' ' ' GLY . 63.5 m . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 108.429 -0.952 . . . . 0.98999999999999999 108.429 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.442 ' CB ' ' HZ1' ' A' ' 4' ' ' LYS . 9.5 mtpm? -41.86 80.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 2.6600000000000001 111.961 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 136.83 -37.81 1.82 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.713 -0.676 . . . . 0.33000000000000002 112.511 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.6 -119.63 0.66 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.383 -0.437 . . . . 0.40000000000000002 112.017 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.4 m -143.81 169.48 17.69 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.342 -0.505 . . . . 0.94999999999999996 110.769 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -95.07 134.37 37.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.421 0.629 . . . . 1.1699999999999999 111.059 -178.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.7 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 42.4 m-70 -130.47 134.83 47.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.987 -1.006 . . . . 0.26000000000000001 109.582 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.51 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -77.14 141.42 40.16 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.847 -0.341 . . . . 0.59999999999999998 110.757 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.66 -42.78 2.52 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.122 -0.561 . . . . 0.28000000000000003 112.784 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.97 -137.92 3.21 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.484 -0.865 . . . . 0.17000000000000001 112.169 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.6 m -153.62 141.98 14.15 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.363 -0.236 . . . . 0.19 110.363 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 17' ' ' LEU . 32.4 Cg_exo -50.33 131.75 32.6 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.259 1.306 . . . . 0.28000000000000003 109.602 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -36.3 -32.28 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.26 0.35 . . . . 1.9199999999999999 111.503 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.47 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -65.68 -48.31 72.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.445 0.64 . . . . 0.51000000000000001 110.618 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' PRO . 32.7 mt -74.27 153.28 39.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.993 1.109 . . . . 1.03 113.993 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.437 HG12 ' CB ' ' A' ' 36' ' ' ALA . 1.7 pp -108.95 138.73 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 113.037 -1.892 . . . . 1.0700000000000001 110.166 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -71.38 96.6 1.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.977 0.418 . . . . 1.49 111.23 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.515 ' CG1' ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -74.46 -33.84 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.32 0.581 . . . . 1.0600000000000001 110.411 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.34 -160.95 26.69 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.176 -0.769 . . . . 0.20999999999999999 111.176 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.4 p -91.64 -172.41 3.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.013 0.407 . . . . 1.3700000000000001 110.229 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.629 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 41.4 t . . . . . 0 C--N 1.32 -0.692 0 N-CA-C 109.415 -0.587 . . . . 1.1599999999999999 109.415 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.629 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 81.8 mtm180 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.05 0.453 . . . . 0.78000000000000003 111.694 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.51 138.11 40.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.458 -0.792 . . . . 1.25 109.06 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.423 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -91.36 125.34 36.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.016 -0.735 . . . . 0.71999999999999997 109.016 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.7 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 3.6 m -114.05 139.04 49.6 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.392 -0.822 . . . . 0.16 111.429 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -133.72 172.04 13.32 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.215 -1.357 . . . . 0.98999999999999999 107.734 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.733 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 39.0 m95 -89.15 139.18 28.7 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-O 121.581 0.705 . . . . 0.52000000000000002 112.049 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.9 Cg_endo -56.77 -15.98 18.26 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 125.231 3.954 . . . . 0.34000000000000002 117.413 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.733 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -28.84 -34.23 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 119.301 0.955 . . . . 0.32000000000000001 112.787 -177.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -157.52 35.61 0.27 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.941 -0.763 . . . . 1.8999999999999999 108.941 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.437 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.571 -0.728 . . . . 1.3200000000000001 110.233 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.613 ' O ' ' N ' ' A' ' 5' ' ' GLY . 64.5 m . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 108.807 -0.812 . . . . 0.98999999999999999 108.807 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -41.79 81.09 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.385 0.428 . . . . 2.6600000000000001 111.954 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 133.7 -35.08 2.31 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.004 -0.617 . . . . 0.33000000000000002 113.151 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.436 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -158.57 -135.35 1.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.834 -0.698 . . . . 0.40000000000000002 112.413 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 30' ' ' CYS . 20.3 m -124.92 159.6 30.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.007 0.432 . . . . 0.94999999999999996 111.592 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -96.11 138.46 33.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.816 -0.629 . . . . 1.1699999999999999 110.12 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.564 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 40.4 m-70 -135.82 138.8 42.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.765 -0.652 . . . . 0.26000000000000001 109.463 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.542 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 1.4 t80 -72.18 133.25 45.03 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.621 -0.432 . . . . 0.59999999999999998 111.329 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.49 -45.36 1.4 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.119 -0.562 . . . . 0.28000000000000003 113.679 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.65 -134.91 2.0 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.577 -0.82 . . . . 0.17000000000000001 112.1 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.9 m -149.77 139.62 13.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.741 0.305 . . . . 0.19 111.756 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 16' ' ' HIS . 52.6 Cg_exo -47.85 131.45 20.69 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.664 1.576 . . . . 0.28000000000000003 109.565 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m -36.97 -26.71 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.398 0.436 . . . . 1.9199999999999999 111.572 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -77.43 -48.86 16.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.049 0.452 . . . . 0.51000000000000001 111.177 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.85 144.5 45.44 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.558 0.947 . . . . 1.03 113.558 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.8 pp -95.86 136.37 27.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 113.393 -1.73 . . . . 1.0700000000000001 110.151 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.419 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 20.7 tptm -68.38 103.06 1.53 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.391 -0.368 . . . . 1.49 110.07 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -80.31 -33.87 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.986 0.422 . . . . 1.0600000000000001 110.326 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.05 -156.01 21.68 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.595 -0.729 . . . . 0.20999999999999999 111.52 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 p -92.81 170.25 9.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.935 0.368 . . . . 1.3700000000000001 110.632 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.549 ' HB3' ' C ' ' A' ' 27' ' ' ARG . 48.9 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 116.122 -0.49 . . . . 1.1599999999999999 109.892 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.549 ' C ' ' HB3' ' A' ' 23' ' ' CYS . 89.9 mtm180 . . . . . 0 CA--C 1.514 -0.436 0 CA-C-O 120.947 0.403 . . . . 0.78000000000000003 111.915 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.419 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 16.3 m -101.09 139.05 37.31 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.365 -0.834 . . . . 1.25 109.534 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.417 ' HB3' HG22 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -92.85 126.01 37.73 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.511 -0.551 . . . . 0.71999999999999997 109.511 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 3.4 m -120.64 146.26 46.57 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.788 0.804 . . . . 0.16 111.368 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -135.54 173.48 11.67 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.206 -1.361 . . . . 0.98999999999999999 107.679 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.702 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 35.8 m95 -88.27 138.17 30.62 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-O 121.696 0.76 . . . . 0.52000000000000002 112.389 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.61 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 28.2 Cg_endo -59.89 -12.78 19.8 Favored 'Trans proline' 0 N--CA 1.485 0.978 0 C-N-CA 125.101 3.867 . . . . 0.34000000000000002 116.935 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TRP . . . . . 0.702 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -27.92 -36.58 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 119.085 0.857 . . . . 0.32000000000000001 112.794 -177.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.563 ' ND2' ' CE3' ' A' ' 34' ' ' TRP . 12.8 p30 -159.09 29.38 0.21 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.684 0.754 . . . . 1.8999999999999999 109.667 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.785 -1.098 . . . . 1.3200000000000001 110.064 -179.831 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.411 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 1.1 tm? . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 109.953 -0.388 . . . . 2.23 109.953 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 22.3 t80 -76.25 162.91 27.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.052 0.453 . . . . 0.62 110.446 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.62 ' O ' ' N ' ' A' ' 5' ' ' GLY . 70.7 m -142.02 140.11 32.55 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.182 -0.673 . . . . 0.98999999999999999 109.182 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -42.82 80.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.582 0.551 . . . . 2.6600000000000001 111.789 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.62 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 132.46 -35.11 2.39 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 121.002 -0.618 . . . . 0.33000000000000002 113.022 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.402 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.34 -121.96 0.82 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.025 -0.607 . . . . 0.40000000000000002 112.497 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 m -141.56 162.19 36.08 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.479 -0.424 . . . . 0.94999999999999996 110.788 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.5 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -95.42 144.57 25.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.744 -0.662 . . . . 1.1699999999999999 110.847 -178.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.503 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.4 m-70 -142.09 128.7 20.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.49 -0.777 . . . . 0.26000000000000001 109.64 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 26' ' ' PHE . 1.6 t80 -66.23 126.41 28.62 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.841 -0.429 . . . . 0.59999999999999998 109.841 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.44 -51.73 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.829 -0.7 . . . . 0.28000000000000003 112.826 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.62 -128.9 1.2 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.809 -0.71 . . . . 0.17000000000000001 111.994 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.1 m -148.8 136.72 11.3 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.81 0.338 . . . . 0.19 111.737 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.19 133.7 42.24 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.71 1.606 . . . . 0.28000000000000003 109.182 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 p -36.56 -36.29 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.822 0.344 . . . . 1.9199999999999999 111.665 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -63.58 -48.3 77.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.158 -0.473 . . . . 0.51000000000000001 111.487 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.1 mt -74.47 177.3 6.07 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.144 1.165 . . . . 1.03 114.144 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 31' ' ' ALA . 1.6 pp -131.61 136.18 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 113.183 -1.826 . . . . 1.0700000000000001 109.237 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -66.9 102.42 0.96 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.776 0.322 . . . . 1.49 110.353 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.542 ' CG1' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.55 -33.47 15.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 1.0600000000000001 110.023 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.22 -163.4 34.18 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.55 -0.75 . . . . 0.20999999999999999 111.36 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.38 148.63 24.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.869 0.334 . . . . 1.3700000000000001 110.178 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.67 ' SG ' ' N ' ' A' ' 24' ' ' PHE . 28.9 t -96.9 -166.83 1.46 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 1.1599999999999999 108.847 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.67 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 8.1 t80 -61.23 107.39 0.75 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.423 -0.954 . . . . 1.1100000000000001 108.423 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.07 -136.67 30.89 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.879 -1.055 . . . . 1.75 113.638 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -56.39 -12.65 1.76 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.038 1.125 . . . . 1.1200000000000001 114.038 -178.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.6 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 80.9 mtm180 -75.75 159.85 30.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.184 0.516 . . . . 0.78000000000000003 112.337 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -111.12 137.17 49.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.186 -0.916 . . . . 1.25 109.679 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.13 126.57 38.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.695 -0.483 . . . . 0.71999999999999997 109.695 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.503 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 7.6 m -120.85 140.89 51.14 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.918 0.866 . . . . 0.16 111.942 -177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.542 ' HB1' ' CG1' ' A' ' 20' ' ' VAL . . . -129.5 173.53 10.48 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.123 -1.399 . . . . 0.98999999999999999 108.287 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.705 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 31.3 m95 -84.95 140.41 37.3 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-O 121.477 0.656 . . . . 0.52000000000000002 112.056 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.597 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 19.7 Cg_endo -58.35 -15.78 25.78 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 125.107 3.872 . . . . 0.34000000000000002 117.521 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.705 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -29.79 -33.41 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 119.228 0.922 . . . . 0.32000000000000001 113.176 -177.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.628 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -157.62 40.82 0.29 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.929 -0.767 . . . . 1.8999999999999999 108.929 -177.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.493 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.002 -0.999 . . . . 1.3200000000000001 110.649 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.442 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 37.5 tp . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.506 -0.183 . . . . 2.23 110.506 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 28.5 t80 -76.2 164.13 26.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.665 -0.865 . . . . 0.62 108.665 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.66 ' O ' ' N ' ' A' ' 5' ' ' GLY . 62.4 m -143.9 137.74 28.06 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.339 -0.986 . . . . 0.98999999999999999 108.339 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.554 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 8.0 mtpm? -43.24 79.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 2.6600000000000001 111.278 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.66 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 138.47 -37.6 1.78 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.984 -0.627 . . . . 0.33000000000000002 112.509 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.7 -118.48 0.58 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.35 -0.453 . . . . 0.40000000000000002 112.108 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.0 m -149.4 165.04 33.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.127 0.489 . . . . 0.94999999999999996 111.098 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.454 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -96.69 140.54 31.13 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.499 -0.773 . . . . 1.1699999999999999 110.81 -178.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.427 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 27.4 m-70 -135.36 134.33 39.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.36 -0.837 . . . . 0.26000000000000001 108.865 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.527 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -69.11 123.91 22.36 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.804 -0.358 . . . . 0.59999999999999998 110.555 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.05 -48.88 0.9 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.127 -0.558 . . . . 0.28000000000000003 112.823 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.23 -128.29 1.18 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 121.096 -0.573 . . . . 0.17000000000000001 111.932 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.5 m -148.24 141.82 15.84 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.592 0.234 . . . . 0.19 111.53 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' O ' ' N ' ' A' ' 17' ' ' LEU . 25.1 Cg_exo -55.84 132.27 51.02 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.543 1.496 . . . . 0.28000000000000003 108.979 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -36.22 -33.26 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 O-C-N 123.188 0.305 . . . . 1.9199999999999999 111.758 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.422 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -66.07 -48.32 71.37 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.561 -0.456 . . . . 0.51000000000000001 110.901 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.407 ' N ' ' O ' ' A' ' 14' ' ' PRO . 22.5 mt -71.61 179.65 2.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.751 1.389 . . . . 1.03 114.751 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 31' ' ' ALA . 1.4 pp -135.48 136.6 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 113.14 -1.846 . . . . 1.0700000000000001 109.093 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -65.75 102.06 0.71 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.784 0.326 . . . . 1.49 110.6 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.54 ' CG1' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.9 -34.09 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.206 0.527 . . . . 1.0600000000000001 109.867 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.99 -169.69 42.85 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.188 -0.765 . . . . 0.20999999999999999 111.188 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.5 p -84.94 153.0 23.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.13 0.465 . . . . 1.3700000000000001 111.078 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.573 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 44.6 t -98.0 -162.68 0.97 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.655 -0.702 . . . . 1.1599999999999999 109.912 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.488 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 52.9 t80 -82.23 134.48 35.29 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.354 0.597 . . . . 1.1100000000000001 111.684 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.16 -43.16 0.65 Allowed Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 116.324 1.289 . . . . 1.75 116.324 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.695 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -178.9 -16.65 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 117.762 0.781 . . . . 1.1200000000000001 112.786 -176.217 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.573 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 86.5 mtm180 -66.18 161.71 21.42 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.626 -0.261 . . . . 0.78000000000000003 110.901 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.3 m -103.1 138.14 40.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.078 -0.712 . . . . 1.25 109.078 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.409 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -92.32 126.72 37.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.863 -0.421 . . . . 0.71999999999999997 109.863 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.427 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 5.8 m -122.77 140.84 52.47 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.009 0.909 . . . . 0.16 112.737 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.54 ' HB1' ' CG1' ' A' ' 20' ' ' VAL . . . -127.97 173.12 10.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.064 -1.425 . . . . 0.98999999999999999 107.881 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.705 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 36.6 m95 -86.87 140.58 33.1 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-O 121.439 0.637 . . . . 0.52000000000000002 111.81 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.562 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 30.9 Cg_endo -61.32 -13.21 27.41 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 125.131 3.887 . . . . 0.34000000000000002 117.259 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.705 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -29.38 -34.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 119.13 0.877 . . . . 0.32000000000000001 112.399 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.606 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.4 OUTLIER -156.58 38.67 0.33 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.774 -0.825 . . . . 1.8999999999999999 108.774 -178.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.412 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.554 -0.748 . . . . 1.3200000000000001 109.88 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.423 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.5 tm? . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 109.438 -0.579 . . . . 2.23 109.438 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.425 ' CD2' ' N ' ' A' ' 3' ' ' CYS . 27.1 t80 -84.98 161.48 19.76 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.425 0.631 . . . . 0.62 111.254 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.601 ' O ' ' N ' ' A' ' 5' ' ' GLY . 46.5 m -146.68 137.62 24.08 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.197 -1.038 . . . . 0.98999999999999999 108.197 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -35.02 81.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.557 0.535 . . . . 2.6600000000000001 112.44 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 135.54 -44.44 1.17 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.043 -0.598 . . . . 0.33000000000000002 113.233 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.432 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.27 -140.49 3.05 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.703 -0.76 . . . . 0.40000000000000002 112.624 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 30' ' ' CYS . 4.8 m -116.42 160.71 20.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.065 0.459 . . . . 0.94999999999999996 111.675 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -95.11 149.47 21.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.599 -0.728 . . . . 1.1699999999999999 110.273 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.516 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 25.9 m-70 -144.59 133.5 22.56 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.627 -0.715 . . . . 0.26000000000000001 109.608 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.533 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 2.1 t80 -70.74 131.37 43.76 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 116.311 -0.404 . . . . 0.59999999999999998 110.398 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.09 -48.68 0.93 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.257 -0.497 . . . . 0.28000000000000003 112.686 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.87 -133.64 1.75 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.794 -0.717 . . . . 0.17000000000000001 111.983 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 88.3 m -152.4 139.9 12.94 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.643 0.259 . . . . 0.19 111.41 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' HIS . 51.1 Cg_exo -48.46 133.27 25.63 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.561 1.507 . . . . 0.28000000000000003 109.553 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.4 m -36.02 -33.02 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 O-C-N 123.367 0.417 . . . . 1.9199999999999999 111.54 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.478 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -71.96 -48.84 42.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.316 -0.402 . . . . 0.51000000000000001 111.737 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.459 HD22 ' NE1' ' A' ' 32' ' ' TRP . 24.9 mt -73.0 143.03 47.74 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.055 1.131 . . . . 1.03 114.055 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.413 HD11 ' O ' ' A' ' 18' ' ' ILE . 1.8 pp -95.55 137.0 24.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 113.047 -1.888 . . . . 1.0700000000000001 110.396 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 21' ' ' GLY . 24.4 tptm -67.82 100.65 0.96 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.333 -0.394 . . . . 1.49 110.089 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.513 ' CG1' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.49 -33.4 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 1.0600000000000001 110.942 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.404 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . 173.24 -155.79 23.21 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.774 -0.727 . . . . 0.20999999999999999 111.879 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.18 146.26 23.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.231 0.539 . . . . 1.3700000000000001 111.696 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.658 ' SG ' ' N ' ' A' ' 24' ' ' PHE . 43.1 t -101.25 -165.21 1.18 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.465 -0.789 . . . . 1.1599999999999999 109.412 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.658 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 36.8 t80 -57.55 107.65 0.47 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.629 -0.878 . . . . 1.1100000000000001 108.629 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.8 -137.44 39.02 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 115.034 -0.985 . . . . 1.75 113.313 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -56.39 -13.28 2.12 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.476 0.917 . . . . 1.1200000000000001 113.476 -179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.619 HH21 ' HB3' ' A' ' 24' ' ' PHE . 75.0 mtm180 -69.32 159.01 33.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.276 0.56 . . . . 0.78000000000000003 112.444 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -110.33 138.7 46.36 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.036 -0.984 . . . . 1.25 109.576 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -92.53 125.6 37.24 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.111 -0.7 . . . . 0.71999999999999997 109.111 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.516 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 3.3 m -119.59 146.67 45.31 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.745 0.783 . . . . 0.16 110.955 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.513 ' HB1' ' CG1' ' A' ' 20' ' ' VAL . . . -138.85 173.5 11.51 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.244 -1.344 . . . . 0.98999999999999999 107.681 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.705 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 33.7 m95 -88.98 138.47 29.2 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-O 121.505 0.669 . . . . 0.52000000000000002 112.54 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.623 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 17.8 Cg_endo -57.36 -16.95 24.77 Favored 'Trans proline' 0 N--CA 1.487 1.114 1 C-N-CA 125.357 4.038 . . . . 0.34000000000000002 117.011 -177.649 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.705 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -27.27 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.435 0.902 . . . . 0.32000000000000001 113.435 -177.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.565 ' N ' ' O ' ' A' ' 33' ' ' PRO . 15.1 p30 -159.28 29.35 0.2 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.915 0.865 . . . . 1.8999999999999999 109.735 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.411 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--N 1.313 -1.022 0 CA-C-N 114.68 -1.145 . . . . 1.3200000000000001 110.209 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 31.7 tp . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.62 0.248 . . . . 2.23 110.685 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.625 ' CE1' ' O ' ' A' ' 3' ' ' CYS . 27.9 t80 -76.73 165.18 25.09 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.247 0.546 . . . . 0.62 109.865 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.638 ' O ' ' N ' ' A' ' 5' ' ' GLY . 40.7 t -144.08 145.24 32.03 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.975 -1.12 . . . . 0.98999999999999999 107.975 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -45.58 81.58 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.21 0.529 . . . . 2.6600000000000001 111.23 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.638 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 127.18 -32.65 3.53 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.563 -0.744 . . . . 0.33000000000000002 112.772 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.481 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -153.25 -114.03 0.54 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.917 -0.659 . . . . 0.40000000000000002 113.05 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 30' ' ' CYS . 19.2 m -150.31 171.35 17.12 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.484 -0.421 . . . . 0.94999999999999996 111.589 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.1 m -95.59 144.01 26.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 1.1699999999999999 111.45 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.54 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 50.7 m-70 -150.5 123.13 8.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.852 -0.613 . . . . 0.26000000000000001 109.656 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.621 ' CE1' ' HB2' ' A' ' 26' ' ' PHE . 2.0 t80 -67.32 127.92 34.48 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.71 -0.396 . . . . 0.59999999999999998 110.152 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.14 -55.83 0.49 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.189 -0.529 . . . . 0.28000000000000003 113.113 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.88 -129.66 1.11 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.547 -0.835 . . . . 0.17000000000000001 112.497 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 93.6 m -151.14 143.91 16.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.723 0.297 . . . . 0.19 111.549 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -56.66 134.06 61.98 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.789 1.659 . . . . 0.28000000000000003 109.526 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.6 p -36.11 -33.88 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.396 0.435 . . . . 1.9199999999999999 111.473 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.49 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -67.64 -47.29 70.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.028 -0.533 . . . . 0.51000000000000001 111.511 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.84 -176.64 2.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.699 1.0 . . . . 1.03 113.699 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 31' ' ' ALA . 1.4 pp -138.62 135.22 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 113.793 -1.549 . . . . 1.0700000000000001 108.662 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 21.0 tptm -64.87 95.29 0.15 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.416 -0.356 . . . . 1.49 110.842 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.542 HG23 ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -71.88 -31.5 41.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.142 0.496 . . . . 1.0600000000000001 109.769 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.75 -149.88 14.77 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.544 -0.753 . . . . 0.20999999999999999 111.323 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.1 p -109.4 143.76 38.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.781 0.324 . . . . 1.3700000000000001 110.132 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.738 ' SG ' ' HA ' ' A' ' 29' ' ' CYS . 84.3 m -97.42 -163.62 1.06 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.217 -0.447 . . . . 1.1599999999999999 110.155 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.541 ' HB3' HH21 ' A' ' 27' ' ' ARG . 14.3 t80 -53.27 105.2 0.12 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.727 0.775 . . . . 1.1100000000000001 109.195 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.28 -138.33 29.11 Favored Glycine 0 N--CA 1.432 -1.594 0 CA-C-N 114.227 -1.351 . . . . 1.75 114.41 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -55.9 -17.67 7.06 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.062 1.345 . . . . 1.1200000000000001 114.481 -178.124 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.541 HH21 ' HB3' ' A' ' 24' ' ' PHE . 76.9 mtm180 -73.1 153.92 40.6 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.096 0.776 . . . . 0.78000000000000003 113.096 -177.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.484 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 27.7 m -102.84 140.04 37.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.857 -1.065 . . . . 1.25 110.695 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.738 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -93.3 125.04 37.69 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.236 -1.024 . . . . 0.71999999999999997 108.236 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.54 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 13.2 m -121.72 138.26 54.42 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.789 0.804 . . . . 0.16 111.705 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.558 ' O ' HG13 ' A' ' 18' ' ' ILE . . . -129.9 174.66 9.54 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.276 -1.329 . . . . 0.98999999999999999 108.381 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.734 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 45.4 m95 -87.25 142.11 33.24 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-O 121.412 0.625 . . . . 0.52000000000000002 111.413 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.8 Cg_endo -58.38 -23.61 64.31 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 125.004 3.802 . . . . 0.34000000000000002 117.413 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.734 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -21.9 -37.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.264 1.209 . . . . 0.32000000000000001 114.264 -177.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -155.04 20.58 0.44 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.936 0.398 . . . . 1.8999999999999999 110.64 -177.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.517 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.39 -0.815 . . . . 1.3200000000000001 111.059 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.712 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.2 tm? . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.94 -0.392 . . . . 2.23 109.94 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 14.9 t80 -83.57 157.08 22.45 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.054 -0.658 . . . . 0.62 110.574 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.667 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 45.8 m -143.74 140.41 29.96 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.24 -1.022 . . . . 0.98999999999999999 108.24 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.418 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 6.9 mtpm? -40.66 80.58 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.422 0.451 . . . . 2.6600000000000001 111.765 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.641 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 136.78 -38.0 1.8 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.179 -0.534 . . . . 0.33000000000000002 112.931 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.79 -121.89 0.67 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.363 -0.446 . . . . 0.40000000000000002 112.071 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.0 m -145.41 163.55 34.27 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.488 -0.419 . . . . 0.94999999999999996 110.143 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.712 ' SG ' ' HB3' ' A' ' 1' ' ' LEU . 0.5 OUTLIER -95.82 138.27 33.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.307 0.575 . . . . 1.1699999999999999 111.61 -177.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.619 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.5 m-70 -127.56 135.09 49.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.181 -0.918 . . . . 0.26000000000000001 109.198 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.477 ' CB ' ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -71.45 134.81 46.85 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.863 -0.421 . . . . 0.59999999999999998 109.863 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.39 -42.09 1.98 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.89 -0.671 . . . . 0.28000000000000003 112.411 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.86 -129.53 1.72 Allowed Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.699 -0.763 . . . . 0.17000000000000001 112.313 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.7 m -151.86 140.6 13.67 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.534 0.207 . . . . 0.19 111.335 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 16' ' ' HIS . 36.8 Cg_exo -52.64 134.61 53.93 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.573 1.515 . . . . 0.28000000000000003 109.548 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -35.61 -33.59 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.113 0.482 . . . . 1.9199999999999999 111.774 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -69.14 -49.16 59.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.74 -0.664 . . . . 0.51000000000000001 111.62 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 30.7 mt -75.04 147.53 40.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.312 1.227 . . . . 1.03 114.312 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.462 ' CD1' ' HB1' ' A' ' 31' ' ' ALA . 1.6 pp -98.25 138.39 23.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 112.876 -1.966 . . . . 1.0700000000000001 110.133 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 21' ' ' GLY . 21.2 tptm -72.45 105.4 4.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.531 -0.304 . . . . 1.49 110.259 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.505 ' CG1' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -83.74 -32.77 9.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.128 0.489 . . . . 1.0600000000000001 110.115 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.462 ' O ' ' CE ' ' A' ' 19' ' ' LYS . . . 175.83 -156.76 22.34 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 111.077 -0.809 . . . . 0.20999999999999999 111.077 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 18.4 t -95.58 -170.61 2.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.258 0.529 . . . . 1.3700000000000001 109.953 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.644 ' SG ' ' HG ' ' A' ' 1' ' ' LEU . 51.2 t -143.76 -165.42 2.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.664 0.268 . . . . 1.1599999999999999 110.932 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.549 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 25.2 t80 -65.99 130.44 43.25 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.731 0.777 . . . . 1.1100000000000001 112.5 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.57 -42.8 0.44 Allowed Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 113.776 -1.556 . . . . 1.75 115.997 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER 179.08 -10.97 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.466 0.633 . . . . 1.1200000000000001 112.371 -176.057 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' CYS . 85.9 mtm180 -65.63 158.99 25.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.838 0.352 . . . . 0.78000000000000003 111.574 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.42 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 9.7 m -100.97 138.52 37.9 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.657 -0.702 . . . . 1.25 109.429 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.447 ' HB3' HG21 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -91.47 126.12 36.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.145 0.498 . . . . 0.71999999999999997 109.795 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.619 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 4.5 m -117.75 143.76 45.94 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.893 0.854 . . . . 0.16 111.183 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB1' ' CG1' ' A' ' 20' ' ' VAL . . . -134.81 173.16 12.01 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.049 -1.432 . . . . 0.98999999999999999 107.236 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.744 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 42.6 m95 -89.31 140.56 28.65 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-O 121.577 0.703 . . . . 0.52000000000000002 112.157 -178.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 35' ' ' ASN . 29.8 Cg_endo -60.44 -16.75 43.77 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 125.078 3.852 . . . . 0.34000000000000002 116.781 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.744 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.4 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.605 0.965 . . . . 0.32000000000000001 113.605 -177.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.595 ' ND2' ' CE3' ' A' ' 34' ' ' TRP . 12.1 p30 -158.59 20.59 0.22 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.167 0.508 . . . . 1.8999999999999999 110.482 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--N 1.316 -0.869 0 CA-C-O 118.435 -0.793 . . . . 1.3200000000000001 110.827 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 110.362 -0.236 . . . . 2.23 110.362 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 29.0 t80 -82.5 166.46 19.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.386 -0.598 . . . . 0.62 109.386 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 5' ' ' GLY . 92.5 m -145.63 136.92 24.92 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.489 -0.93 . . . . 0.98999999999999999 108.489 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -40.91 83.29 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.533 0.52 . . . . 2.6600000000000001 111.449 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.604 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 131.44 -41.59 1.49 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.647 -0.706 . . . . 0.33000000000000002 112.357 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . -149.4 -126.01 1.43 Allowed Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.957 -0.457 . . . . 0.40000000000000002 111.957 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 m -135.24 167.09 21.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.129 0.49 . . . . 0.94999999999999996 110.899 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.59 ' SG ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -95.84 134.2 39.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.76 -0.655 . . . . 1.1699999999999999 110.407 -179.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.609 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 38.0 m-70 -130.6 135.35 47.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.36 -0.836 . . . . 0.26000000000000001 109.461 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.476 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -74.54 135.47 42.15 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.738 -0.385 . . . . 0.59999999999999998 110.203 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.36 -43.99 1.59 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.016 -0.612 . . . . 0.28000000000000003 112.896 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.93 -129.8 1.59 Allowed Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.728 -0.748 . . . . 0.17000000000000001 111.989 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.2 m -152.35 144.47 16.64 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.493 0.187 . . . . 0.19 111.037 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 16' ' ' HIS . 29.1 Cg_exo -55.63 134.08 61.84 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.557 1.504 . . . . 0.28000000000000003 109.235 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.5 m -34.76 -32.67 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.277 0.473 . . . . 1.9199999999999999 112.277 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -69.51 -48.92 59.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.958 0.409 . . . . 0.51000000000000001 111.58 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 37.8 mt -73.47 149.22 42.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.623 1.342 . . . . 1.03 114.623 -176.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.463 ' CD1' ' HB3' ' A' ' 36' ' ' ALA . 2.0 pp -99.91 138.56 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 112.94 -1.937 . . . . 1.0700000000000001 110.257 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.428 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 22.2 tptm -69.97 97.09 1.1 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.442 -0.344 . . . . 1.49 110.599 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -73.81 -31.12 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.016 0.436 . . . . 1.0600000000000001 110.297 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.71 -151.19 16.49 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.941 -0.647 . . . . 0.20999999999999999 111.912 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.5 p -96.68 178.11 5.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.71 0.291 . . . . 1.3700000000000001 110.986 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.622 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 43.7 t -135.12 -163.87 1.44 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.226 -0.443 . . . . 1.1599999999999999 109.844 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.607 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 11.7 t80 -72.79 135.73 45.31 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.648 0.737 . . . . 1.1100000000000001 112.326 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.86 -46.05 0.42 Allowed Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 113.66 -1.609 . . . . 1.75 115.925 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.691 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -180.0 -5.56 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 117.038 0.419 . . . . 1.1200000000000001 111.727 -176.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.622 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 80.4 mtm180 -66.96 159.86 27.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.055 0.455 . . . . 0.78000000000000003 111.569 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.428 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 50.8 m -102.54 138.85 38.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.272 -0.876 . . . . 1.25 109.144 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.453 ' HB3' HG21 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -91.97 126.21 36.97 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.357 -0.608 . . . . 0.71999999999999997 109.357 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.609 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 5.1 m -118.58 139.34 51.63 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.917 0.865 . . . . 0.16 111.47 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.501 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -135.04 173.17 12.03 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.963 -1.471 . . . . 0.98999999999999999 107.331 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.729 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 45.6 m95 -86.34 139.58 34.08 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-O 121.485 0.66 . . . . 0.52000000000000002 112.076 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 35' ' ' ASN . 10.3 Cg_endo -54.04 -25.81 38.38 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 125.204 3.936 . . . . 0.34000000000000002 117.448 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.729 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -23.14 -38.16 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.012 1.116 . . . . 0.32000000000000001 114.012 -177.037 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.615 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.3 OUTLIER -158.54 40.75 0.25 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.621 -0.511 . . . . 1.8999999999999999 109.621 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.463 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.18 -0.914 . . . . 1.3200000000000001 110.825 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 36.5 tp . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.112 -0.329 . . . . 2.23 110.112 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 34.9 t80 -79.94 162.82 24.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.46 0.647 . . . . 0.62 110.197 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 5' ' ' GLY . 76.8 m -150.18 137.69 19.8 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.745 -1.205 . . . . 0.98999999999999999 107.745 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -34.02 78.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.927 0.714 . . . . 2.6600000000000001 112.927 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.64 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 134.55 -43.29 1.27 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.712 -0.756 . . . . 0.33000000000000002 113.394 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.56 -136.71 2.51 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.662 -0.78 . . . . 0.40000000000000002 112.772 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -116.26 162.23 17.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.243 0.544 . . . . 0.94999999999999996 111.344 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -96.08 139.09 32.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.631 -0.713 . . . . 1.1699999999999999 109.888 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.62 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 27.1 m-70 -134.02 132.77 40.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.26000000000000001 109.81 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.518 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -73.01 132.94 44.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.303 -0.408 . . . . 0.59999999999999998 110.226 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.02 -48.16 0.98 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.129 -0.558 . . . . 0.28000000000000003 112.631 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.4 -139.74 4.02 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 111.423 -0.671 . . . . 0.17000000000000001 111.423 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.4 m -147.13 137.41 12.35 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.675 0.238 . . . . 0.19 111.158 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 17' ' ' LEU . 32.8 Cg_exo -52.54 133.22 48.57 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.833 1.689 . . . . 0.28000000000000003 109.602 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.5 t -35.91 -34.19 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.328 0.393 . . . . 1.9199999999999999 111.779 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.476 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -62.55 -48.62 78.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.235 0.54 . . . . 0.51000000000000001 110.386 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 14' ' ' PRO . 37.1 mt -77.32 155.32 32.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.637 1.208 . . . . 1.03 114.088 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 33' ' ' PRO . 1.8 pp -108.42 134.21 51.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 112.704 -2.043 . . . . 1.0700000000000001 110.005 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' HE3' ' HB3' ' A' ' 28' ' ' SER . 22.4 tptm -68.71 93.47 0.53 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.809 0.337 . . . . 1.49 110.211 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.412 ' CG1' ' HB1' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -71.46 -28.67 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.41 0.624 . . . . 1.0600000000000001 109.863 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.31 -156.55 27.76 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.611 -0.996 . . . . 0.20999999999999999 110.611 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.47 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 14.1 t -94.47 -179.94 5.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 117.213 0.506 . . . . 1.3700000000000001 109.692 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.621 ' SG ' ' N ' ' A' ' 24' ' ' PHE . 42.4 t -123.87 -164.86 1.28 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.197 -0.456 . . . . 1.1599999999999999 110.355 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.621 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 34.4 t80 -73.58 133.1 43.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.613 0.72 . . . . 1.1100000000000001 111.718 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.12 -43.48 0.53 Allowed Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.157 -1.383 . . . . 1.75 115.841 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER 179.45 -13.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.734 0.767 . . . . 1.1200000000000001 112.684 -176.389 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.599 ' C ' ' HB3' ' A' ' 23' ' ' CYS . 79.8 mtm180 -64.8 166.29 9.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.072 -0.344 . . . . 0.78000000000000003 110.072 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.443 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . 58.8 m -105.58 141.24 37.38 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.911 -0.774 . . . . 1.25 108.911 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 22' ' ' SER . 0.9 OUTLIER -91.65 125.65 36.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.183 0.516 . . . . 0.71999999999999997 109.803 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.62 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 4.4 m -120.03 138.6 53.42 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.934 0.873 . . . . 0.16 110.728 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.441 ' O ' HG13 ' A' ' 18' ' ' ILE . . . -136.25 173.66 11.46 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.119 -1.401 . . . . 0.98999999999999999 107.455 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.746 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 52.1 m95 -87.45 141.81 32.65 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-O 121.443 0.64 . . . . 0.52000000000000002 111.996 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' ASN . 16.8 Cg_endo -57.56 -21.15 44.95 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 125.179 3.919 . . . . 0.34000000000000002 117.565 -176.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.746 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.16 -35.91 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.65 0.981 . . . . 0.32000000000000001 113.65 -177.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.629 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -155.28 31.83 0.38 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.401 -0.592 . . . . 1.8999999999999999 109.401 -177.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.408 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 119.051 -0.5 . . . . 1.3200000000000001 110.121 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.495 HD23 ' SG ' ' A' ' 8' ' ' CYS . 19.4 tp . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 110.088 -0.338 . . . . 2.23 110.088 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.502 ' CE1' ' O ' ' A' ' 3' ' ' CYS . 19.3 t80 -87.23 160.58 18.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.887 -0.412 . . . . 0.62 109.887 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.835 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 94.8 m -136.64 144.19 43.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.027 -0.731 . . . . 0.98999999999999999 109.027 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -48.67 79.33 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.747 0.308 . . . . 2.6600000000000001 110.745 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 131.76 -28.34 3.56 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.626 -0.797 . . . . 0.33000000000000002 112.857 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.17 -121.33 0.64 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.923 -0.656 . . . . 0.40000000000000002 112.699 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -148.79 173.14 13.58 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.58 -0.365 . . . . 0.94999999999999996 110.844 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' SG ' ' A' ' 3' ' ' CYS . 86.8 m -93.53 143.16 26.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.974 -0.557 . . . . 1.1699999999999999 111.027 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.655 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 37.3 m-70 -144.44 122.12 11.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.605 -0.725 . . . . 0.26000000000000001 109.401 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 26' ' ' PHE . 2.7 t80 -69.14 136.61 52.43 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 120.268 -0.573 . . . . 0.59999999999999998 109.863 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.42 -45.71 1.27 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.028 -0.606 . . . . 0.28000000000000003 112.037 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.74 -134.89 3.12 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.987 -0.845 . . . . 0.17000000000000001 110.987 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.4 m -148.05 142.77 16.85 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 120.572 0.225 . . . . 0.19 110.933 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 16' ' ' HIS . 51.8 Cg_exo -50.6 132.91 37.19 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.659 1.572 . . . . 0.28000000000000003 109.804 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 p -36.16 -26.82 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.598 0.592 . . . . 1.9199999999999999 112.598 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -78.85 -45.51 20.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.085 0.469 . . . . 0.51000000000000001 111.526 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' A' ' 14' ' ' PRO . 32.8 mt -74.29 143.2 45.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.341 1.067 . . . . 1.03 113.861 -177.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.447 HD11 ' CB ' ' A' ' 31' ' ' ALA . 1.9 pp -95.96 138.72 20.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.182 -1.826 . . . . 1.0700000000000001 110.504 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -72.43 100.38 2.68 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.178 -0.465 . . . . 1.49 110.84 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.489 ' CG1' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -74.2 -36.41 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.169 -0.308 . . . . 1.0600000000000001 110.169 179.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.39 -161.3 28.64 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.062 -0.589 . . . . 0.20999999999999999 112.178 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.55 138.91 34.25 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.494 0.318 . . . . 1.3700000000000001 110.721 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 98.5 m -97.97 -164.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.498 -0.319 . . . . 1.1599999999999999 110.857 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -52.89 109.24 0.39 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.743 0.782 . . . . 1.1100000000000001 109.342 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.63 -134.6 44.44 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.265 -1.334 . . . . 1.75 113.861 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -60.89 -8.39 3.09 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 114.4 1.259 . . . . 1.1200000000000001 114.4 -178.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.475 ' N ' ' HD1' ' A' ' 26' ' ' PHE . 68.7 mtm180 -78.51 153.0 31.7 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.34 0.867 . . . . 0.78000000000000003 113.34 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 m -105.43 140.81 37.98 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.669 -1.15 . . . . 1.25 110.506 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -92.88 125.75 37.63 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.557 -0.905 . . . . 0.71999999999999997 108.557 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.655 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 4.3 m -118.27 137.38 53.09 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.804 0.811 . . . . 0.16 111.291 -177.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.489 ' HB2' ' CG1' ' A' ' 20' ' ' VAL . . . -133.98 171.92 13.54 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.398 -1.274 . . . . 0.98999999999999999 108.014 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.711 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 37.1 m95 -88.74 139.31 29.43 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-O 121.446 0.641 . . . . 0.52000000000000002 112.073 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.602 ' O ' ' N ' ' A' ' 35' ' ' ASN . 12.3 Cg_endo -54.54 -20.95 22.55 Favored 'Trans proline' 0 N--CA 1.486 1.086 1 C-N-CA 125.339 4.026 . . . . 0.34000000000000002 117.663 -177.519 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.711 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.16 -34.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.614 0.968 . . . . 0.32000000000000001 113.614 -177.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.638 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -158.23 37.76 0.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.848 -0.797 . . . . 1.8999999999999999 108.848 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.416 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.081 -0.962 . . . . 1.3200000000000001 110.191 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 22.9 tp . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.684 0.278 . . . . 2.23 110.927 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 28.1 t80 -85.04 165.16 17.76 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.148 -0.686 . . . . 0.62 109.148 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.632 ' O ' ' N ' ' A' ' 5' ' ' GLY . 63.5 m -144.78 138.11 26.91 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.429 -0.952 . . . . 0.98999999999999999 108.429 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.442 ' CB ' ' HZ1' ' A' ' 4' ' ' LYS . 9.5 mtpm? -41.86 80.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 2.6600000000000001 111.961 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.632 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 136.83 -37.81 1.82 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.713 -0.676 . . . . 0.33000000000000002 112.511 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.6 -119.63 0.66 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.383 -0.437 . . . . 0.40000000000000002 112.017 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.4 m -143.81 169.48 17.69 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.342 -0.505 . . . . 0.94999999999999996 110.769 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -95.07 134.37 37.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.421 0.629 . . . . 1.1699999999999999 111.059 -178.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.7 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 42.4 m-70 -130.47 134.83 47.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.987 -1.006 . . . . 0.26000000000000001 109.582 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.51 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -77.14 141.42 40.16 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.847 -0.341 . . . . 0.59999999999999998 110.757 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.66 -42.78 2.52 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.122 -0.561 . . . . 0.28000000000000003 112.784 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.97 -137.92 3.21 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.484 -0.865 . . . . 0.17000000000000001 112.169 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.6 m -153.62 141.98 14.15 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.363 -0.236 . . . . 0.19 110.363 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.456 ' O ' ' N ' ' A' ' 17' ' ' LEU . 32.4 Cg_exo -50.33 131.75 32.6 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.259 1.306 . . . . 0.28000000000000003 109.602 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -36.3 -32.28 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.26 0.35 . . . . 1.9199999999999999 111.503 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.47 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -65.68 -48.31 72.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.445 0.64 . . . . 0.51000000000000001 110.618 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 14' ' ' PRO . 32.7 mt -74.27 153.28 39.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.993 1.109 . . . . 1.03 113.993 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.437 HG12 ' CB ' ' A' ' 36' ' ' ALA . 1.7 pp -108.95 138.73 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 113.037 -1.892 . . . . 1.0700000000000001 110.166 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -71.38 96.6 1.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.977 0.418 . . . . 1.49 111.23 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.515 ' CG1' ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -74.46 -33.84 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.32 0.581 . . . . 1.0600000000000001 110.411 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.34 -160.95 26.69 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.176 -0.769 . . . . 0.20999999999999999 111.176 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.4 p -91.64 -172.41 3.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.013 0.407 . . . . 1.3700000000000001 110.229 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.629 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 41.4 t -140.04 -164.68 1.75 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.415 -0.587 . . . . 1.1599999999999999 109.415 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.621 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 18.7 t80 -72.57 134.83 45.38 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.649 0.738 . . . . 1.1100000000000001 112.067 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.47 -46.26 0.51 Allowed Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 113.843 -1.526 . . . . 1.75 115.698 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.706 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -179.29 -6.58 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 117.194 0.497 . . . . 1.1200000000000001 112.015 -176.286 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.629 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 81.8 mtm180 -66.35 159.58 26.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.05 0.453 . . . . 0.78000000000000003 111.694 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.51 138.11 40.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.458 -0.792 . . . . 1.25 109.06 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.423 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -91.36 125.34 36.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.016 -0.735 . . . . 0.71999999999999997 109.016 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.7 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 3.6 m -114.05 139.04 49.6 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.392 -0.822 . . . . 0.16 111.429 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.515 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -133.72 172.04 13.32 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.215 -1.357 . . . . 0.98999999999999999 107.734 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.733 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 39.0 m95 -89.15 139.18 28.7 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-O 121.581 0.705 . . . . 0.52000000000000002 112.049 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.9 Cg_endo -56.77 -15.98 18.26 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 125.231 3.954 . . . . 0.34000000000000002 117.413 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.733 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -28.84 -34.23 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 119.301 0.955 . . . . 0.32000000000000001 112.787 -177.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.618 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -157.52 35.61 0.27 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.941 -0.763 . . . . 1.8999999999999999 108.941 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.437 ' CB ' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.571 -0.728 . . . . 1.3200000000000001 110.233 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.406 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 109.794 -0.447 . . . . 2.23 109.794 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 22.8 t80 -77.67 162.31 27.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.156 0.503 . . . . 0.62 110.503 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.613 ' O ' ' N ' ' A' ' 5' ' ' GLY . 64.5 m -142.25 140.22 32.2 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.807 -0.812 . . . . 0.98999999999999999 108.807 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -41.79 81.09 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.385 0.428 . . . . 2.6600000000000001 111.954 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.613 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . 133.7 -35.08 2.31 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.004 -0.617 . . . . 0.33000000000000002 113.151 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.436 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -158.57 -135.35 1.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.834 -0.698 . . . . 0.40000000000000002 112.413 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.415 ' O ' ' HB2' ' A' ' 30' ' ' CYS . 20.3 m -124.92 159.6 30.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.007 0.432 . . . . 0.94999999999999996 111.592 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -96.11 138.46 33.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.816 -0.629 . . . . 1.1699999999999999 110.12 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.564 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 40.4 m-70 -135.82 138.8 42.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.765 -0.652 . . . . 0.26000000000000001 109.463 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.542 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 1.4 t80 -72.18 133.25 45.03 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.621 -0.432 . . . . 0.59999999999999998 111.329 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.49 -45.36 1.4 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.119 -0.562 . . . . 0.28000000000000003 113.679 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.65 -134.91 2.0 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.577 -0.82 . . . . 0.17000000000000001 112.1 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.9 m -149.77 139.62 13.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.741 0.305 . . . . 0.19 111.756 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 16' ' ' HIS . 52.6 Cg_exo -47.85 131.45 20.69 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.664 1.576 . . . . 0.28000000000000003 109.565 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m -36.97 -26.71 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.398 0.436 . . . . 1.9199999999999999 111.572 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -77.43 -48.86 16.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.049 0.452 . . . . 0.51000000000000001 111.177 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.85 144.5 45.44 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.558 0.947 . . . . 1.03 113.558 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.8 pp -95.86 136.37 27.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 113.393 -1.73 . . . . 1.0700000000000001 110.151 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.419 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 20.7 tptm -68.38 103.06 1.53 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.391 -0.368 . . . . 1.49 110.07 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -80.31 -33.87 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.986 0.422 . . . . 1.0600000000000001 110.326 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.05 -156.01 21.68 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.595 -0.729 . . . . 0.20999999999999999 111.52 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 p -92.81 170.25 9.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.935 0.368 . . . . 1.3700000000000001 110.632 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.549 ' HB3' ' C ' ' A' ' 27' ' ' ARG . 48.9 t -121.54 -164.49 1.14 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.122 -0.49 . . . . 1.1599999999999999 109.892 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.542 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 44.1 t80 -77.54 136.59 38.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.61 0.719 . . . . 1.1100000000000001 112.03 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' C ' ' CG ' ' A' ' 26' ' ' PHE . . . 71.61 -45.56 0.84 Allowed Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.036 -1.438 . . . . 1.75 115.876 177.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.763 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER 179.54 -12.35 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.285 0.542 . . . . 1.1200000000000001 112.02 -175.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.549 ' C ' ' HB3' ' A' ' 23' ' ' CYS . 89.9 mtm180 -66.52 161.59 22.62 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.158 -0.474 . . . . 0.78000000000000003 111.915 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.419 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 16.3 m -101.09 139.05 37.31 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.365 -0.834 . . . . 1.25 109.534 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.417 ' HB3' HG22 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -92.85 126.01 37.73 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.511 -0.551 . . . . 0.71999999999999997 109.511 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.564 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 3.4 m -120.64 146.26 46.57 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.788 0.804 . . . . 0.16 111.368 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.533 ' HB3' ' CG1' ' A' ' 20' ' ' VAL . . . -135.54 173.48 11.67 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.206 -1.361 . . . . 0.98999999999999999 107.679 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.702 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 35.8 m95 -88.27 138.17 30.62 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-O 121.696 0.76 . . . . 0.52000000000000002 112.389 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.61 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 28.2 Cg_endo -59.89 -12.78 19.8 Favored 'Trans proline' 0 N--CA 1.485 0.978 0 C-N-CA 125.101 3.867 . . . . 0.34000000000000002 116.935 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . 0.702 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -27.92 -36.58 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 119.085 0.857 . . . . 0.32000000000000001 112.794 -177.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.563 ' ND2' ' CE3' ' A' ' 34' ' ' TRP . 12.8 p30 -159.09 29.38 0.21 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.684 0.754 . . . . 1.8999999999999999 109.667 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.785 -1.098 . . . . 1.3200000000000001 110.064 -179.831 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.62 ' O ' ' N ' ' A' ' 5' ' ' GLY . 70.7 m . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.182 -0.673 . . . . 0.99 109.182 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -42.82 80.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.582 0.551 . . . . 2.2 111.789 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.674 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 132.46 -35.11 2.39 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 121.002 -0.618 . . . . 0.33 113.022 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.34 -121.96 0.82 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.025 -0.607 . . . . 0.4 112.497 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 m -141.56 162.19 36.08 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.479 -0.424 . . . . 0.74 110.788 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.5 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -95.42 144.57 25.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.744 -0.662 . . . . 1.04 110.847 -178.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -142.09 128.7 20.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.49 -0.777 . . . . 0.17 109.64 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.503 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 1.6 t80 -66.23 126.41 28.62 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.841 -0.429 . . . . 0.49 109.841 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.44 -51.73 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.829 -0.7 . . . . 0.28 112.826 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.62 -128.9 1.2 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.809 -0.71 . . . . 0.17 111.994 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.1 m -148.8 136.72 11.3 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.81 0.338 . . . . 0.19 111.737 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.19 133.7 42.24 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.71 1.606 . . . . 0.22 109.182 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 p -36.56 -36.29 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.822 0.344 . . . . 1.4 111.665 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.413 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -63.58 -48.3 77.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.158 -0.473 . . . . 0.41 111.487 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.1 mt -74.47 177.3 6.07 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.144 1.165 . . . . 0.56 114.144 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.96 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.6 pp -131.61 136.18 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 113.183 -1.826 . . . . 0.14 109.237 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -66.9 102.42 0.96 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.776 0.322 . . . . 0.77 110.353 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.55 -33.47 15.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.21 110.023 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.22 -163.4 34.18 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.55 -0.75 . . . . 0.2 111.36 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.38 148.63 24.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.869 0.334 . . . . 1.01 110.178 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.605 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 28.9 t . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 1.16 108.847 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.605 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 80.9 mtm180 . . . . . 0 CA--C 1.515 -0.389 0 CA-C-O 121.184 0.516 . . . . 0.64 112.337 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -111.12 137.17 49.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.186 -0.916 . . . . 0.68 109.679 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.13 126.57 38.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.695 -0.483 . . . . 0.72 109.695 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 7.6 m -120.85 140.89 51.14 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.918 0.866 . . . . 0.16 111.942 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -129.5 173.53 10.48 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.123 -1.399 . . . . 0.12 108.287 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.762 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 31.3 m95 -84.95 140.41 37.3 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-O 121.477 0.656 . . . . 0.43 112.056 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.605 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 19.7 Cg_endo -58.35 -15.78 25.78 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 125.107 3.872 . . . . 0.27 117.521 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.762 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -29.79 -33.41 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 119.228 0.922 . . . . 0.32 113.176 -177.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.66 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -157.62 40.82 0.29 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.929 -0.767 . . . . 1.9 108.929 -177.859 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.96 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.002 -0.999 . . . . 1.32 110.649 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.66 ' O ' ' N ' ' A' ' 5' ' ' GLY . 62.4 m . . . . . 0 CA--C 1.512 -0.494 0 N-CA-C 108.339 -0.986 . . . . 0.99 108.339 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 8.0 mtpm? -43.24 79.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 2.2 111.278 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.698 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 138.47 -37.6 1.78 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.984 -0.627 . . . . 0.33 112.509 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.7 -118.48 0.58 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.35 -0.453 . . . . 0.4 112.108 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.0 m -149.4 165.04 33.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.127 0.489 . . . . 0.74 111.098 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -96.69 140.54 31.13 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.499 -0.773 . . . . 1.04 110.81 -178.642 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -135.36 134.33 39.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.36 -0.837 . . . . 0.17 108.865 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.557 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -69.11 123.91 22.36 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.804 -0.358 . . . . 0.49 110.555 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.05 -48.88 0.9 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.127 -0.558 . . . . 0.28 112.823 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.23 -128.29 1.18 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 121.096 -0.573 . . . . 0.17 111.932 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.5 m -148.24 141.82 15.84 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.592 0.234 . . . . 0.19 111.53 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 17' ' ' LEU . 25.1 Cg_exo -55.84 132.27 51.02 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.543 1.496 . . . . 0.22 108.979 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -36.22 -33.26 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 O-C-N 123.188 0.305 . . . . 1.4 111.758 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.449 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -66.07 -48.32 71.37 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.561 -0.456 . . . . 0.41 110.901 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' PRO . 22.5 mt -71.61 179.65 2.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.751 1.389 . . . . 0.56 114.751 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.82 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.4 pp -135.48 136.6 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 113.14 -1.846 . . . . 0.14 109.093 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -65.75 102.06 0.71 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.784 0.326 . . . . 0.77 110.6 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.9 -34.09 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.206 0.527 . . . . 0.21 109.867 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.99 -169.69 42.85 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.188 -0.765 . . . . 0.2 111.188 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.5 p -84.94 153.0 23.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.13 0.465 . . . . 1.01 111.078 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.601 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 44.6 t . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.655 -0.702 . . . . 1.16 109.912 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 86.5 mtm180 . . . . . 0 CA--C 1.515 -0.395 0 CA-C-O 120.642 0.258 . . . . 0.64 110.901 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 71.3 m -103.1 138.14 40.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.078 -0.712 . . . . 0.68 109.078 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -92.32 126.72 37.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.863 -0.421 . . . . 0.72 109.863 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.8 m -122.77 140.84 52.47 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.009 0.909 . . . . 0.16 112.737 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.78 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -127.97 173.12 10.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.064 -1.425 . . . . 0.12 107.881 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.763 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 36.6 m95 -86.87 140.58 33.1 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-O 121.439 0.637 . . . . 0.43 111.81 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.576 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 30.9 Cg_endo -61.32 -13.21 27.41 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 125.131 3.887 . . . . 0.27 117.259 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.763 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -29.38 -34.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 119.13 0.877 . . . . 0.32 112.399 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.64 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.4 OUTLIER -156.58 38.67 0.33 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.774 -0.825 . . . . 1.9 108.774 -178.214 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.82 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.554 -0.748 . . . . 1.32 109.88 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.601 ' O ' ' N ' ' A' ' 5' ' ' GLY . 46.5 m . . . . . 0 N--CA 1.445 -0.689 0 N-CA-C 108.197 -1.038 . . . . 0.99 108.197 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -35.02 81.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.557 0.535 . . . . 2.2 112.44 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.815 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 135.54 -44.44 1.17 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.043 -0.598 . . . . 0.33 113.233 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.27 -140.49 3.05 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.703 -0.76 . . . . 0.4 112.624 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 30' ' ' CYS . 4.8 m -116.42 160.71 20.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.065 0.459 . . . . 0.74 111.675 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -95.11 149.47 21.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.599 -0.728 . . . . 1.04 110.273 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -144.59 133.5 22.56 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.627 -0.715 . . . . 0.17 109.608 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.56 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 2.1 t80 -70.74 131.37 43.76 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 116.311 -0.404 . . . . 0.49 110.398 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.09 -48.68 0.93 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.257 -0.497 . . . . 0.28 112.686 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.87 -133.64 1.75 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.794 -0.717 . . . . 0.17 111.983 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 88.3 m -152.4 139.9 12.94 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.643 0.259 . . . . 0.19 111.41 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' HIS . 51.1 Cg_exo -48.46 133.27 25.63 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.561 1.507 . . . . 0.22 109.553 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.4 m -36.02 -33.02 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 O-C-N 123.367 0.417 . . . . 1.4 111.54 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.505 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -71.96 -48.84 42.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.316 -0.402 . . . . 0.41 111.737 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.47 HD21 ' NE1' ' A' ' 32' ' ' TRP . 24.9 mt -73.0 143.03 47.74 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.055 1.131 . . . . 0.56 114.055 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.792 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.8 pp -95.55 137.0 24.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 113.047 -1.888 . . . . 0.14 110.396 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 21' ' ' GLY . 24.4 tptm -67.82 100.65 0.96 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.333 -0.394 . . . . 0.77 110.089 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.49 -33.4 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.21 110.942 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.435 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . 173.24 -155.79 23.21 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.774 -0.727 . . . . 0.2 111.879 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.18 146.26 23.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.231 0.539 . . . . 1.01 111.696 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.578 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 43.1 t . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.465 -0.789 . . . . 1.16 109.412 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.578 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 75.0 mtm180 . . . . . 0 CA--C 1.513 -0.468 0 CA-C-O 121.276 0.56 . . . . 0.64 112.444 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -110.33 138.7 46.36 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.036 -0.984 . . . . 0.68 109.576 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -92.53 125.6 37.24 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.111 -0.7 . . . . 0.72 109.111 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 7' ' ' SER . 3.3 m -119.59 146.67 45.31 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.745 0.783 . . . . 0.16 110.955 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.815 ' HB1' ' HA3' ' A' ' 5' ' ' GLY . . . -138.85 173.5 11.51 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.244 -1.344 . . . . 0.12 107.681 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.759 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 33.7 m95 -88.98 138.47 29.2 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-O 121.505 0.669 . . . . 0.43 112.54 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.632 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 17.8 Cg_endo -57.36 -16.95 24.77 Favored 'Trans proline' 0 N--CA 1.487 1.114 1 C-N-CA 125.357 4.038 . . . . 0.27 117.011 -177.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.759 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -27.27 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.435 0.902 . . . . 0.32 113.435 -177.373 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.578 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 1.1 p-10 -159.28 29.35 0.2 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.915 0.865 . . . . 1.9 109.735 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.783 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--N 1.313 -1.022 0 CA-C-N 114.68 -1.145 . . . . 1.32 110.209 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.638 ' O ' ' N ' ' A' ' 5' ' ' GLY . 40.7 t . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 107.975 -1.12 . . . . 0.99 107.975 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -45.58 81.58 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.21 0.529 . . . . 2.2 111.23 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.669 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 127.18 -32.65 3.53 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.563 -0.744 . . . . 0.33 112.772 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.505 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -153.25 -114.03 0.54 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.917 -0.659 . . . . 0.4 113.05 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 30' ' ' CYS . 19.2 m -150.31 171.35 17.12 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.484 -0.421 . . . . 0.74 111.589 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.1 m -95.59 144.01 26.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 1.04 111.45 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -150.5 123.13 8.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.852 -0.613 . . . . 0.17 109.656 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.545 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 2.0 t80 -67.32 127.92 34.48 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.71 -0.396 . . . . 0.49 110.152 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.14 -55.83 0.49 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.189 -0.529 . . . . 0.28 113.113 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.88 -129.66 1.11 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.547 -0.835 . . . . 0.17 112.497 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 93.6 m -151.14 143.91 16.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.723 0.297 . . . . 0.19 111.549 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -56.66 134.06 61.98 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.789 1.659 . . . . 0.22 109.526 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.6 p -36.11 -33.88 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.396 0.435 . . . . 1.4 111.473 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.506 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -67.64 -47.29 70.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.028 -0.533 . . . . 0.41 111.511 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.84 -176.64 2.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.699 1.0 . . . . 0.56 113.699 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.78 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.4 pp -138.62 135.22 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 113.793 -1.549 . . . . 0.14 108.662 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 21.0 tptm -64.87 95.29 0.15 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.416 -0.356 . . . . 0.77 110.842 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.634 HG21 ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -71.88 -31.5 41.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.142 0.496 . . . . 0.21 109.769 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.75 -149.88 14.77 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.544 -0.753 . . . . 0.2 111.323 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.1 p -109.4 143.76 38.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.781 0.324 . . . . 1.01 110.132 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.741 ' SG ' ' HA ' ' A' ' 29' ' ' CYS . 84.3 m . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 116.217 -0.447 . . . . 1.16 110.155 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HG2' ' HB2' ' A' ' 10' ' ' PHE . 76.9 mtm180 . . . . . 0 CA--C 1.511 -0.535 0 N-CA-C 113.096 0.776 . . . . 0.64 113.096 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.483 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 27.7 m -102.84 140.04 37.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.857 -1.065 . . . . 0.68 110.695 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.741 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -93.3 125.04 37.69 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.236 -1.024 . . . . 0.72 108.236 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 7' ' ' SER . 13.2 m -121.72 138.26 54.42 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.789 0.804 . . . . 0.16 111.705 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.78 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -129.9 174.66 9.54 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.276 -1.329 . . . . 0.12 108.381 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.796 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 45.4 m95 -87.25 142.11 33.24 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-O 121.412 0.625 . . . . 0.43 111.413 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.8 Cg_endo -58.38 -23.61 64.31 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 125.004 3.802 . . . . 0.27 117.413 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.796 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -21.9 -37.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.264 1.209 . . . . 0.32 114.264 -177.166 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -155.04 20.58 0.44 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.936 0.398 . . . . 1.9 110.64 -177.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.772 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.39 -0.815 . . . . 1.32 111.059 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 45.8 m . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 108.24 -1.022 . . . . 0.99 108.24 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 6.9 mtpm? -40.66 80.58 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.422 0.451 . . . . 2.2 111.765 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.663 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 136.78 -38.0 1.8 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.179 -0.534 . . . . 0.33 112.931 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.79 -121.89 0.67 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.363 -0.446 . . . . 0.4 112.071 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.0 m -145.41 163.55 34.27 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.488 -0.419 . . . . 0.74 110.143 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.686 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -95.82 138.27 33.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.307 0.575 . . . . 1.04 111.61 -177.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -127.56 135.09 49.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.181 -0.918 . . . . 0.17 109.198 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.498 ' CB ' ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -71.45 134.81 46.85 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.863 -0.421 . . . . 0.49 109.863 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.39 -42.09 1.98 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.89 -0.671 . . . . 0.28 112.411 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.86 -129.53 1.72 Allowed Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.699 -0.763 . . . . 0.17 112.313 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.7 m -151.86 140.6 13.67 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.534 0.207 . . . . 0.19 111.335 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 16' ' ' HIS . 36.8 Cg_exo -52.64 134.61 53.93 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.573 1.515 . . . . 0.22 109.548 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -35.61 -33.59 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.113 0.482 . . . . 1.4 111.774 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.454 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -69.14 -49.16 59.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.74 -0.664 . . . . 0.41 111.62 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.476 HD21 ' CE2' ' A' ' 32' ' ' TRP . 30.7 mt -75.04 147.53 40.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.312 1.227 . . . . 0.56 114.312 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.876 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.6 pp -98.25 138.39 23.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 112.876 -1.966 . . . . 0.14 110.133 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 21' ' ' GLY . 21.2 tptm -72.45 105.4 4.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.531 -0.304 . . . . 0.77 110.259 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -83.74 -32.77 9.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.128 0.489 . . . . 0.21 110.115 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.462 ' O ' ' CE ' ' A' ' 19' ' ' LYS . . . 175.83 -156.76 22.34 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 111.077 -0.809 . . . . 0.2 111.077 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 18.4 t -95.58 -170.61 2.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.258 0.529 . . . . 1.01 109.953 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' ARG . 51.2 t . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 120.664 0.268 . . . . 1.16 110.932 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' CYS . 85.9 mtm180 . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 120.838 0.352 . . . . 0.64 111.574 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.414 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 9.7 m -100.97 138.52 37.9 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.657 -0.702 . . . . 0.68 109.429 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.546 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -91.47 126.12 36.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.145 0.498 . . . . 0.72 109.795 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.5 m -117.75 143.76 45.94 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.893 0.854 . . . . 0.16 111.183 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.833 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -134.81 173.16 12.01 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.049 -1.432 . . . . 0.12 107.236 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.806 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 42.6 m95 -89.31 140.56 28.65 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-O 121.577 0.703 . . . . 0.43 112.157 -178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 35' ' ' ASN . 29.8 Cg_endo -60.44 -16.75 43.77 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 125.078 3.852 . . . . 0.27 116.781 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.806 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.4 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.605 0.965 . . . . 0.32 113.605 -177.443 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.588 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -158.59 20.59 0.22 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.167 0.508 . . . . 1.9 110.482 -177.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.876 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--N 1.316 -0.869 0 CA-C-O 118.435 -0.793 . . . . 1.32 110.827 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 5' ' ' GLY . 92.5 m . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 108.489 -0.93 . . . . 0.99 108.489 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -40.91 83.29 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.533 0.52 . . . . 2.2 111.449 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.645 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 131.44 -41.59 1.49 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.647 -0.706 . . . . 0.33 112.357 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . -149.4 -126.01 1.43 Allowed Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.957 -0.457 . . . . 0.4 111.957 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 m -135.24 167.09 21.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.129 0.49 . . . . 0.74 110.899 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' SG ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -95.84 134.2 39.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.76 -0.655 . . . . 1.04 110.407 -179.192 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -130.6 135.35 47.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.36 -0.836 . . . . 0.17 109.461 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -74.54 135.47 42.15 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.738 -0.385 . . . . 0.49 110.203 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.36 -43.99 1.59 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.016 -0.612 . . . . 0.28 112.896 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.93 -129.8 1.59 Allowed Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.728 -0.748 . . . . 0.17 111.989 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.2 m -152.35 144.47 16.64 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.493 0.187 . . . . 0.19 111.037 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 16' ' ' HIS . 29.1 Cg_exo -55.63 134.08 61.84 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.557 1.504 . . . . 0.22 109.235 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.5 m -34.76 -32.67 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.277 0.473 . . . . 1.4 112.277 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -69.51 -48.92 59.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.958 0.409 . . . . 0.41 111.58 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.437 HD21 ' CE2' ' A' ' 32' ' ' TRP . 37.8 mt -73.47 149.22 42.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.623 1.342 . . . . 0.56 114.623 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.853 HG12 ' HB3' ' A' ' 36' ' ' ALA . 2.0 pp -99.91 138.56 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 112.94 -1.937 . . . . 0.14 110.257 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 22.2 tptm -69.97 97.09 1.1 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.442 -0.344 . . . . 0.77 110.599 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -73.81 -31.12 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.016 0.436 . . . . 0.21 110.297 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.71 -151.19 16.49 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.941 -0.647 . . . . 0.2 111.912 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.5 p -96.68 178.11 5.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.71 0.291 . . . . 1.01 110.986 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.626 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 43.7 t . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 116.226 -0.443 . . . . 1.16 109.844 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.626 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 80.4 mtm180 . . . . . 0 CA--C 1.514 -0.436 0 CA-C-O 121.055 0.455 . . . . 0.64 111.569 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.424 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 50.8 m -102.54 138.85 38.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.272 -0.876 . . . . 0.68 109.144 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.477 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -91.97 126.21 36.97 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.357 -0.608 . . . . 0.72 109.357 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.1 m -118.58 139.34 51.63 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.917 0.865 . . . . 0.16 111.47 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.803 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -135.04 173.17 12.03 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.963 -1.471 . . . . 0.12 107.331 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.792 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 45.6 m95 -86.34 139.58 34.08 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-O 121.485 0.66 . . . . 0.43 112.076 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 35' ' ' ASN . 10.3 Cg_endo -54.04 -25.81 38.38 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 125.204 3.936 . . . . 0.27 117.448 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.792 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -23.14 -38.16 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.012 1.116 . . . . 0.32 114.012 -177.037 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.647 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.3 OUTLIER -158.54 40.75 0.25 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.621 -0.511 . . . . 1.9 109.621 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.853 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.18 -0.914 . . . . 1.32 110.825 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 5' ' ' GLY . 76.8 m . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 107.745 -1.205 . . . . 0.99 107.745 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -34.02 78.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.927 0.714 . . . . 2.2 112.927 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.75 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 134.55 -43.29 1.27 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.712 -0.756 . . . . 0.33 113.394 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.56 -136.71 2.51 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.662 -0.78 . . . . 0.4 112.772 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -116.26 162.23 17.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.243 0.544 . . . . 0.74 111.344 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -96.08 139.09 32.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.631 -0.713 . . . . 1.04 109.888 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -134.02 132.77 40.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.17 109.81 -178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.54 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -73.01 132.94 44.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.303 -0.408 . . . . 0.49 110.226 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.02 -48.16 0.98 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.129 -0.558 . . . . 0.28 112.631 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.4 -139.74 4.02 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 111.423 -0.671 . . . . 0.17 111.423 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.4 m -147.13 137.41 12.35 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.675 0.238 . . . . 0.19 111.158 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 17' ' ' LEU . 32.8 Cg_exo -52.54 133.22 48.57 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.833 1.689 . . . . 0.22 109.602 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.5 t -35.91 -34.19 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.328 0.393 . . . . 1.4 111.779 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.494 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -62.55 -48.62 78.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.235 0.54 . . . . 0.41 110.386 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.432 HD21 ' CE2' ' A' ' 32' ' ' TRP . 37.1 mt -77.32 155.32 32.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.637 1.208 . . . . 0.56 114.088 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.891 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.8 pp -108.42 134.21 51.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 112.704 -2.043 . . . . 0.14 110.005 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 22.4 tptm -68.71 93.47 0.53 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.809 0.337 . . . . 0.77 110.211 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -71.46 -28.67 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.41 0.624 . . . . 0.21 109.863 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.31 -156.55 27.76 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.611 -0.996 . . . . 0.2 110.611 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.47 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 14.1 t -94.47 -179.94 5.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 117.213 0.506 . . . . 1.01 109.692 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.631 ' HB3' ' C ' ' A' ' 27' ' ' ARG . 42.4 t . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 116.197 -0.456 . . . . 1.16 110.355 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.631 ' C ' ' HB3' ' A' ' 23' ' ' CYS . 79.8 mtm180 . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 110.072 -0.344 . . . . 0.64 110.072 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.429 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 58.8 m -105.58 141.24 37.38 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.911 -0.774 . . . . 0.68 108.911 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 22' ' ' SER . 0.9 OUTLIER -91.65 125.65 36.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.183 0.516 . . . . 0.72 109.803 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.4 m -120.03 138.6 53.42 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.934 0.873 . . . . 0.16 110.728 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.75 ' HB1' ' HA3' ' A' ' 5' ' ' GLY . . . -136.25 173.66 11.46 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.119 -1.401 . . . . 0.12 107.455 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.817 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 52.1 m95 -87.45 141.81 32.65 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-O 121.443 0.64 . . . . 0.43 111.996 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' ASN . 16.8 Cg_endo -57.56 -21.15 44.95 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 125.179 3.919 . . . . 0.27 117.565 -176.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.817 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.16 -35.91 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.65 0.981 . . . . 0.32 113.65 -177.494 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.661 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -155.28 31.83 0.38 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.401 -0.592 . . . . 1.9 109.401 -177.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.891 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 119.051 -0.5 . . . . 1.32 110.121 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.835 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 94.8 m . . . . . 0 CA--C 1.511 -0.52 0 N-CA-C 109.027 -0.731 . . . . 0.99 109.027 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -48.67 79.33 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.747 0.308 . . . . 2.2 110.745 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.761 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 131.76 -28.34 3.56 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.626 -0.797 . . . . 0.33 112.857 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.17 -121.33 0.64 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.923 -0.656 . . . . 0.4 112.699 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -148.79 173.14 13.58 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.58 -0.365 . . . . 0.74 110.844 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' SG ' ' A' ' 3' ' ' CYS . 86.8 m -93.53 143.16 26.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.974 -0.557 . . . . 1.04 111.027 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -144.44 122.12 11.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.605 -0.725 . . . . 0.17 109.401 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.482 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 2.7 t80 -69.14 136.61 52.43 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 120.268 -0.573 . . . . 0.49 109.863 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.42 -45.71 1.27 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.028 -0.606 . . . . 0.28 112.037 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.74 -134.89 3.12 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.987 -0.845 . . . . 0.17 110.987 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.4 m -148.05 142.77 16.85 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 120.572 0.225 . . . . 0.19 110.933 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 16' ' ' HIS . 51.8 Cg_exo -50.6 132.91 37.19 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.659 1.572 . . . . 0.22 109.804 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 p -36.16 -26.82 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.598 0.592 . . . . 1.4 112.598 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -78.85 -45.51 20.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.085 0.469 . . . . 0.41 111.526 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.8 mt -74.29 143.2 45.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.341 1.067 . . . . 0.56 113.861 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.834 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.9 pp -95.96 138.72 20.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.182 -1.826 . . . . 0.14 110.504 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -72.43 100.38 2.68 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.178 -0.465 . . . . 0.77 110.84 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.809 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -74.2 -36.41 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.169 -0.308 . . . . 0.21 110.169 179.107 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.39 -161.3 28.64 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.062 -0.589 . . . . 0.2 112.178 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.55 138.91 34.25 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.494 0.318 . . . . 1.01 110.721 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 98.5 m . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.498 -0.319 . . . . 1.16 110.857 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 10' ' ' PHE . 68.7 mtm180 . . . . . 0 CA--C 1.509 -0.611 0 N-CA-C 113.34 0.867 . . . . 0.64 113.34 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 m -105.43 140.81 37.98 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.669 -1.15 . . . . 0.68 110.506 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -92.88 125.75 37.63 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.557 -0.905 . . . . 0.72 108.557 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.3 m -118.27 137.38 53.09 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.804 0.811 . . . . 0.16 111.291 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.834 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -133.98 171.92 13.54 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.398 -1.274 . . . . 0.12 108.014 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.768 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 37.1 m95 -88.74 139.31 29.43 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-O 121.446 0.641 . . . . 0.43 112.073 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.602 ' O ' ' N ' ' A' ' 35' ' ' ASN . 12.3 Cg_endo -54.54 -20.95 22.55 Favored 'Trans proline' 0 N--CA 1.486 1.086 1 C-N-CA 125.339 4.026 . . . . 0.27 117.663 -177.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.768 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.16 -34.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.614 0.968 . . . . 0.32 113.614 -177.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.671 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -158.23 37.76 0.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.848 -0.797 . . . . 1.9 108.848 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.803 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.081 -0.962 . . . . 1.32 110.191 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.632 ' O ' ' N ' ' A' ' 5' ' ' GLY . 63.5 m . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 108.429 -0.952 . . . . 0.99 108.429 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 9.5 mtpm? -41.86 80.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 2.2 111.961 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.706 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 136.83 -37.81 1.82 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.713 -0.676 . . . . 0.33 112.511 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.6 -119.63 0.66 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.383 -0.437 . . . . 0.4 112.017 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.4 m -143.81 169.48 17.69 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.342 -0.505 . . . . 0.74 110.769 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -95.07 134.37 37.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.421 0.629 . . . . 1.04 111.059 -178.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -130.47 134.83 47.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.987 -1.006 . . . . 0.17 109.582 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.526 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -77.14 141.42 40.16 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.847 -0.341 . . . . 0.49 110.757 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.66 -42.78 2.52 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.122 -0.561 . . . . 0.28 112.784 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.97 -137.92 3.21 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.484 -0.865 . . . . 0.17 112.169 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.6 m -153.62 141.98 14.15 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.363 -0.236 . . . . 0.19 110.363 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 17' ' ' LEU . 32.4 Cg_exo -50.33 131.75 32.6 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.259 1.306 . . . . 0.22 109.602 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -36.3 -32.28 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.26 0.35 . . . . 1.4 111.503 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.488 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -65.68 -48.31 72.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.445 0.64 . . . . 0.41 110.618 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 14' ' ' PRO . 32.7 mt -74.27 153.28 39.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.993 1.109 . . . . 0.56 113.993 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.831 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.7 pp -108.95 138.73 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 113.037 -1.892 . . . . 0.14 110.166 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -71.38 96.6 1.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.977 0.418 . . . . 0.77 111.23 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -74.46 -33.84 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.32 0.581 . . . . 0.21 110.411 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.34 -160.95 26.69 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.176 -0.769 . . . . 0.2 111.176 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.4 p -91.64 -172.41 3.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.013 0.407 . . . . 1.01 110.229 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.636 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 41.4 t . . . . . 0 C--N 1.32 -0.692 0 N-CA-C 109.415 -0.587 . . . . 1.16 109.415 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.636 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 81.8 mtm180 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.05 0.453 . . . . 0.64 111.694 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.51 138.11 40.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.458 -0.792 . . . . 0.68 109.06 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.562 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -91.36 125.34 36.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.016 -0.735 . . . . 0.72 109.016 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.05 139.04 49.6 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.392 -0.822 . . . . 0.16 111.429 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.817 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -133.72 172.04 13.32 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.215 -1.357 . . . . 0.12 107.734 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.797 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 39.0 m95 -89.15 139.18 28.7 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-O 121.581 0.705 . . . . 0.43 112.049 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.571 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 18.9 Cg_endo -56.77 -15.98 18.26 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 125.231 3.954 . . . . 0.27 117.413 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.797 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -28.84 -34.23 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 119.301 0.955 . . . . 0.32 112.787 -177.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.646 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -157.52 35.61 0.27 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.941 -0.763 . . . . 1.9 108.941 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.831 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.571 -0.728 . . . . 1.32 110.233 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.613 ' O ' ' N ' ' A' ' 5' ' ' GLY . 64.5 m . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 108.807 -0.812 . . . . 0.99 108.807 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -41.79 81.09 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.385 0.428 . . . . 2.2 111.954 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.705 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 133.7 -35.08 2.31 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.004 -0.617 . . . . 0.33 113.151 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.466 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -158.57 -135.35 1.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.834 -0.698 . . . . 0.4 112.413 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 30' ' ' CYS . 20.3 m -124.92 159.6 30.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.007 0.432 . . . . 0.74 111.592 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -96.11 138.46 33.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.816 -0.629 . . . . 1.04 110.12 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -135.82 138.8 42.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.765 -0.652 . . . . 0.17 109.463 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 1.4 t80 -72.18 133.25 45.03 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.621 -0.432 . . . . 0.49 111.329 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.49 -45.36 1.4 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.119 -0.562 . . . . 0.28 113.679 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.65 -134.91 2.0 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.577 -0.82 . . . . 0.17 112.1 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.9 m -149.77 139.62 13.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.741 0.305 . . . . 0.19 111.756 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 16' ' ' HIS . 52.6 Cg_exo -47.85 131.45 20.69 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.664 1.576 . . . . 0.22 109.565 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m -36.97 -26.71 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.398 0.436 . . . . 1.4 111.572 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -77.43 -48.86 16.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.049 0.452 . . . . 0.41 111.177 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.444 HD21 ' CE2' ' A' ' 32' ' ' TRP . 19.8 mt -73.85 144.5 45.44 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.558 0.947 . . . . 0.56 113.558 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.77 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.8 pp -95.86 136.37 27.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 113.393 -1.73 . . . . 0.14 110.151 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 20.7 tptm -68.38 103.06 1.53 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.391 -0.368 . . . . 0.77 110.07 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -80.31 -33.87 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.986 0.422 . . . . 0.21 110.326 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.05 -156.01 21.68 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.595 -0.729 . . . . 0.2 111.52 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 p -92.81 170.25 9.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.935 0.368 . . . . 1.01 110.632 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.579 ' HB3' ' C ' ' A' ' 27' ' ' ARG . 48.9 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 116.122 -0.49 . . . . 1.16 109.892 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.579 ' C ' ' HB3' ' A' ' 23' ' ' CYS . 89.9 mtm180 . . . . . 0 CA--C 1.514 -0.436 0 CA-C-O 120.947 0.403 . . . . 0.64 111.915 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.413 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 16.3 m -101.09 139.05 37.31 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.365 -0.834 . . . . 0.68 109.534 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.454 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -92.85 126.01 37.73 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.511 -0.551 . . . . 0.72 109.511 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 7' ' ' SER . 3.4 m -120.64 146.26 46.57 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.788 0.804 . . . . 0.16 111.368 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.77 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -135.54 173.48 11.67 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.206 -1.361 . . . . 0.12 107.679 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.76 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 35.8 m95 -88.27 138.17 30.62 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-O 121.696 0.76 . . . . 0.43 112.389 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.619 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 28.2 Cg_endo -59.89 -12.78 19.8 Favored 'Trans proline' 0 N--CA 1.485 0.978 0 C-N-CA 125.101 3.867 . . . . 0.27 116.935 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TRP . . . . . 0.76 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -27.92 -36.58 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 119.085 0.857 . . . . 0.32 112.794 -177.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.56 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 1.0 OUTLIER -159.09 29.38 0.21 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.684 0.754 . . . . 1.9 109.667 -178.178 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.656 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.785 -1.098 . . . . 1.32 110.064 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 2' ' ' PHE . 1.1 tm? . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 109.953 -0.388 . . . . 1.61 109.953 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 22.3 t80 -76.25 162.91 27.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.052 0.453 . . . . 0.56 110.446 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.62 ' O ' ' N ' ' A' ' 5' ' ' GLY . 70.7 m -142.02 140.11 32.55 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.182 -0.673 . . . . 0.99 109.182 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -42.82 80.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.582 0.551 . . . . 2.2 111.789 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.674 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 132.46 -35.11 2.39 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 121.002 -0.618 . . . . 0.33 113.022 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.34 -121.96 0.82 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.025 -0.607 . . . . 0.4 112.497 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 m -141.56 162.19 36.08 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.479 -0.424 . . . . 0.74 110.788 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.5 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -95.42 144.57 25.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.744 -0.662 . . . . 1.04 110.847 -178.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -142.09 128.7 20.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.49 -0.777 . . . . 0.17 109.64 -178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 26' ' ' PHE . 1.6 t80 -66.23 126.41 28.62 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.841 -0.429 . . . . 0.49 109.841 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.44 -51.73 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.829 -0.7 . . . . 0.28 112.826 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.62 -128.9 1.2 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.809 -0.71 . . . . 0.17 111.994 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.1 m -148.8 136.72 11.3 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.81 0.338 . . . . 0.19 111.737 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.19 133.7 42.24 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.71 1.606 . . . . 0.22 109.182 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 p -36.56 -36.29 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.822 0.344 . . . . 1.4 111.665 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.413 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -63.58 -48.3 77.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.158 -0.473 . . . . 0.41 111.487 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.1 mt -74.47 177.3 6.07 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.144 1.165 . . . . 0.56 114.144 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.96 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.6 pp -131.61 136.18 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 113.183 -1.826 . . . . 0.14 109.237 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -66.9 102.42 0.96 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.776 0.322 . . . . 0.77 110.353 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.55 -33.47 15.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.21 110.023 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.22 -163.4 34.18 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.55 -0.75 . . . . 0.2 111.36 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.38 148.63 24.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.869 0.334 . . . . 1.01 110.178 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.67 ' SG ' ' N ' ' A' ' 24' ' ' PHE . 28.9 t -96.9 -166.83 1.46 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 1.16 108.847 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.67 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 8.1 t80 -61.23 107.39 0.75 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.423 -0.954 . . . . 0.88 108.423 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.07 -136.67 30.89 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.879 -1.055 . . . . 1.75 113.638 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -56.39 -12.65 1.76 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.038 1.125 . . . . 0.7 114.038 -178.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.605 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 80.9 mtm180 -75.75 159.85 30.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.184 0.516 . . . . 0.64 112.337 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -111.12 137.17 49.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.186 -0.916 . . . . 0.68 109.679 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.13 126.57 38.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.695 -0.483 . . . . 0.72 109.695 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 7.6 m -120.85 140.89 51.14 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.918 0.866 . . . . 0.16 111.942 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -129.5 173.53 10.48 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.123 -1.399 . . . . 0.12 108.287 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.762 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 31.3 m95 -84.95 140.41 37.3 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-O 121.477 0.656 . . . . 0.43 112.056 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.605 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 19.7 Cg_endo -58.35 -15.78 25.78 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 125.107 3.872 . . . . 0.27 117.521 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.762 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -29.79 -33.41 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 119.228 0.922 . . . . 0.32 113.176 -177.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.66 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -157.62 40.82 0.29 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.929 -0.767 . . . . 1.9 108.929 -177.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.96 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.002 -0.999 . . . . 1.32 110.649 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 37.5 tp . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.506 -0.183 . . . . 1.61 110.506 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 28.5 t80 -76.2 164.13 26.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.665 -0.865 . . . . 0.56 108.665 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.66 ' O ' ' N ' ' A' ' 5' ' ' GLY . 62.4 m -143.9 137.74 28.06 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.339 -0.986 . . . . 0.99 108.339 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 8.0 mtpm? -43.24 79.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 2.2 111.278 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.698 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 138.47 -37.6 1.78 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.984 -0.627 . . . . 0.33 112.509 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.7 -118.48 0.58 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.35 -0.453 . . . . 0.4 112.108 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.0 m -149.4 165.04 33.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.127 0.489 . . . . 0.74 111.098 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -96.69 140.54 31.13 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.499 -0.773 . . . . 1.04 110.81 -178.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.7 m80 -135.36 134.33 39.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.36 -0.837 . . . . 0.17 108.865 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.557 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -69.11 123.91 22.36 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.804 -0.358 . . . . 0.49 110.555 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.05 -48.88 0.9 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.127 -0.558 . . . . 0.28 112.823 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.23 -128.29 1.18 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 121.096 -0.573 . . . . 0.17 111.932 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.5 m -148.24 141.82 15.84 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.592 0.234 . . . . 0.19 111.53 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 17' ' ' LEU . 25.1 Cg_exo -55.84 132.27 51.02 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.543 1.496 . . . . 0.22 108.979 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -36.22 -33.26 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 O-C-N 123.188 0.305 . . . . 1.4 111.758 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.449 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -66.07 -48.32 71.37 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.561 -0.456 . . . . 0.41 110.901 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' PRO . 22.5 mt -71.61 179.65 2.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.751 1.389 . . . . 0.56 114.751 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.82 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.4 pp -135.48 136.6 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 113.14 -1.846 . . . . 0.14 109.093 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -65.75 102.06 0.71 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.784 0.326 . . . . 0.77 110.6 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.9 -34.09 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.206 0.527 . . . . 0.21 109.867 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.99 -169.69 42.85 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.188 -0.765 . . . . 0.2 111.188 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.5 p -84.94 153.0 23.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.13 0.465 . . . . 1.01 111.078 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.601 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 44.6 t -98.0 -162.68 0.97 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.655 -0.702 . . . . 1.16 109.912 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.526 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 52.9 t80 -82.23 134.48 35.29 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.354 0.597 . . . . 0.88 111.684 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.16 -43.16 0.65 Allowed Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 116.324 1.289 . . . . 1.75 116.324 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.695 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -178.9 -16.65 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 117.762 0.781 . . . . 0.7 112.786 -176.217 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 86.5 mtm180 -66.18 161.71 21.42 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.626 -0.261 . . . . 0.64 110.901 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 71.3 m -103.1 138.14 40.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.078 -0.712 . . . . 0.68 109.078 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -92.32 126.72 37.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.863 -0.421 . . . . 0.72 109.863 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.8 m -122.77 140.84 52.47 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.009 0.909 . . . . 0.16 112.737 -177.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.78 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -127.97 173.12 10.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.064 -1.425 . . . . 0.12 107.881 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.763 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 36.6 m95 -86.87 140.58 33.1 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-O 121.439 0.637 . . . . 0.43 111.81 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.576 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 30.9 Cg_endo -61.32 -13.21 27.41 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 125.131 3.887 . . . . 0.27 117.259 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.763 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -29.38 -34.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 119.13 0.877 . . . . 0.32 112.399 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.64 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.4 OUTLIER -156.58 38.67 0.33 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.774 -0.825 . . . . 1.9 108.774 -178.214 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.82 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.554 -0.748 . . . . 1.32 109.88 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 2' ' ' PHE . 1.5 tm? . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 109.438 -0.579 . . . . 1.61 109.438 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.458 ' O ' HD13 ' A' ' 1' ' ' LEU . 27.1 t80 -84.98 161.48 19.76 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.425 0.631 . . . . 0.56 111.254 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.601 ' O ' ' N ' ' A' ' 5' ' ' GLY . 46.5 m -146.68 137.62 24.08 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.197 -1.038 . . . . 0.99 108.197 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -35.02 81.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.557 0.535 . . . . 2.2 112.44 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.815 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 135.54 -44.44 1.17 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.043 -0.598 . . . . 0.33 113.233 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.27 -140.49 3.05 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.703 -0.76 . . . . 0.4 112.624 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 30' ' ' CYS . 4.8 m -116.42 160.71 20.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.065 0.459 . . . . 0.74 111.675 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -95.11 149.47 21.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.599 -0.728 . . . . 1.04 110.273 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -144.59 133.5 22.56 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.627 -0.715 . . . . 0.17 109.608 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.56 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 2.1 t80 -70.74 131.37 43.76 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 116.311 -0.404 . . . . 0.49 110.398 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.09 -48.68 0.93 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.257 -0.497 . . . . 0.28 112.686 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.87 -133.64 1.75 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.794 -0.717 . . . . 0.17 111.983 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 88.3 m -152.4 139.9 12.94 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.643 0.259 . . . . 0.19 111.41 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' HIS . 51.1 Cg_exo -48.46 133.27 25.63 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.561 1.507 . . . . 0.22 109.553 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.4 m -36.02 -33.02 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 O-C-N 123.367 0.417 . . . . 1.4 111.54 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.505 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -71.96 -48.84 42.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.316 -0.402 . . . . 0.41 111.737 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.47 HD21 ' NE1' ' A' ' 32' ' ' TRP . 24.9 mt -73.0 143.03 47.74 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.055 1.131 . . . . 0.56 114.055 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.792 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.8 pp -95.55 137.0 24.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 113.047 -1.888 . . . . 0.14 110.396 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 21' ' ' GLY . 24.4 tptm -67.82 100.65 0.96 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.333 -0.394 . . . . 0.77 110.089 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.49 -33.4 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.21 110.942 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.435 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . 173.24 -155.79 23.21 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.774 -0.727 . . . . 0.2 111.879 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.18 146.26 23.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.231 0.539 . . . . 1.01 111.696 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.658 ' SG ' ' N ' ' A' ' 24' ' ' PHE . 43.1 t -101.25 -165.21 1.18 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.465 -0.789 . . . . 1.16 109.412 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.658 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 36.8 t80 -57.55 107.65 0.47 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.629 -0.878 . . . . 0.88 108.629 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.8 -137.44 39.02 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 115.034 -0.985 . . . . 1.75 113.313 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -56.39 -13.28 2.12 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.476 0.917 . . . . 0.7 113.476 -179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.647 HH21 ' HB3' ' A' ' 24' ' ' PHE . 75.0 mtm180 -69.32 159.01 33.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.276 0.56 . . . . 0.64 112.444 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -110.33 138.7 46.36 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.036 -0.984 . . . . 0.68 109.576 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -92.53 125.6 37.24 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.111 -0.7 . . . . 0.72 109.111 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 7' ' ' SER . 3.3 m -119.59 146.67 45.31 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.745 0.783 . . . . 0.16 110.955 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.815 ' HB1' ' HA3' ' A' ' 5' ' ' GLY . . . -138.85 173.5 11.51 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.244 -1.344 . . . . 0.12 107.681 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.759 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 33.7 m95 -88.98 138.47 29.2 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-O 121.505 0.669 . . . . 0.43 112.54 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.632 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 17.8 Cg_endo -57.36 -16.95 24.77 Favored 'Trans proline' 0 N--CA 1.487 1.114 1 C-N-CA 125.357 4.038 . . . . 0.27 117.011 -177.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.759 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -27.27 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.435 0.902 . . . . 0.32 113.435 -177.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.578 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 1.1 p-10 -159.28 29.35 0.2 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.915 0.865 . . . . 1.9 109.735 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.783 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--N 1.313 -1.022 0 CA-C-N 114.68 -1.145 . . . . 1.32 110.209 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 31.7 tp . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.62 0.248 . . . . 1.61 110.685 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.625 ' CE1' ' O ' ' A' ' 3' ' ' CYS . 27.9 t80 -76.73 165.18 25.09 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.247 0.546 . . . . 0.56 109.865 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.638 ' O ' ' N ' ' A' ' 5' ' ' GLY . 40.7 t -144.08 145.24 32.03 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.975 -1.12 . . . . 0.99 107.975 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -45.58 81.58 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.21 0.529 . . . . 2.2 111.23 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.669 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 127.18 -32.65 3.53 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.563 -0.744 . . . . 0.33 112.772 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.505 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -153.25 -114.03 0.54 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.917 -0.659 . . . . 0.4 113.05 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 30' ' ' CYS . 19.2 m -150.31 171.35 17.12 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.484 -0.421 . . . . 0.74 111.589 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.1 m -95.59 144.01 26.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 1.04 111.45 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -150.5 123.13 8.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.852 -0.613 . . . . 0.17 109.656 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.622 ' CE1' ' HB2' ' A' ' 26' ' ' PHE . 2.0 t80 -67.32 127.92 34.48 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.71 -0.396 . . . . 0.49 110.152 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.14 -55.83 0.49 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.189 -0.529 . . . . 0.28 113.113 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.88 -129.66 1.11 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.547 -0.835 . . . . 0.17 112.497 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 93.6 m -151.14 143.91 16.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.723 0.297 . . . . 0.19 111.549 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -56.66 134.06 61.98 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.789 1.659 . . . . 0.22 109.526 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.6 p -36.11 -33.88 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.396 0.435 . . . . 1.4 111.473 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.506 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -67.64 -47.29 70.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.028 -0.533 . . . . 0.41 111.511 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.84 -176.64 2.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.699 1.0 . . . . 0.56 113.699 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.78 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.4 pp -138.62 135.22 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 113.793 -1.549 . . . . 0.14 108.662 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 21.0 tptm -64.87 95.29 0.15 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.416 -0.356 . . . . 0.77 110.842 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.634 HG21 ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -71.88 -31.5 41.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.142 0.496 . . . . 0.21 109.769 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.75 -149.88 14.77 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.544 -0.753 . . . . 0.2 111.323 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.1 p -109.4 143.76 38.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.781 0.324 . . . . 1.01 110.132 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.741 ' SG ' ' HA ' ' A' ' 29' ' ' CYS . 84.3 m -97.42 -163.62 1.06 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.217 -0.447 . . . . 1.16 110.155 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.557 ' HB3' HH21 ' A' ' 27' ' ' ARG . 14.3 t80 -53.27 105.2 0.12 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.727 0.775 . . . . 0.88 109.195 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.28 -138.33 29.11 Favored Glycine 0 N--CA 1.432 -1.594 0 CA-C-N 114.227 -1.351 . . . . 1.75 114.41 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -55.9 -17.67 7.06 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.062 1.345 . . . . 0.7 114.481 -178.124 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.557 HH21 ' HB3' ' A' ' 24' ' ' PHE . 76.9 mtm180 -73.1 153.92 40.6 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.096 0.776 . . . . 0.64 113.096 -177.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.483 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 27.7 m -102.84 140.04 37.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.857 -1.065 . . . . 0.68 110.695 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.741 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -93.3 125.04 37.69 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.236 -1.024 . . . . 0.72 108.236 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.44 ' O ' ' N ' ' A' ' 7' ' ' SER . 13.2 m -121.72 138.26 54.42 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.789 0.804 . . . . 0.16 111.705 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.78 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -129.9 174.66 9.54 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.276 -1.329 . . . . 0.12 108.381 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.796 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 45.4 m95 -87.25 142.11 33.24 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-O 121.412 0.625 . . . . 0.43 111.413 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.8 Cg_endo -58.38 -23.61 64.31 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 125.004 3.802 . . . . 0.27 117.413 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.796 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -21.9 -37.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.264 1.209 . . . . 0.32 114.264 -177.166 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -155.04 20.58 0.44 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.936 0.398 . . . . 1.9 110.64 -177.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.772 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.39 -0.815 . . . . 1.32 111.059 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.729 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.2 tm? . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.94 -0.392 . . . . 1.61 109.94 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 14.9 t80 -83.57 157.08 22.45 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.054 -0.658 . . . . 0.56 110.574 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 45.8 m -143.74 140.41 29.96 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.24 -1.022 . . . . 0.99 108.24 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 6.9 mtpm? -40.66 80.58 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.422 0.451 . . . . 2.2 111.765 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.663 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 136.78 -38.0 1.8 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.179 -0.534 . . . . 0.33 112.931 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.79 -121.89 0.67 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.363 -0.446 . . . . 0.4 112.071 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.0 m -145.41 163.55 34.27 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.488 -0.419 . . . . 0.74 110.143 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 1' ' ' LEU . 0.5 OUTLIER -95.82 138.27 33.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.307 0.575 . . . . 1.04 111.61 -177.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -127.56 135.09 49.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.181 -0.918 . . . . 0.17 109.198 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.498 ' CB ' ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -71.45 134.81 46.85 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.863 -0.421 . . . . 0.49 109.863 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.39 -42.09 1.98 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.89 -0.671 . . . . 0.28 112.411 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.86 -129.53 1.72 Allowed Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.699 -0.763 . . . . 0.17 112.313 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.7 m -151.86 140.6 13.67 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.534 0.207 . . . . 0.19 111.335 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 16' ' ' HIS . 36.8 Cg_exo -52.64 134.61 53.93 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.573 1.515 . . . . 0.22 109.548 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -35.61 -33.59 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.113 0.482 . . . . 1.4 111.774 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.454 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -69.14 -49.16 59.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.74 -0.664 . . . . 0.41 111.62 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.476 HD21 ' CE2' ' A' ' 32' ' ' TRP . 30.7 mt -75.04 147.53 40.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.312 1.227 . . . . 0.56 114.312 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.876 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.6 pp -98.25 138.39 23.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 112.876 -1.966 . . . . 0.14 110.133 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 21' ' ' GLY . 21.2 tptm -72.45 105.4 4.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.531 -0.304 . . . . 0.77 110.259 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -83.74 -32.77 9.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.128 0.489 . . . . 0.21 110.115 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.462 ' O ' ' CE ' ' A' ' 19' ' ' LYS . . . 175.83 -156.76 22.34 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 111.077 -0.809 . . . . 0.2 111.077 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 18.4 t -95.58 -170.61 2.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.258 0.529 . . . . 1.01 109.953 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.66 ' SG ' ' HG ' ' A' ' 1' ' ' LEU . 51.2 t -143.76 -165.42 2.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.664 0.268 . . . . 1.16 110.932 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.564 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 25.2 t80 -65.99 130.44 43.25 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.731 0.777 . . . . 0.88 112.5 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.57 -42.8 0.44 Allowed Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 113.776 -1.556 . . . . 1.75 115.997 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER 179.08 -10.97 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.466 0.633 . . . . 0.7 112.371 -176.057 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' CYS . 85.9 mtm180 -65.63 158.99 25.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.838 0.352 . . . . 0.64 111.574 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.414 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 9.7 m -100.97 138.52 37.9 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.657 -0.702 . . . . 0.68 109.429 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.546 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -91.47 126.12 36.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.145 0.498 . . . . 0.72 109.795 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.5 m -117.75 143.76 45.94 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.893 0.854 . . . . 0.16 111.183 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.833 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -134.81 173.16 12.01 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.049 -1.432 . . . . 0.12 107.236 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.806 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 42.6 m95 -89.31 140.56 28.65 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-O 121.577 0.703 . . . . 0.43 112.157 -178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 35' ' ' ASN . 29.8 Cg_endo -60.44 -16.75 43.77 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 125.078 3.852 . . . . 0.27 116.781 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.806 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.4 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.605 0.965 . . . . 0.32 113.605 -177.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.588 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -158.59 20.59 0.22 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.167 0.508 . . . . 1.9 110.482 -177.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.876 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--N 1.316 -0.869 0 CA-C-O 118.435 -0.793 . . . . 1.32 110.827 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 110.362 -0.236 . . . . 1.61 110.362 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 29.0 t80 -82.5 166.46 19.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.386 -0.598 . . . . 0.56 109.386 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 5' ' ' GLY . 92.5 m -145.63 136.92 24.92 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.489 -0.93 . . . . 0.99 108.489 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -40.91 83.29 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.533 0.52 . . . . 2.2 111.449 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.645 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 131.44 -41.59 1.49 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.647 -0.706 . . . . 0.33 112.357 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . -149.4 -126.01 1.43 Allowed Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.957 -0.457 . . . . 0.4 111.957 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 m -135.24 167.09 21.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.129 0.49 . . . . 0.74 110.899 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' SG ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -95.84 134.2 39.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.76 -0.655 . . . . 1.04 110.407 -179.192 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -130.6 135.35 47.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.36 -0.836 . . . . 0.17 109.461 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -74.54 135.47 42.15 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.738 -0.385 . . . . 0.49 110.203 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.36 -43.99 1.59 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.016 -0.612 . . . . 0.28 112.896 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.93 -129.8 1.59 Allowed Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.728 -0.748 . . . . 0.17 111.989 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.2 m -152.35 144.47 16.64 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.493 0.187 . . . . 0.19 111.037 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 16' ' ' HIS . 29.1 Cg_exo -55.63 134.08 61.84 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.557 1.504 . . . . 0.22 109.235 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.5 m -34.76 -32.67 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.277 0.473 . . . . 1.4 112.277 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -69.51 -48.92 59.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.958 0.409 . . . . 0.41 111.58 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.437 HD21 ' CE2' ' A' ' 32' ' ' TRP . 37.8 mt -73.47 149.22 42.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.623 1.342 . . . . 0.56 114.623 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.853 HG12 ' HB3' ' A' ' 36' ' ' ALA . 2.0 pp -99.91 138.56 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 112.94 -1.937 . . . . 0.14 110.257 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 22.2 tptm -69.97 97.09 1.1 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.442 -0.344 . . . . 0.77 110.599 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -73.81 -31.12 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.016 0.436 . . . . 0.21 110.297 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.71 -151.19 16.49 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.941 -0.647 . . . . 0.2 111.912 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.5 p -96.68 178.11 5.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.71 0.291 . . . . 1.01 110.986 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.626 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 43.7 t -135.12 -163.87 1.44 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.226 -0.443 . . . . 1.16 109.844 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.607 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 11.7 t80 -72.79 135.73 45.31 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.648 0.737 . . . . 0.88 112.326 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.86 -46.05 0.42 Allowed Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 113.66 -1.609 . . . . 1.75 115.925 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.691 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -180.0 -5.56 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 117.038 0.419 . . . . 0.7 111.727 -176.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.626 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 80.4 mtm180 -66.96 159.86 27.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.055 0.455 . . . . 0.64 111.569 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.424 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 50.8 m -102.54 138.85 38.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.272 -0.876 . . . . 0.68 109.144 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.477 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -91.97 126.21 36.97 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.357 -0.608 . . . . 0.72 109.357 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 5.1 m -118.58 139.34 51.63 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.917 0.865 . . . . 0.16 111.47 -177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.803 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -135.04 173.17 12.03 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.963 -1.471 . . . . 0.12 107.331 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.792 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 45.6 m95 -86.34 139.58 34.08 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-O 121.485 0.66 . . . . 0.43 112.076 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 35' ' ' ASN . 10.3 Cg_endo -54.04 -25.81 38.38 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 125.204 3.936 . . . . 0.27 117.448 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.792 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -23.14 -38.16 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.012 1.116 . . . . 0.32 114.012 -177.037 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.647 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.3 OUTLIER -158.54 40.75 0.25 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.621 -0.511 . . . . 1.9 109.621 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.853 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.18 -0.914 . . . . 1.32 110.825 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 36.5 tp . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.112 -0.329 . . . . 1.61 110.112 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 34.9 t80 -79.94 162.82 24.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.46 0.647 . . . . 0.56 110.197 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 5' ' ' GLY . 76.8 m -150.18 137.69 19.8 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.745 -1.205 . . . . 0.99 107.745 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -34.02 78.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.927 0.714 . . . . 2.2 112.927 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.75 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 134.55 -43.29 1.27 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.712 -0.756 . . . . 0.33 113.394 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.56 -136.71 2.51 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.662 -0.78 . . . . 0.4 112.772 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -116.26 162.23 17.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.243 0.544 . . . . 0.74 111.344 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -96.08 139.09 32.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.631 -0.713 . . . . 1.04 109.888 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -134.02 132.77 40.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.17 109.81 -178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.54 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -73.01 132.94 44.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.303 -0.408 . . . . 0.49 110.226 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.02 -48.16 0.98 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.129 -0.558 . . . . 0.28 112.631 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.4 -139.74 4.02 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 111.423 -0.671 . . . . 0.17 111.423 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.4 m -147.13 137.41 12.35 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.675 0.238 . . . . 0.19 111.158 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 17' ' ' LEU . 32.8 Cg_exo -52.54 133.22 48.57 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.833 1.689 . . . . 0.22 109.602 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.5 t -35.91 -34.19 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.328 0.393 . . . . 1.4 111.779 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.494 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -62.55 -48.62 78.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.235 0.54 . . . . 0.41 110.386 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.432 HD21 ' CE2' ' A' ' 32' ' ' TRP . 37.1 mt -77.32 155.32 32.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.637 1.208 . . . . 0.56 114.088 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.891 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.8 pp -108.42 134.21 51.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 112.704 -2.043 . . . . 0.14 110.005 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 22.4 tptm -68.71 93.47 0.53 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.809 0.337 . . . . 0.77 110.211 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -71.46 -28.67 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.41 0.624 . . . . 0.21 109.863 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.31 -156.55 27.76 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.611 -0.996 . . . . 0.2 110.611 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.47 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 14.1 t -94.47 -179.94 5.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 117.213 0.506 . . . . 1.01 109.692 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.631 ' HB3' ' C ' ' A' ' 27' ' ' ARG . 42.4 t -123.87 -164.86 1.28 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.197 -0.456 . . . . 1.16 110.355 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.621 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 34.4 t80 -73.58 133.1 43.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.613 0.72 . . . . 0.88 111.718 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.12 -43.48 0.53 Allowed Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.157 -1.383 . . . . 1.75 115.841 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER 179.45 -13.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.734 0.767 . . . . 0.7 112.684 -176.389 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.631 ' C ' ' HB3' ' A' ' 23' ' ' CYS . 79.8 mtm180 -64.8 166.29 9.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.072 -0.344 . . . . 0.64 110.072 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.429 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 58.8 m -105.58 141.24 37.38 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.911 -0.774 . . . . 0.68 108.911 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 22' ' ' SER . 0.9 OUTLIER -91.65 125.65 36.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.183 0.516 . . . . 0.72 109.803 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.4 m -120.03 138.6 53.42 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.934 0.873 . . . . 0.16 110.728 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.75 ' HB1' ' HA3' ' A' ' 5' ' ' GLY . . . -136.25 173.66 11.46 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.119 -1.401 . . . . 0.12 107.455 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.817 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 52.1 m95 -87.45 141.81 32.65 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-O 121.443 0.64 . . . . 0.43 111.996 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' ASN . 16.8 Cg_endo -57.56 -21.15 44.95 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 125.179 3.919 . . . . 0.27 117.565 -176.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.817 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.16 -35.91 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.65 0.981 . . . . 0.32 113.65 -177.494 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.661 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -155.28 31.83 0.38 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.401 -0.592 . . . . 1.9 109.401 -177.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.891 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 119.051 -0.5 . . . . 1.32 110.121 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.652 HD23 ' SG ' ' A' ' 8' ' ' CYS . 19.4 tp . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 110.088 -0.338 . . . . 1.61 110.088 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.502 ' CE1' ' O ' ' A' ' 3' ' ' CYS . 19.3 t80 -87.23 160.58 18.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.887 -0.412 . . . . 0.56 109.887 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.835 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 94.8 m -136.64 144.19 43.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.027 -0.731 . . . . 0.99 109.027 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -48.67 79.33 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.747 0.308 . . . . 2.2 110.745 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.761 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 131.76 -28.34 3.56 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.626 -0.797 . . . . 0.33 112.857 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.17 -121.33 0.64 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.923 -0.656 . . . . 0.4 112.699 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -148.79 173.14 13.58 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.58 -0.365 . . . . 0.74 110.844 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' SG ' ' A' ' 3' ' ' CYS . 86.8 m -93.53 143.16 26.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.974 -0.557 . . . . 1.04 111.027 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -144.44 122.12 11.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.605 -0.725 . . . . 0.17 109.401 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 26' ' ' PHE . 2.7 t80 -69.14 136.61 52.43 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 120.268 -0.573 . . . . 0.49 109.863 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.42 -45.71 1.27 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.028 -0.606 . . . . 0.28 112.037 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.74 -134.89 3.12 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.987 -0.845 . . . . 0.17 110.987 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.4 m -148.05 142.77 16.85 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 120.572 0.225 . . . . 0.19 110.933 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 16' ' ' HIS . 51.8 Cg_exo -50.6 132.91 37.19 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.659 1.572 . . . . 0.22 109.804 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 p -36.16 -26.82 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.598 0.592 . . . . 1.4 112.598 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -78.85 -45.51 20.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.085 0.469 . . . . 0.41 111.526 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.8 mt -74.29 143.2 45.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.341 1.067 . . . . 0.56 113.861 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.834 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.9 pp -95.96 138.72 20.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.182 -1.826 . . . . 0.14 110.504 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -72.43 100.38 2.68 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.178 -0.465 . . . . 0.77 110.84 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.809 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -74.2 -36.41 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.169 -0.308 . . . . 0.21 110.169 179.107 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.39 -161.3 28.64 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.062 -0.589 . . . . 0.2 112.178 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.55 138.91 34.25 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.494 0.318 . . . . 1.01 110.721 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 98.5 m -97.97 -164.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.498 -0.319 . . . . 1.16 110.857 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -52.89 109.24 0.39 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.743 0.782 . . . . 0.88 109.342 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.63 -134.6 44.44 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.265 -1.334 . . . . 1.75 113.861 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -60.89 -8.39 3.09 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 114.4 1.259 . . . . 0.7 114.4 -178.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 10' ' ' PHE . 68.7 mtm180 -78.51 153.0 31.7 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.34 0.867 . . . . 0.64 113.34 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 m -105.43 140.81 37.98 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.669 -1.15 . . . . 0.68 110.506 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -92.88 125.75 37.63 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.557 -0.905 . . . . 0.72 108.557 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 4.3 m -118.27 137.38 53.09 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.804 0.811 . . . . 0.16 111.291 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.834 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -133.98 171.92 13.54 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.398 -1.274 . . . . 0.12 108.014 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.768 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 37.1 m95 -88.74 139.31 29.43 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-O 121.446 0.641 . . . . 0.43 112.073 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.602 ' O ' ' N ' ' A' ' 35' ' ' ASN . 12.3 Cg_endo -54.54 -20.95 22.55 Favored 'Trans proline' 0 N--CA 1.486 1.086 1 C-N-CA 125.339 4.026 . . . . 0.27 117.663 -177.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.768 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.16 -34.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.614 0.968 . . . . 0.32 113.614 -177.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.671 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -158.23 37.76 0.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.848 -0.797 . . . . 1.9 108.848 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.803 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.081 -0.962 . . . . 1.32 110.191 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 22.9 tp . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.684 0.278 . . . . 1.61 110.927 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 28.1 t80 -85.04 165.16 17.76 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.148 -0.686 . . . . 0.56 109.148 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.632 ' O ' ' N ' ' A' ' 5' ' ' GLY . 63.5 m -144.78 138.11 26.91 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.429 -0.952 . . . . 0.99 108.429 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 9.5 mtpm? -41.86 80.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 2.2 111.961 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.706 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 136.83 -37.81 1.82 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.713 -0.676 . . . . 0.33 112.511 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.6 -119.63 0.66 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.383 -0.437 . . . . 0.4 112.017 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.4 m -143.81 169.48 17.69 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.342 -0.505 . . . . 0.74 110.769 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -95.07 134.37 37.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.421 0.629 . . . . 1.04 111.059 -178.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -130.47 134.83 47.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.987 -1.006 . . . . 0.17 109.582 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.526 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -77.14 141.42 40.16 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.847 -0.341 . . . . 0.49 110.757 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.66 -42.78 2.52 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.122 -0.561 . . . . 0.28 112.784 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.97 -137.92 3.21 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.484 -0.865 . . . . 0.17 112.169 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.6 m -153.62 141.98 14.15 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.363 -0.236 . . . . 0.19 110.363 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 17' ' ' LEU . 32.4 Cg_exo -50.33 131.75 32.6 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.259 1.306 . . . . 0.22 109.602 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -36.3 -32.28 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.26 0.35 . . . . 1.4 111.503 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.488 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -65.68 -48.31 72.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.445 0.64 . . . . 0.41 110.618 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 14' ' ' PRO . 32.7 mt -74.27 153.28 39.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.993 1.109 . . . . 0.56 113.993 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.831 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.7 pp -108.95 138.73 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 113.037 -1.892 . . . . 0.14 110.166 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -71.38 96.6 1.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.977 0.418 . . . . 0.77 111.23 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -74.46 -33.84 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.32 0.581 . . . . 0.21 110.411 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.34 -160.95 26.69 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.176 -0.769 . . . . 0.2 111.176 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.4 p -91.64 -172.41 3.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.013 0.407 . . . . 1.01 110.229 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.636 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 41.4 t -140.04 -164.68 1.75 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.415 -0.587 . . . . 1.16 109.415 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.621 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 18.7 t80 -72.57 134.83 45.38 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.649 0.738 . . . . 0.88 112.067 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.47 -46.26 0.51 Allowed Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 113.843 -1.526 . . . . 1.75 115.698 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.706 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -179.29 -6.58 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 117.194 0.497 . . . . 0.7 112.015 -176.286 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.636 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 81.8 mtm180 -66.35 159.58 26.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.05 0.453 . . . . 0.64 111.694 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.51 138.11 40.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.458 -0.792 . . . . 0.68 109.06 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.562 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -91.36 125.34 36.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.016 -0.735 . . . . 0.72 109.016 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 3.6 m -114.05 139.04 49.6 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.392 -0.822 . . . . 0.16 111.429 -177.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.817 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -133.72 172.04 13.32 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.215 -1.357 . . . . 0.12 107.734 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.797 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 39.0 m95 -89.15 139.18 28.7 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-O 121.581 0.705 . . . . 0.43 112.049 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.571 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 18.9 Cg_endo -56.77 -15.98 18.26 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 125.231 3.954 . . . . 0.27 117.413 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.797 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -28.84 -34.23 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 119.301 0.955 . . . . 0.32 112.787 -177.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.646 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -157.52 35.61 0.27 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.941 -0.763 . . . . 1.9 108.941 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.831 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.571 -0.728 . . . . 1.32 110.233 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.44 HD13 ' N ' ' A' ' 2' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 109.794 -0.447 . . . . 1.61 109.794 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 22.8 t80 -77.67 162.31 27.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.156 0.503 . . . . 0.56 110.503 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.613 ' O ' ' N ' ' A' ' 5' ' ' GLY . 64.5 m -142.25 140.22 32.2 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.807 -0.812 . . . . 0.99 108.807 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -41.79 81.09 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.385 0.428 . . . . 2.2 111.954 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.705 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 133.7 -35.08 2.31 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.004 -0.617 . . . . 0.33 113.151 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.466 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -158.57 -135.35 1.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.834 -0.698 . . . . 0.4 112.413 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 30' ' ' CYS . 20.3 m -124.92 159.6 30.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.007 0.432 . . . . 0.74 111.592 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -96.11 138.46 33.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.816 -0.629 . . . . 1.04 110.12 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.2 m80 -135.82 138.8 42.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.765 -0.652 . . . . 0.17 109.463 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 1.4 t80 -72.18 133.25 45.03 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.621 -0.432 . . . . 0.49 111.329 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.49 -45.36 1.4 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.119 -0.562 . . . . 0.28 113.679 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.65 -134.91 2.0 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.577 -0.82 . . . . 0.17 112.1 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.9 m -149.77 139.62 13.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.741 0.305 . . . . 0.19 111.756 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 16' ' ' HIS . 52.6 Cg_exo -47.85 131.45 20.69 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.664 1.576 . . . . 0.22 109.565 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m -36.97 -26.71 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.398 0.436 . . . . 1.4 111.572 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -77.43 -48.86 16.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.049 0.452 . . . . 0.41 111.177 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.444 HD21 ' CE2' ' A' ' 32' ' ' TRP . 19.8 mt -73.85 144.5 45.44 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.558 0.947 . . . . 0.56 113.558 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.77 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.8 pp -95.86 136.37 27.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 113.393 -1.73 . . . . 0.14 110.151 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 20.7 tptm -68.38 103.06 1.53 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.391 -0.368 . . . . 0.77 110.07 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -80.31 -33.87 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.986 0.422 . . . . 0.21 110.326 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.05 -156.01 21.68 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.595 -0.729 . . . . 0.2 111.52 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 p -92.81 170.25 9.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.935 0.368 . . . . 1.01 110.632 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.579 ' HB3' ' C ' ' A' ' 27' ' ' ARG . 48.9 t -121.54 -164.49 1.14 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.122 -0.49 . . . . 1.16 109.892 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.542 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 44.1 t80 -77.54 136.59 38.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.61 0.719 . . . . 0.88 112.03 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' C ' ' CG ' ' A' ' 26' ' ' PHE . . . 71.61 -45.56 0.84 Allowed Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.036 -1.438 . . . . 1.75 115.876 177.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.763 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER 179.54 -12.35 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.285 0.542 . . . . 0.7 112.02 -175.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.579 ' C ' ' HB3' ' A' ' 23' ' ' CYS . 89.9 mtm180 -66.52 161.59 22.62 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.158 -0.474 . . . . 0.64 111.915 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.413 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 16.3 m -101.09 139.05 37.31 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.365 -0.834 . . . . 0.68 109.534 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.454 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -92.85 126.01 37.73 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.511 -0.551 . . . . 0.72 109.511 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 7' ' ' SER . 3.4 m -120.64 146.26 46.57 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.788 0.804 . . . . 0.16 111.368 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.77 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -135.54 173.48 11.67 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.206 -1.361 . . . . 0.12 107.679 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.76 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 35.8 m95 -88.27 138.17 30.62 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-O 121.696 0.76 . . . . 0.43 112.389 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.619 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 28.2 Cg_endo -59.89 -12.78 19.8 Favored 'Trans proline' 0 N--CA 1.485 0.978 0 C-N-CA 125.101 3.867 . . . . 0.27 116.935 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TRP . . . . . 0.76 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -27.92 -36.58 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 119.085 0.857 . . . . 0.32 112.794 -177.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.56 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 1.0 OUTLIER -159.09 29.38 0.21 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.684 0.754 . . . . 1.9 109.667 -178.178 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.656 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.785 -1.098 . . . . 1.32 110.064 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.62 ' O ' ' N ' ' A' ' 5' ' ' GLY . 70.7 m . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.182 -0.673 . . . . 0.98999999999999999 109.182 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -42.82 80.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.582 0.551 . . . . 2.2000000000000002 111.789 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.674 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 132.46 -35.11 2.39 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 121.002 -0.618 . . . . 0.33000000000000002 113.022 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.34 -121.96 0.82 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.025 -0.607 . . . . 0.40000000000000002 112.497 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 m -141.56 162.19 36.08 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.479 -0.424 . . . . 0.73999999999999999 110.788 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.5 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -95.42 144.57 25.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.744 -0.662 . . . . 1.04 110.847 -178.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.506 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.4 m-70 -142.09 128.7 20.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.49 -0.777 . . . . 0.17000000000000001 109.64 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.503 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 1.6 t80 -66.23 126.41 28.62 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.841 -0.429 . . . . 0.48999999999999999 109.841 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.44 -51.73 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.829 -0.7 . . . . 0.28000000000000003 112.826 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.62 -128.9 1.2 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.809 -0.71 . . . . 0.17000000000000001 111.994 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.1 m -148.8 136.72 11.3 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.81 0.338 . . . . 0.19 111.737 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.19 133.7 42.24 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.71 1.606 . . . . 0.22 109.182 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 p -36.56 -36.29 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.822 0.344 . . . . 1.3999999999999999 111.665 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.413 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -63.58 -48.3 77.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.158 -0.473 . . . . 0.40999999999999998 111.487 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.1 mt -74.47 177.3 6.07 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.144 1.165 . . . . 0.56000000000000005 114.144 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.96 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.6 pp -131.61 136.18 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 113.183 -1.826 . . . . 0.14000000000000001 109.237 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -66.9 102.42 0.96 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.776 0.322 . . . . 0.77000000000000002 110.353 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.55 -33.47 15.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.20999999999999999 110.023 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.22 -163.4 34.18 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.55 -0.75 . . . . 0.20000000000000001 111.36 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.38 148.63 24.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.869 0.334 . . . . 1.01 110.178 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.605 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 28.9 t . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 1.1599999999999999 108.847 179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.605 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 80.9 mtm180 . . . . . 0 CA--C 1.515 -0.389 0 CA-C-O 121.184 0.516 . . . . 0.64000000000000001 112.337 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -111.12 137.17 49.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.186 -0.916 . . . . 0.68000000000000005 109.679 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.13 126.57 38.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.695 -0.483 . . . . 0.71999999999999997 109.695 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.506 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 7.6 m -120.85 140.89 51.14 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.918 0.866 . . . . 0.16 111.942 -177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -129.5 173.53 10.48 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.123 -1.399 . . . . 0.12 108.287 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.762 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 31.3 m95 -84.95 140.41 37.3 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-O 121.477 0.656 . . . . 0.42999999999999999 112.056 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.605 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 19.7 Cg_endo -58.35 -15.78 25.78 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 125.107 3.872 . . . . 0.27000000000000002 117.521 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.762 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -29.79 -33.41 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 119.228 0.922 . . . . 0.32000000000000001 113.176 -177.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.66 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -157.62 40.82 0.29 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.929 -0.767 . . . . 1.8999999999999999 108.929 -177.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.96 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.002 -0.999 . . . . 1.3200000000000001 110.649 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.66 ' O ' ' N ' ' A' ' 5' ' ' GLY . 62.4 m . . . . . 0 CA--C 1.512 -0.494 0 N-CA-C 108.339 -0.986 . . . . 0.98999999999999999 108.339 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 8.0 mtpm? -43.24 79.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 2.2000000000000002 111.278 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.698 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 138.47 -37.6 1.78 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.984 -0.627 . . . . 0.33000000000000002 112.509 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.7 -118.48 0.58 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.35 -0.453 . . . . 0.40000000000000002 112.108 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.0 m -149.4 165.04 33.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.127 0.489 . . . . 0.73999999999999999 111.098 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -96.69 140.54 31.13 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.499 -0.773 . . . . 1.04 110.81 -178.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.428 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 27.4 m-70 -135.36 134.33 39.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.36 -0.837 . . . . 0.17000000000000001 108.865 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.557 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -69.11 123.91 22.36 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.804 -0.358 . . . . 0.48999999999999999 110.555 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.05 -48.88 0.9 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.127 -0.558 . . . . 0.28000000000000003 112.823 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.23 -128.29 1.18 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 121.096 -0.573 . . . . 0.17000000000000001 111.932 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.5 m -148.24 141.82 15.84 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.592 0.234 . . . . 0.19 111.53 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 17' ' ' LEU . 25.1 Cg_exo -55.84 132.27 51.02 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.543 1.496 . . . . 0.22 108.979 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -36.22 -33.26 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 O-C-N 123.188 0.305 . . . . 1.3999999999999999 111.758 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.449 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -66.07 -48.32 71.37 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.561 -0.456 . . . . 0.40999999999999998 110.901 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' PRO . 22.5 mt -71.61 179.65 2.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.751 1.389 . . . . 0.56000000000000005 114.751 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.82 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.4 pp -135.48 136.6 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 113.14 -1.846 . . . . 0.14000000000000001 109.093 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -65.75 102.06 0.71 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.784 0.326 . . . . 0.77000000000000002 110.6 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.9 -34.09 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.206 0.527 . . . . 0.20999999999999999 109.867 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.99 -169.69 42.85 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.188 -0.765 . . . . 0.20000000000000001 111.188 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.5 p -84.94 153.0 23.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.13 0.465 . . . . 1.01 111.078 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.601 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 44.6 t . . . . . 0 C--N 1.323 -0.581 0 CA-C-N 115.655 -0.702 . . . . 1.1599999999999999 109.912 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 86.5 mtm180 . . . . . 0 CA--C 1.515 -0.395 0 CA-C-O 120.642 0.258 . . . . 0.64000000000000001 110.901 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 71.3 m -103.1 138.14 40.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.078 -0.712 . . . . 0.68000000000000005 109.078 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -92.32 126.72 37.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.863 -0.421 . . . . 0.71999999999999997 109.863 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.428 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 5.8 m -122.77 140.84 52.47 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.009 0.909 . . . . 0.16 112.737 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.78 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -127.97 173.12 10.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.064 -1.425 . . . . 0.12 107.881 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.763 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 36.6 m95 -86.87 140.58 33.1 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-O 121.439 0.637 . . . . 0.42999999999999999 111.81 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.576 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 30.9 Cg_endo -61.32 -13.21 27.41 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 125.131 3.887 . . . . 0.27000000000000002 117.259 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.763 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -29.38 -34.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 119.13 0.877 . . . . 0.32000000000000001 112.399 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.64 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.4 OUTLIER -156.58 38.67 0.33 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.774 -0.825 . . . . 1.8999999999999999 108.774 -178.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.82 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.554 -0.748 . . . . 1.3200000000000001 109.88 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.601 ' O ' ' N ' ' A' ' 5' ' ' GLY . 46.5 m . . . . . 0 N--CA 1.445 -0.689 0 N-CA-C 108.197 -1.038 . . . . 0.98999999999999999 108.197 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -35.02 81.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.557 0.535 . . . . 2.2000000000000002 112.44 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.815 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 135.54 -44.44 1.17 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.043 -0.598 . . . . 0.33000000000000002 113.233 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.27 -140.49 3.05 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.703 -0.76 . . . . 0.40000000000000002 112.624 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 30' ' ' CYS . 4.8 m -116.42 160.71 20.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.065 0.459 . . . . 0.73999999999999999 111.675 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -95.11 149.47 21.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.599 -0.728 . . . . 1.04 110.273 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.519 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 25.9 m-70 -144.59 133.5 22.56 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.627 -0.715 . . . . 0.17000000000000001 109.608 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.56 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 2.1 t80 -70.74 131.37 43.76 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 116.311 -0.404 . . . . 0.48999999999999999 110.398 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.09 -48.68 0.93 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.257 -0.497 . . . . 0.28000000000000003 112.686 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.87 -133.64 1.75 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.794 -0.717 . . . . 0.17000000000000001 111.983 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 88.3 m -152.4 139.9 12.94 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.643 0.259 . . . . 0.19 111.41 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' HIS . 51.1 Cg_exo -48.46 133.27 25.63 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.561 1.507 . . . . 0.22 109.553 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.4 m -36.02 -33.02 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 O-C-N 123.367 0.417 . . . . 1.3999999999999999 111.54 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.505 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -71.96 -48.84 42.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.316 -0.402 . . . . 0.40999999999999998 111.737 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.47 HD21 ' NE1' ' A' ' 32' ' ' TRP . 24.9 mt -73.0 143.03 47.74 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.055 1.131 . . . . 0.56000000000000005 114.055 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.792 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.8 pp -95.55 137.0 24.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 113.047 -1.888 . . . . 0.14000000000000001 110.396 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 21' ' ' GLY . 24.4 tptm -67.82 100.65 0.96 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.333 -0.394 . . . . 0.77000000000000002 110.089 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.49 -33.4 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.20999999999999999 110.942 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.435 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . 173.24 -155.79 23.21 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.774 -0.727 . . . . 0.20000000000000001 111.879 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.18 146.26 23.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.231 0.539 . . . . 1.01 111.696 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.578 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 43.1 t . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.465 -0.789 . . . . 1.1599999999999999 109.412 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.578 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 75.0 mtm180 . . . . . 0 CA--C 1.513 -0.468 0 CA-C-O 121.276 0.56 . . . . 0.64000000000000001 112.444 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -110.33 138.7 46.36 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.036 -0.984 . . . . 0.68000000000000005 109.576 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -92.53 125.6 37.24 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.111 -0.7 . . . . 0.71999999999999997 109.111 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.519 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 3.3 m -119.59 146.67 45.31 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.745 0.783 . . . . 0.16 110.955 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.815 ' HB1' ' HA3' ' A' ' 5' ' ' GLY . . . -138.85 173.5 11.51 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.244 -1.344 . . . . 0.12 107.681 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.759 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 33.7 m95 -88.98 138.47 29.2 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-O 121.505 0.669 . . . . 0.42999999999999999 112.54 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.632 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 17.8 Cg_endo -57.36 -16.95 24.77 Favored 'Trans proline' 0 N--CA 1.487 1.114 1 C-N-CA 125.357 4.038 . . . . 0.27000000000000002 117.011 -177.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.759 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -27.27 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.435 0.902 . . . . 0.32000000000000001 113.435 -177.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.578 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 15.1 p30 -159.28 29.35 0.2 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.915 0.865 . . . . 1.8999999999999999 109.735 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.783 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--N 1.313 -1.022 0 CA-C-N 114.68 -1.145 . . . . 1.3200000000000001 110.209 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.638 ' O ' ' N ' ' A' ' 5' ' ' GLY . 40.7 t . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 107.975 -1.12 . . . . 0.98999999999999999 107.975 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -45.58 81.58 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.21 0.529 . . . . 2.2000000000000002 111.23 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.669 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 127.18 -32.65 3.53 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.563 -0.744 . . . . 0.33000000000000002 112.772 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.505 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -153.25 -114.03 0.54 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.917 -0.659 . . . . 0.40000000000000002 113.05 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 30' ' ' CYS . 19.2 m -150.31 171.35 17.12 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.484 -0.421 . . . . 0.73999999999999999 111.589 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.1 m -95.59 144.01 26.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 1.04 111.45 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.547 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 50.7 m-70 -150.5 123.13 8.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.852 -0.613 . . . . 0.17000000000000001 109.656 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.545 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 2.0 t80 -67.32 127.92 34.48 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.71 -0.396 . . . . 0.48999999999999999 110.152 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.14 -55.83 0.49 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.189 -0.529 . . . . 0.28000000000000003 113.113 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.88 -129.66 1.11 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.547 -0.835 . . . . 0.17000000000000001 112.497 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 93.6 m -151.14 143.91 16.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.723 0.297 . . . . 0.19 111.549 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -56.66 134.06 61.98 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.789 1.659 . . . . 0.22 109.526 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.6 p -36.11 -33.88 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.396 0.435 . . . . 1.3999999999999999 111.473 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.506 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -67.64 -47.29 70.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.028 -0.533 . . . . 0.40999999999999998 111.511 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.84 -176.64 2.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.699 1.0 . . . . 0.56000000000000005 113.699 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.78 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.4 pp -138.62 135.22 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 113.793 -1.549 . . . . 0.14000000000000001 108.662 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 21.0 tptm -64.87 95.29 0.15 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.416 -0.356 . . . . 0.77000000000000002 110.842 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.634 HG21 ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -71.88 -31.5 41.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.142 0.496 . . . . 0.20999999999999999 109.769 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.75 -149.88 14.77 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.544 -0.753 . . . . 0.20000000000000001 111.323 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.1 p -109.4 143.76 38.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.781 0.324 . . . . 1.01 110.132 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.741 ' SG ' ' HA ' ' A' ' 29' ' ' CYS . 84.3 m . . . . . 0 C--N 1.319 -0.733 0 CA-C-N 116.217 -0.447 . . . . 1.1599999999999999 110.155 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.545 ' HG2' ' HB2' ' A' ' 10' ' ' PHE . 76.9 mtm180 . . . . . 0 CA--C 1.511 -0.535 0 N-CA-C 113.096 0.776 . . . . 0.64000000000000001 113.096 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.483 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 27.7 m -102.84 140.04 37.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.857 -1.065 . . . . 0.68000000000000005 110.695 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.741 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -93.3 125.04 37.69 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.236 -1.024 . . . . 0.71999999999999997 108.236 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.547 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 13.2 m -121.72 138.26 54.42 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.789 0.804 . . . . 0.16 111.705 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.78 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -129.9 174.66 9.54 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.276 -1.329 . . . . 0.12 108.381 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.796 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 45.4 m95 -87.25 142.11 33.24 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-O 121.412 0.625 . . . . 0.42999999999999999 111.413 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.8 Cg_endo -58.38 -23.61 64.31 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 125.004 3.802 . . . . 0.27000000000000002 117.413 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.796 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -21.9 -37.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.264 1.209 . . . . 0.32000000000000001 114.264 -177.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -155.04 20.58 0.44 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.936 0.398 . . . . 1.8999999999999999 110.64 -177.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.772 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.39 -0.815 . . . . 1.3200000000000001 111.059 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 45.8 m . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 108.24 -1.022 . . . . 0.98999999999999999 108.24 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 6.9 mtpm? -40.66 80.58 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.422 0.451 . . . . 2.2000000000000002 111.765 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.663 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 136.78 -38.0 1.8 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.179 -0.534 . . . . 0.33000000000000002 112.931 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.79 -121.89 0.67 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.363 -0.446 . . . . 0.40000000000000002 112.071 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.0 m -145.41 163.55 34.27 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.488 -0.419 . . . . 0.73999999999999999 110.143 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.686 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -95.82 138.27 33.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.307 0.575 . . . . 1.04 111.61 -177.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.626 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.5 m-70 -127.56 135.09 49.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.181 -0.918 . . . . 0.17000000000000001 109.198 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.498 ' CB ' ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -71.45 134.81 46.85 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.863 -0.421 . . . . 0.48999999999999999 109.863 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.39 -42.09 1.98 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.89 -0.671 . . . . 0.28000000000000003 112.411 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.86 -129.53 1.72 Allowed Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.699 -0.763 . . . . 0.17000000000000001 112.313 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.7 m -151.86 140.6 13.67 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.534 0.207 . . . . 0.19 111.335 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 16' ' ' HIS . 36.8 Cg_exo -52.64 134.61 53.93 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.573 1.515 . . . . 0.22 109.548 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -35.61 -33.59 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.113 0.482 . . . . 1.3999999999999999 111.774 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -69.14 -49.16 59.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.74 -0.664 . . . . 0.40999999999999998 111.62 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.476 HD21 ' CE2' ' A' ' 32' ' ' TRP . 30.7 mt -75.04 147.53 40.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.312 1.227 . . . . 0.56000000000000005 114.312 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.876 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.6 pp -98.25 138.39 23.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 112.876 -1.966 . . . . 0.14000000000000001 110.133 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 21' ' ' GLY . 21.2 tptm -72.45 105.4 4.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.531 -0.304 . . . . 0.77000000000000002 110.259 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -83.74 -32.77 9.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.128 0.489 . . . . 0.20999999999999999 110.115 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.462 ' O ' ' CE ' ' A' ' 19' ' ' LYS . . . 175.83 -156.76 22.34 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 111.077 -0.809 . . . . 0.20000000000000001 111.077 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 18.4 t -95.58 -170.61 2.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.258 0.529 . . . . 1.01 109.953 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.551 ' N ' ' O ' ' A' ' 27' ' ' ARG . 51.2 t . . . . . 0 C--N 1.322 -0.595 0 CA-C-O 120.664 0.268 . . . . 1.1599999999999999 110.932 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' CYS . 85.9 mtm180 . . . . . 0 CA--C 1.514 -0.408 0 CA-C-O 120.838 0.352 . . . . 0.64000000000000001 111.574 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.414 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 9.7 m -100.97 138.52 37.9 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.657 -0.702 . . . . 0.68000000000000005 109.429 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.546 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -91.47 126.12 36.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.145 0.498 . . . . 0.71999999999999997 109.795 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.626 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 4.5 m -117.75 143.76 45.94 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.893 0.854 . . . . 0.16 111.183 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.833 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -134.81 173.16 12.01 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.049 -1.432 . . . . 0.12 107.236 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.806 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 42.6 m95 -89.31 140.56 28.65 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-O 121.577 0.703 . . . . 0.42999999999999999 112.157 -178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 35' ' ' ASN . 29.8 Cg_endo -60.44 -16.75 43.77 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 125.078 3.852 . . . . 0.27000000000000002 116.781 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.806 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.4 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.605 0.965 . . . . 0.32000000000000001 113.605 -177.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.595 ' ND2' ' CE3' ' A' ' 34' ' ' TRP . 12.1 p30 -158.59 20.59 0.22 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.167 0.508 . . . . 1.8999999999999999 110.482 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.876 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--N 1.316 -0.869 0 CA-C-O 118.435 -0.793 . . . . 1.3200000000000001 110.827 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 5' ' ' GLY . 92.5 m . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 108.489 -0.93 . . . . 0.98999999999999999 108.489 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -40.91 83.29 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.533 0.52 . . . . 2.2000000000000002 111.449 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.645 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 131.44 -41.59 1.49 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.647 -0.706 . . . . 0.33000000000000002 112.357 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . -149.4 -126.01 1.43 Allowed Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.957 -0.457 . . . . 0.40000000000000002 111.957 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 m -135.24 167.09 21.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.129 0.49 . . . . 0.73999999999999999 110.899 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' SG ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -95.84 134.2 39.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.76 -0.655 . . . . 1.04 110.407 -179.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.61 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 38.0 m-70 -130.6 135.35 47.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.36 -0.836 . . . . 0.17000000000000001 109.461 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -74.54 135.47 42.15 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.738 -0.385 . . . . 0.48999999999999999 110.203 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.36 -43.99 1.59 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.016 -0.612 . . . . 0.28000000000000003 112.896 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.93 -129.8 1.59 Allowed Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.728 -0.748 . . . . 0.17000000000000001 111.989 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.2 m -152.35 144.47 16.64 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.493 0.187 . . . . 0.19 111.037 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 16' ' ' HIS . 29.1 Cg_exo -55.63 134.08 61.84 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.557 1.504 . . . . 0.22 109.235 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.5 m -34.76 -32.67 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.277 0.473 . . . . 1.3999999999999999 112.277 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -69.51 -48.92 59.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.958 0.409 . . . . 0.40999999999999998 111.58 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.437 HD21 ' CE2' ' A' ' 32' ' ' TRP . 37.8 mt -73.47 149.22 42.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.623 1.342 . . . . 0.56000000000000005 114.623 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.853 HG12 ' HB3' ' A' ' 36' ' ' ALA . 2.0 pp -99.91 138.56 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 112.94 -1.937 . . . . 0.14000000000000001 110.257 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 22.2 tptm -69.97 97.09 1.1 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.442 -0.344 . . . . 0.77000000000000002 110.599 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -73.81 -31.12 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.016 0.436 . . . . 0.20999999999999999 110.297 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.71 -151.19 16.49 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.941 -0.647 . . . . 0.20000000000000001 111.912 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.5 p -96.68 178.11 5.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.71 0.291 . . . . 1.01 110.986 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.626 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 43.7 t . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 116.226 -0.443 . . . . 1.1599999999999999 109.844 -179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.626 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 80.4 mtm180 . . . . . 0 CA--C 1.514 -0.436 0 CA-C-O 121.055 0.455 . . . . 0.64000000000000001 111.569 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.424 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 50.8 m -102.54 138.85 38.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.272 -0.876 . . . . 0.68000000000000005 109.144 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.477 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -91.97 126.21 36.97 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.357 -0.608 . . . . 0.71999999999999997 109.357 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.61 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 5.1 m -118.58 139.34 51.63 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.917 0.865 . . . . 0.16 111.47 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.803 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -135.04 173.17 12.03 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.963 -1.471 . . . . 0.12 107.331 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.792 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 45.6 m95 -86.34 139.58 34.08 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-O 121.485 0.66 . . . . 0.42999999999999999 112.076 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 35' ' ' ASN . 10.3 Cg_endo -54.04 -25.81 38.38 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 125.204 3.936 . . . . 0.27000000000000002 117.448 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.792 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -23.14 -38.16 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.012 1.116 . . . . 0.32000000000000001 114.012 -177.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.647 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.3 OUTLIER -158.54 40.75 0.25 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.621 -0.511 . . . . 1.8999999999999999 109.621 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.853 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.18 -0.914 . . . . 1.3200000000000001 110.825 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 5' ' ' GLY . 76.8 m . . . . . 0 N--CA 1.443 -0.803 0 N-CA-C 107.745 -1.205 . . . . 0.98999999999999999 107.745 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -34.02 78.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.927 0.714 . . . . 2.2000000000000002 112.927 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.75 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 134.55 -43.29 1.27 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.712 -0.756 . . . . 0.33000000000000002 113.394 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.56 -136.71 2.51 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.662 -0.78 . . . . 0.40000000000000002 112.772 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -116.26 162.23 17.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.243 0.544 . . . . 0.73999999999999999 111.344 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -96.08 139.09 32.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.631 -0.713 . . . . 1.04 109.888 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.622 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 27.1 m-70 -134.02 132.77 40.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.17000000000000001 109.81 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.54 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -73.01 132.94 44.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.303 -0.408 . . . . 0.48999999999999999 110.226 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.02 -48.16 0.98 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.129 -0.558 . . . . 0.28000000000000003 112.631 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.4 -139.74 4.02 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 111.423 -0.671 . . . . 0.17000000000000001 111.423 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.4 m -147.13 137.41 12.35 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.675 0.238 . . . . 0.19 111.158 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 17' ' ' LEU . 32.8 Cg_exo -52.54 133.22 48.57 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.833 1.689 . . . . 0.22 109.602 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.5 t -35.91 -34.19 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.328 0.393 . . . . 1.3999999999999999 111.779 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.494 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -62.55 -48.62 78.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.235 0.54 . . . . 0.40999999999999998 110.386 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.432 HD21 ' CE2' ' A' ' 32' ' ' TRP . 37.1 mt -77.32 155.32 32.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.637 1.208 . . . . 0.56000000000000005 114.088 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.891 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.8 pp -108.42 134.21 51.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 112.704 -2.043 . . . . 0.14000000000000001 110.005 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' A' ' 28' ' ' SER . 22.4 tptm -68.71 93.47 0.53 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.809 0.337 . . . . 0.77000000000000002 110.211 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -71.46 -28.67 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.41 0.624 . . . . 0.20999999999999999 109.863 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.31 -156.55 27.76 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.611 -0.996 . . . . 0.20000000000000001 110.611 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.47 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 14.1 t -94.47 -179.94 5.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 117.213 0.506 . . . . 1.01 109.692 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.631 ' HB3' ' C ' ' A' ' 27' ' ' ARG . 42.4 t . . . . . 0 C--N 1.317 -0.838 0 CA-C-N 116.197 -0.456 . . . . 1.1599999999999999 110.355 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.631 ' C ' ' HB3' ' A' ' 23' ' ' CYS . 79.8 mtm180 . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 110.072 -0.344 . . . . 0.64000000000000001 110.072 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.429 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . 58.8 m -105.58 141.24 37.38 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.911 -0.774 . . . . 0.68000000000000005 108.911 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 22' ' ' SER . 0.9 OUTLIER -91.65 125.65 36.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.183 0.516 . . . . 0.71999999999999997 109.803 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.622 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 4.4 m -120.03 138.6 53.42 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.934 0.873 . . . . 0.16 110.728 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.75 ' HB1' ' HA3' ' A' ' 5' ' ' GLY . . . -136.25 173.66 11.46 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.119 -1.401 . . . . 0.12 107.455 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.817 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 52.1 m95 -87.45 141.81 32.65 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-O 121.443 0.64 . . . . 0.42999999999999999 111.996 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' ASN . 16.8 Cg_endo -57.56 -21.15 44.95 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 125.179 3.919 . . . . 0.27000000000000002 117.565 -176.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.817 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.16 -35.91 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.65 0.981 . . . . 0.32000000000000001 113.65 -177.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.661 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -155.28 31.83 0.38 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.401 -0.592 . . . . 1.8999999999999999 109.401 -177.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.891 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 119.051 -0.5 . . . . 1.3200000000000001 110.121 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.835 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 94.8 m . . . . . 0 CA--C 1.511 -0.52 0 N-CA-C 109.027 -0.731 . . . . 0.98999999999999999 109.027 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -48.67 79.33 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.747 0.308 . . . . 2.2000000000000002 110.745 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.761 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 131.76 -28.34 3.56 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.626 -0.797 . . . . 0.33000000000000002 112.857 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.17 -121.33 0.64 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.923 -0.656 . . . . 0.40000000000000002 112.699 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -148.79 173.14 13.58 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.58 -0.365 . . . . 0.73999999999999999 110.844 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' SG ' ' A' ' 3' ' ' CYS . 86.8 m -93.53 143.16 26.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.974 -0.557 . . . . 1.04 111.027 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.658 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 37.3 m-70 -144.44 122.12 11.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.605 -0.725 . . . . 0.17000000000000001 109.401 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.482 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 2.7 t80 -69.14 136.61 52.43 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 120.268 -0.573 . . . . 0.48999999999999999 109.863 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.42 -45.71 1.27 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.028 -0.606 . . . . 0.28000000000000003 112.037 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.74 -134.89 3.12 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.987 -0.845 . . . . 0.17000000000000001 110.987 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.4 m -148.05 142.77 16.85 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 120.572 0.225 . . . . 0.19 110.933 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 16' ' ' HIS . 51.8 Cg_exo -50.6 132.91 37.19 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.659 1.572 . . . . 0.22 109.804 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 p -36.16 -26.82 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.598 0.592 . . . . 1.3999999999999999 112.598 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -78.85 -45.51 20.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.085 0.469 . . . . 0.40999999999999998 111.526 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.8 mt -74.29 143.2 45.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.341 1.067 . . . . 0.56000000000000005 113.861 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.834 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.9 pp -95.96 138.72 20.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.182 -1.826 . . . . 0.14000000000000001 110.504 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -72.43 100.38 2.68 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.178 -0.465 . . . . 0.77000000000000002 110.84 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.809 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -74.2 -36.41 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.169 -0.308 . . . . 0.20999999999999999 110.169 179.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.39 -161.3 28.64 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.062 -0.589 . . . . 0.20000000000000001 112.178 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.55 138.91 34.25 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.494 0.318 . . . . 1.01 110.721 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 98.5 m . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.498 -0.319 . . . . 1.1599999999999999 110.857 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 10' ' ' PHE . 68.7 mtm180 . . . . . 0 CA--C 1.509 -0.611 0 N-CA-C 113.34 0.867 . . . . 0.64000000000000001 113.34 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 m -105.43 140.81 37.98 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.669 -1.15 . . . . 0.68000000000000005 110.506 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -92.88 125.75 37.63 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.557 -0.905 . . . . 0.71999999999999997 108.557 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.658 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 4.3 m -118.27 137.38 53.09 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.804 0.811 . . . . 0.16 111.291 -177.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.834 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -133.98 171.92 13.54 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.398 -1.274 . . . . 0.12 108.014 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.768 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 37.1 m95 -88.74 139.31 29.43 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-O 121.446 0.641 . . . . 0.42999999999999999 112.073 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.602 ' O ' ' N ' ' A' ' 35' ' ' ASN . 12.3 Cg_endo -54.54 -20.95 22.55 Favored 'Trans proline' 0 N--CA 1.486 1.086 1 C-N-CA 125.339 4.026 . . . . 0.27000000000000002 117.663 -177.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.768 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.16 -34.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.614 0.968 . . . . 0.32000000000000001 113.614 -177.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.671 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -158.23 37.76 0.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.848 -0.797 . . . . 1.8999999999999999 108.848 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.803 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.081 -0.962 . . . . 1.3200000000000001 110.191 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.632 ' O ' ' N ' ' A' ' 5' ' ' GLY . 63.5 m . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 108.429 -0.952 . . . . 0.98999999999999999 108.429 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 9.5 mtpm? -41.86 80.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 2.2000000000000002 111.961 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.706 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 136.83 -37.81 1.82 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.713 -0.676 . . . . 0.33000000000000002 112.511 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.6 -119.63 0.66 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.383 -0.437 . . . . 0.40000000000000002 112.017 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.4 m -143.81 169.48 17.69 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.342 -0.505 . . . . 0.73999999999999999 110.769 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -95.07 134.37 37.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.421 0.629 . . . . 1.04 111.059 -178.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.706 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 42.4 m-70 -130.47 134.83 47.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.987 -1.006 . . . . 0.17000000000000001 109.582 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.526 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -77.14 141.42 40.16 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.847 -0.341 . . . . 0.48999999999999999 110.757 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.66 -42.78 2.52 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.122 -0.561 . . . . 0.28000000000000003 112.784 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.97 -137.92 3.21 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.484 -0.865 . . . . 0.17000000000000001 112.169 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.6 m -153.62 141.98 14.15 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.363 -0.236 . . . . 0.19 110.363 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 17' ' ' LEU . 32.4 Cg_exo -50.33 131.75 32.6 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.259 1.306 . . . . 0.22 109.602 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -36.3 -32.28 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.26 0.35 . . . . 1.3999999999999999 111.503 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.488 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -65.68 -48.31 72.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.445 0.64 . . . . 0.40999999999999998 110.618 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 14' ' ' PRO . 32.7 mt -74.27 153.28 39.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.993 1.109 . . . . 0.56000000000000005 113.993 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.831 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.7 pp -108.95 138.73 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 113.037 -1.892 . . . . 0.14000000000000001 110.166 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -71.38 96.6 1.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.977 0.418 . . . . 0.77000000000000002 111.23 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -74.46 -33.84 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.32 0.581 . . . . 0.20999999999999999 110.411 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.34 -160.95 26.69 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.176 -0.769 . . . . 0.20000000000000001 111.176 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.4 p -91.64 -172.41 3.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.013 0.407 . . . . 1.01 110.229 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.636 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 41.4 t . . . . . 0 C--N 1.32 -0.692 0 N-CA-C 109.415 -0.587 . . . . 1.1599999999999999 109.415 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.636 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 81.8 mtm180 . . . . . 0 CA--C 1.513 -0.466 0 CA-C-O 121.05 0.453 . . . . 0.64000000000000001 111.694 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.51 138.11 40.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.458 -0.792 . . . . 0.68000000000000005 109.06 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.562 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -91.36 125.34 36.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.016 -0.735 . . . . 0.71999999999999997 109.016 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.706 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 3.6 m -114.05 139.04 49.6 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.392 -0.822 . . . . 0.16 111.429 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.817 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -133.72 172.04 13.32 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.215 -1.357 . . . . 0.12 107.734 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.797 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 39.0 m95 -89.15 139.18 28.7 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-O 121.581 0.705 . . . . 0.42999999999999999 112.049 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.571 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 18.9 Cg_endo -56.77 -15.98 18.26 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 125.231 3.954 . . . . 0.27000000000000002 117.413 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.797 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -28.84 -34.23 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 119.301 0.955 . . . . 0.32000000000000001 112.787 -177.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.646 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -157.52 35.61 0.27 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.941 -0.763 . . . . 1.8999999999999999 108.941 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.831 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.571 -0.728 . . . . 1.3200000000000001 110.233 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.613 ' O ' ' N ' ' A' ' 5' ' ' GLY . 64.5 m . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 108.807 -0.812 . . . . 0.98999999999999999 108.807 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -41.79 81.09 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.385 0.428 . . . . 2.2000000000000002 111.954 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.705 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 133.7 -35.08 2.31 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.004 -0.617 . . . . 0.33000000000000002 113.151 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.466 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -158.57 -135.35 1.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.834 -0.698 . . . . 0.40000000000000002 112.413 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 30' ' ' CYS . 20.3 m -124.92 159.6 30.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.007 0.432 . . . . 0.73999999999999999 111.592 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -96.11 138.46 33.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.816 -0.629 . . . . 1.04 110.12 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.57 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 40.4 m-70 -135.82 138.8 42.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.765 -0.652 . . . . 0.17000000000000001 109.463 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 1.4 t80 -72.18 133.25 45.03 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.621 -0.432 . . . . 0.48999999999999999 111.329 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.49 -45.36 1.4 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.119 -0.562 . . . . 0.28000000000000003 113.679 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.65 -134.91 2.0 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.577 -0.82 . . . . 0.17000000000000001 112.1 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.9 m -149.77 139.62 13.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.741 0.305 . . . . 0.19 111.756 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 16' ' ' HIS . 52.6 Cg_exo -47.85 131.45 20.69 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.664 1.576 . . . . 0.22 109.565 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m -36.97 -26.71 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.398 0.436 . . . . 1.3999999999999999 111.572 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -77.43 -48.86 16.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.049 0.452 . . . . 0.40999999999999998 111.177 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.444 HD21 ' CE2' ' A' ' 32' ' ' TRP . 19.8 mt -73.85 144.5 45.44 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.558 0.947 . . . . 0.56000000000000005 113.558 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.77 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.8 pp -95.86 136.37 27.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 113.393 -1.73 . . . . 0.14000000000000001 110.151 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 20.7 tptm -68.38 103.06 1.53 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.391 -0.368 . . . . 0.77000000000000002 110.07 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -80.31 -33.87 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.986 0.422 . . . . 0.20999999999999999 110.326 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.05 -156.01 21.68 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.595 -0.729 . . . . 0.20000000000000001 111.52 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 p -92.81 170.25 9.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.935 0.368 . . . . 1.01 110.632 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.579 ' HB3' ' C ' ' A' ' 27' ' ' ARG . 48.9 t . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 116.122 -0.49 . . . . 1.1599999999999999 109.892 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.579 ' C ' ' HB3' ' A' ' 23' ' ' CYS . 89.9 mtm180 . . . . . 0 CA--C 1.514 -0.436 0 CA-C-O 120.947 0.403 . . . . 0.64000000000000001 111.915 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.413 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 16.3 m -101.09 139.05 37.31 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.365 -0.834 . . . . 0.68000000000000005 109.534 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.454 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -92.85 126.01 37.73 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.511 -0.551 . . . . 0.71999999999999997 109.511 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.57 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 3.4 m -120.64 146.26 46.57 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.788 0.804 . . . . 0.16 111.368 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.77 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -135.54 173.48 11.67 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.206 -1.361 . . . . 0.12 107.679 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.76 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 35.8 m95 -88.27 138.17 30.62 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-O 121.696 0.76 . . . . 0.42999999999999999 112.389 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.619 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 28.2 Cg_endo -59.89 -12.78 19.8 Favored 'Trans proline' 0 N--CA 1.485 0.978 0 C-N-CA 125.101 3.867 . . . . 0.27000000000000002 116.935 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TRP . . . . . 0.76 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -27.92 -36.58 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 119.085 0.857 . . . . 0.32000000000000001 112.794 -177.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.563 ' ND2' ' CE3' ' A' ' 34' ' ' TRP . 12.8 p30 -159.09 29.38 0.21 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.684 0.754 . . . . 1.8999999999999999 109.667 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.656 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.785 -1.098 . . . . 1.3200000000000001 110.064 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 2' ' ' PHE . 1.1 tm? . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 109.953 -0.388 . . . . 1.6100000000000001 109.953 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 22.3 t80 -76.25 162.91 27.55 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.052 0.453 . . . . 0.56000000000000005 110.446 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.62 ' O ' ' N ' ' A' ' 5' ' ' GLY . 70.7 m -142.02 140.11 32.55 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.182 -0.673 . . . . 0.98999999999999999 109.182 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 mttp -42.82 80.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 O-C-N 123.582 0.551 . . . . 2.2000000000000002 111.789 -178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.674 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 132.46 -35.11 2.39 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 121.002 -0.618 . . . . 0.33000000000000002 113.022 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.34 -121.96 0.82 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 121.025 -0.607 . . . . 0.40000000000000002 112.497 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.7 m -141.56 162.19 36.08 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.479 -0.424 . . . . 0.73999999999999999 110.788 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.5 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -95.42 144.57 25.83 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.744 -0.662 . . . . 1.04 110.847 -178.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.506 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.4 m-70 -142.09 128.7 20.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.49 -0.777 . . . . 0.17000000000000001 109.64 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.511 ' CE1' ' HB2' ' A' ' 26' ' ' PHE . 1.6 t80 -66.23 126.41 28.62 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.841 -0.429 . . . . 0.48999999999999999 109.841 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 115.44 -51.73 0.7 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.829 -0.7 . . . . 0.28000000000000003 112.826 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -177.62 -128.9 1.2 Allowed Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.809 -0.71 . . . . 0.17000000000000001 111.994 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.1 m -148.8 136.72 11.3 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 120.81 0.338 . . . . 0.19 111.737 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.19 133.7 42.24 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.71 1.606 . . . . 0.22 109.182 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.9 p -36.56 -36.29 0.1 Allowed 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.822 0.344 . . . . 1.3999999999999999 111.665 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.413 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -63.58 -48.3 77.97 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.158 -0.473 . . . . 0.40999999999999998 111.487 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 22.1 mt -74.47 177.3 6.07 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 114.144 1.165 . . . . 0.56000000000000005 114.144 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.96 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.6 pp -131.61 136.18 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 CA-C-N 113.183 -1.826 . . . . 0.14000000000000001 109.237 -179.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -66.9 102.42 0.96 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.776 0.322 . . . . 0.77000000000000002 110.353 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.54 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.55 -33.47 15.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.20999999999999999 110.023 179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.22 -163.4 34.18 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.55 -0.75 . . . . 0.20000000000000001 111.36 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.38 148.63 24.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.869 0.334 . . . . 1.01 110.178 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.67 ' SG ' ' N ' ' A' ' 24' ' ' PHE . 28.9 t -96.9 -166.83 1.46 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.847 -0.797 . . . . 1.1599999999999999 108.847 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.67 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 8.1 t80 -61.23 107.39 0.75 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.423 -0.954 . . . . 0.88 108.423 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.07 -136.67 30.89 Favored Glycine 0 N--CA 1.434 -1.469 0 CA-C-N 114.879 -1.055 . . . . 1.75 113.638 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.591 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -56.39 -12.65 1.76 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 114.038 1.125 . . . . 0.69999999999999996 114.038 -178.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.605 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 80.9 mtm180 -75.75 159.85 30.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.184 0.516 . . . . 0.64000000000000001 112.337 -178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.6 m -111.12 137.17 49.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.186 -0.916 . . . . 0.68000000000000005 109.679 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.13 126.57 38.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.695 -0.483 . . . . 0.71999999999999997 109.695 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.506 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 7.6 m -120.85 140.89 51.14 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 121.918 0.866 . . . . 0.16 111.942 -177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.725 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -129.5 173.53 10.48 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.123 -1.399 . . . . 0.12 108.287 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.762 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 31.3 m95 -84.95 140.41 37.3 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-O 121.477 0.656 . . . . 0.42999999999999999 112.056 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.605 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 19.7 Cg_endo -58.35 -15.78 25.78 Favored 'Trans proline' 0 N--CA 1.487 1.108 0 C-N-CA 125.107 3.872 . . . . 0.27000000000000002 117.521 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.762 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -29.79 -33.41 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.257 0 CA-C-N 119.228 0.922 . . . . 0.32000000000000001 113.176 -177.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.66 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -157.62 40.82 0.29 Allowed 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.929 -0.767 . . . . 1.8999999999999999 108.929 -177.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.96 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.002 -0.999 . . . . 1.3200000000000001 110.649 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.457 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 37.5 tp . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.506 -0.183 . . . . 1.6100000000000001 110.506 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 28.5 t80 -76.2 164.13 26.38 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.665 -0.865 . . . . 0.56000000000000005 108.665 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.66 ' O ' ' N ' ' A' ' 5' ' ' GLY . 62.4 m -143.9 137.74 28.06 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.339 -0.986 . . . . 0.98999999999999999 108.339 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.569 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 8.0 mtpm? -43.24 79.78 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.903 0.382 . . . . 2.2000000000000002 111.278 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.698 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 138.47 -37.6 1.78 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.984 -0.627 . . . . 0.33000000000000002 112.509 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.7 -118.48 0.58 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 121.35 -0.453 . . . . 0.40000000000000002 112.108 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 40.0 m -149.4 165.04 33.25 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.127 0.489 . . . . 0.73999999999999999 111.098 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' SG ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -96.69 140.54 31.13 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.499 -0.773 . . . . 1.04 110.81 -178.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.428 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 27.4 m-70 -135.36 134.33 39.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.36 -0.837 . . . . 0.17000000000000001 108.865 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.557 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -69.11 123.91 22.36 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.804 -0.358 . . . . 0.48999999999999999 110.555 -179.502 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.05 -48.88 0.9 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.127 -0.558 . . . . 0.28000000000000003 112.823 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -179.23 -128.29 1.18 Allowed Glycine 0 N--CA 1.44 -1.034 0 C-N-CA 121.096 -0.573 . . . . 0.17000000000000001 111.932 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.5 m -148.24 141.82 15.84 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.592 0.234 . . . . 0.19 111.53 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 17' ' ' LEU . 25.1 Cg_exo -55.84 132.27 51.02 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.543 1.496 . . . . 0.22 108.979 178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.4 m -36.22 -33.26 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 O-C-N 123.188 0.305 . . . . 1.3999999999999999 111.758 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.449 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -66.07 -48.32 71.37 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.561 -0.456 . . . . 0.40999999999999998 110.901 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.403 ' N ' ' O ' ' A' ' 14' ' ' PRO . 22.5 mt -71.61 179.65 2.96 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.751 1.389 . . . . 0.56000000000000005 114.751 -176.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.82 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.4 pp -135.48 136.6 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 113.14 -1.846 . . . . 0.14000000000000001 109.093 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -65.75 102.06 0.71 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.784 0.326 . . . . 0.77000000000000002 110.6 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.9 -34.09 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.206 0.527 . . . . 0.20999999999999999 109.867 179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.99 -169.69 42.85 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 111.188 -0.765 . . . . 0.20000000000000001 111.188 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.5 p -84.94 153.0 23.1 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.13 0.465 . . . . 1.01 111.078 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.601 ' HB3' ' HB2' ' A' ' 27' ' ' ARG . 44.6 t -98.0 -162.68 0.97 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.655 -0.702 . . . . 1.1599999999999999 109.912 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.526 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 52.9 t80 -82.23 134.48 35.29 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.354 0.597 . . . . 0.88 111.684 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 71.16 -43.16 0.65 Allowed Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 116.324 1.289 . . . . 1.75 116.324 177.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.695 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -178.9 -16.65 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 117.762 0.781 . . . . 0.69999999999999996 112.786 -176.217 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.601 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 86.5 mtm180 -66.18 161.71 21.42 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.626 -0.261 . . . . 0.64000000000000001 110.901 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 8' ' ' CYS . 71.3 m -103.1 138.14 40.33 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.078 -0.712 . . . . 0.68000000000000005 109.078 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.443 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -92.32 126.72 37.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.863 -0.421 . . . . 0.71999999999999997 109.863 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.428 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 5.8 m -122.77 140.84 52.47 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.009 0.909 . . . . 0.16 112.737 -177.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.78 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -127.97 173.12 10.3 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 114.064 -1.425 . . . . 0.12 107.881 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.763 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 36.6 m95 -86.87 140.58 33.1 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-O 121.439 0.637 . . . . 0.42999999999999999 111.81 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.576 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 30.9 Cg_endo -61.32 -13.21 27.41 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 125.131 3.887 . . . . 0.27000000000000002 117.259 -177.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.763 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -29.38 -34.73 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 119.13 0.877 . . . . 0.32000000000000001 112.399 -178.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.64 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.4 OUTLIER -156.58 38.67 0.33 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.774 -0.825 . . . . 1.8999999999999999 108.774 -178.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.82 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-N 115.554 -0.748 . . . . 1.3200000000000001 109.88 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 2' ' ' PHE . 1.5 tm? . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 109.438 -0.579 . . . . 1.6100000000000001 109.438 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.458 ' O ' HD13 ' A' ' 1' ' ' LEU . 27.1 t80 -84.98 161.48 19.76 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.425 0.631 . . . . 0.56000000000000005 111.254 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.601 ' O ' ' N ' ' A' ' 5' ' ' GLY . 46.5 m -146.68 137.62 24.08 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 108.197 -1.038 . . . . 0.98999999999999999 108.197 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -35.02 81.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.557 0.535 . . . . 2.2000000000000002 112.44 -178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.815 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 135.54 -44.44 1.17 Allowed Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 121.043 -0.598 . . . . 0.33000000000000002 113.233 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.462 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -154.27 -140.49 3.05 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.703 -0.76 . . . . 0.40000000000000002 112.624 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 30' ' ' CYS . 4.8 m -116.42 160.71 20.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.065 0.459 . . . . 0.73999999999999999 111.675 -179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 1' ' ' LEU . 0.0 OUTLIER -95.11 149.47 21.25 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.599 -0.728 . . . . 1.04 110.273 -179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.519 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 25.9 m-70 -144.59 133.5 22.56 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.627 -0.715 . . . . 0.17000000000000001 109.608 -178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.56 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 2.1 t80 -70.74 131.37 43.76 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-N 116.311 -0.404 . . . . 0.48999999999999999 110.398 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.09 -48.68 0.93 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.257 -0.497 . . . . 0.28000000000000003 112.686 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.87 -133.64 1.75 Allowed Glycine 0 N--CA 1.439 -1.101 0 C-N-CA 120.794 -0.717 . . . . 0.17000000000000001 111.983 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 88.3 m -152.4 139.9 12.94 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-O 120.643 0.259 . . . . 0.19 111.41 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' O ' ' N ' ' A' ' 16' ' ' HIS . 51.1 Cg_exo -48.46 133.27 25.63 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 121.561 1.507 . . . . 0.22 109.553 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.4 m -36.02 -33.02 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.814 0 O-C-N 123.367 0.417 . . . . 1.3999999999999999 111.54 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.505 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -71.96 -48.84 42.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.316 -0.402 . . . . 0.40999999999999998 111.737 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.47 HD21 ' NE1' ' A' ' 32' ' ' TRP . 24.9 mt -73.0 143.03 47.74 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.055 1.131 . . . . 0.56000000000000005 114.055 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.792 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.8 pp -95.55 137.0 24.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 113.047 -1.888 . . . . 0.14000000000000001 110.396 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE2' ' O ' ' A' ' 21' ' ' GLY . 24.4 tptm -67.82 100.65 0.96 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.333 -0.394 . . . . 0.77000000000000002 110.089 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.463 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -79.49 -33.4 15.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.777 0.322 . . . . 0.20999999999999999 110.942 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.435 ' O ' ' HE2' ' A' ' 19' ' ' LYS . . . 173.24 -155.79 23.21 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.774 -0.727 . . . . 0.20000000000000001 111.879 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.18 146.26 23.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.231 0.539 . . . . 1.01 111.696 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.658 ' SG ' ' N ' ' A' ' 24' ' ' PHE . 43.1 t -101.25 -165.21 1.18 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.465 -0.789 . . . . 1.1599999999999999 109.412 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.658 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 36.8 t80 -57.55 107.65 0.47 Allowed 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 108.629 -0.878 . . . . 0.88 108.629 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 64.8 -137.44 39.02 Favored Glycine 0 N--CA 1.431 -1.64 0 CA-C-N 115.034 -0.985 . . . . 1.75 113.313 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.65 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -56.39 -13.28 2.12 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 113.476 0.917 . . . . 0.69999999999999996 113.476 -179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.647 HH21 ' HB3' ' A' ' 24' ' ' PHE . 75.0 mtm180 -69.32 159.01 33.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.276 0.56 . . . . 0.64000000000000001 112.444 -178.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.0 m -110.33 138.7 46.36 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.036 -0.984 . . . . 0.68000000000000005 109.576 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.411 ' HA ' ' HB2' ' A' ' 8' ' ' CYS . 0.5 OUTLIER -92.53 125.6 37.24 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.111 -0.7 . . . . 0.71999999999999997 109.111 179.817 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.519 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 3.3 m -119.59 146.67 45.31 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.745 0.783 . . . . 0.16 110.955 -178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.815 ' HB1' ' HA3' ' A' ' 5' ' ' GLY . . . -138.85 173.5 11.51 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 114.244 -1.344 . . . . 0.12 107.681 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.759 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 33.7 m95 -88.98 138.47 29.2 Favored Pre-proline 0 C--N 1.309 -1.183 0 CA-C-O 121.505 0.669 . . . . 0.42999999999999999 112.54 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.632 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 17.8 Cg_endo -57.36 -16.95 24.77 Favored 'Trans proline' 0 N--CA 1.487 1.114 1 C-N-CA 125.357 4.038 . . . . 0.27000000000000002 117.011 -177.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.759 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -27.27 -36.04 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.435 0.902 . . . . 0.32000000000000001 113.435 -177.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.578 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 15.1 p30 -159.28 29.35 0.2 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.915 0.865 . . . . 1.8999999999999999 109.735 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.783 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--N 1.313 -1.022 0 CA-C-N 114.68 -1.145 . . . . 1.3200000000000001 110.209 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 31.7 tp . . . . . 0 N--CA 1.479 0.988 0 CA-C-O 120.62 0.248 . . . . 1.6100000000000001 110.685 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.625 ' CE1' ' O ' ' A' ' 3' ' ' CYS . 27.9 t80 -76.73 165.18 25.09 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.247 0.546 . . . . 0.56000000000000005 109.865 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.638 ' O ' ' N ' ' A' ' 5' ' ' GLY . 40.7 t -144.08 145.24 32.03 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.975 -1.12 . . . . 0.98999999999999999 107.975 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 45.6 mtpt -45.58 81.58 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.21 0.529 . . . . 2.2000000000000002 111.23 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.669 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 127.18 -32.65 3.53 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 115.563 -0.744 . . . . 0.33000000000000002 112.772 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.505 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -153.25 -114.03 0.54 Allowed Glycine 0 CA--C 1.518 0.24 0 C-N-CA 120.917 -0.659 . . . . 0.40000000000000002 113.05 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 30' ' ' CYS . 19.2 m -150.31 171.35 17.12 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.484 -0.421 . . . . 0.73999999999999999 111.589 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 94.1 m -95.59 144.01 26.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.81 -0.632 . . . . 1.04 111.45 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.547 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 50.7 m-70 -150.5 123.13 8.56 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.852 -0.613 . . . . 0.17000000000000001 109.656 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.622 ' CE1' ' HB2' ' A' ' 26' ' ' PHE . 2.0 t80 -67.32 127.92 34.48 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.71 -0.396 . . . . 0.48999999999999999 110.152 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.14 -55.83 0.49 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 121.189 -0.529 . . . . 0.28000000000000003 113.113 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -168.88 -129.66 1.11 Allowed Glycine 0 N--CA 1.441 -0.967 0 C-N-CA 120.547 -0.835 . . . . 0.17000000000000001 112.497 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 93.6 m -151.14 143.91 16.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-O 120.723 0.297 . . . . 0.19 111.549 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -56.66 134.06 61.98 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 121.789 1.659 . . . . 0.22 109.526 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.6 p -36.11 -33.88 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.768 0 O-C-N 123.396 0.435 . . . . 1.3999999999999999 111.473 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.506 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -67.64 -47.29 70.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.028 -0.533 . . . . 0.40999999999999998 111.511 -179.409 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -72.84 -176.64 2.09 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.699 1.0 . . . . 0.56000000000000005 113.699 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.78 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.4 pp -138.62 135.22 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 113.793 -1.549 . . . . 0.14000000000000001 108.662 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 21.0 tptm -64.87 95.29 0.15 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.416 -0.356 . . . . 0.77000000000000002 110.842 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.634 HG21 ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -71.88 -31.5 41.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.142 0.496 . . . . 0.20999999999999999 109.769 179.207 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.75 -149.88 14.77 Favored Glycine 0 N--CA 1.45 -0.414 0 CA-C-N 115.544 -0.753 . . . . 0.20000000000000001 111.323 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.1 p -109.4 143.76 38.53 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.781 0.324 . . . . 1.01 110.132 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.741 ' SG ' ' HA ' ' A' ' 29' ' ' CYS . 84.3 m -97.42 -163.62 1.06 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.217 -0.447 . . . . 1.1599999999999999 110.155 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.557 ' HB3' HH21 ' A' ' 27' ' ' ARG . 14.3 t80 -53.27 105.2 0.12 Allowed 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.727 0.775 . . . . 0.88 109.195 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.28 -138.33 29.11 Favored Glycine 0 N--CA 1.432 -1.594 0 CA-C-N 114.227 -1.351 . . . . 1.75 114.41 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.642 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -55.9 -17.67 7.06 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.062 1.345 . . . . 0.69999999999999996 114.481 -178.124 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.557 HH21 ' HB3' ' A' ' 24' ' ' PHE . 76.9 mtm180 -73.1 153.92 40.6 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 113.096 0.776 . . . . 0.64000000000000001 113.096 -177.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.483 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 27.7 m -102.84 140.04 37.64 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.857 -1.065 . . . . 0.68000000000000005 110.695 -179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.741 ' HA ' ' SG ' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -93.3 125.04 37.69 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.236 -1.024 . . . . 0.71999999999999997 108.236 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.547 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 13.2 m -121.72 138.26 54.42 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.789 0.804 . . . . 0.16 111.705 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.78 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -129.9 174.66 9.54 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 114.276 -1.329 . . . . 0.12 108.381 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.796 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 45.4 m95 -87.25 142.11 33.24 Favored Pre-proline 0 C--N 1.307 -1.259 0 CA-C-O 121.412 0.625 . . . . 0.42999999999999999 111.413 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.624 ' O ' ' N ' ' A' ' 35' ' ' ASN . 18.8 Cg_endo -58.38 -23.61 64.31 Favored 'Trans proline' 0 N--CA 1.487 1.088 0 C-N-CA 125.004 3.802 . . . . 0.27000000000000002 117.413 -176.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.796 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -21.9 -37.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.264 1.209 . . . . 0.32000000000000001 114.264 -177.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -155.04 20.58 0.44 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.936 0.398 . . . . 1.8999999999999999 110.64 -177.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.772 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.39 -0.815 . . . . 1.3200000000000001 111.059 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.729 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 1.2 tm? . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.94 -0.392 . . . . 1.6100000000000001 109.94 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 14.9 t80 -83.57 157.08 22.45 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 120.054 -0.658 . . . . 0.56000000000000005 110.574 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.686 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 45.8 m -143.74 140.41 29.96 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 108.24 -1.022 . . . . 0.98999999999999999 108.24 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 6.9 mtpm? -40.66 80.58 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 123.422 0.451 . . . . 2.2000000000000002 111.765 -178.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.663 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 136.78 -38.0 1.8 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.179 -0.534 . . . . 0.33000000000000002 112.931 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.79 -121.89 0.67 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.363 -0.446 . . . . 0.40000000000000002 112.071 -179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.0 m -145.41 163.55 34.27 Favored 'General case' 0 C--N 1.32 -0.685 0 O-C-N 122.488 -0.419 . . . . 0.73999999999999999 110.143 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 1' ' ' LEU . 0.5 OUTLIER -95.82 138.27 33.7 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.307 0.575 . . . . 1.04 111.61 -177.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.626 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 31.5 m-70 -127.56 135.09 49.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.181 -0.918 . . . . 0.17000000000000001 109.198 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.498 ' CB ' ' HG2' ' A' ' 27' ' ' ARG . 0.6 OUTLIER -71.45 134.81 46.85 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.863 -0.421 . . . . 0.48999999999999999 109.863 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 104.39 -42.09 1.98 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.89 -0.671 . . . . 0.28000000000000003 112.411 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.86 -129.53 1.72 Allowed Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.699 -0.763 . . . . 0.17000000000000001 112.313 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 89.7 m -151.86 140.6 13.67 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 120.534 0.207 . . . . 0.19 111.335 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.416 ' O ' ' N ' ' A' ' 16' ' ' HIS . 36.8 Cg_exo -52.64 134.61 53.93 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 121.573 1.515 . . . . 0.22 109.548 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -35.61 -33.59 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.113 0.482 . . . . 1.3999999999999999 111.774 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.467 ' CD2' ' N ' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -69.14 -49.16 59.41 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.74 -0.664 . . . . 0.40999999999999998 111.62 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.476 HD21 ' CE2' ' A' ' 32' ' ' TRP . 30.7 mt -75.04 147.53 40.63 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 114.312 1.227 . . . . 0.56000000000000005 114.312 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.876 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.6 pp -98.25 138.39 23.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 112.876 -1.966 . . . . 0.14000000000000001 110.133 178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 21' ' ' GLY . 21.2 tptm -72.45 105.4 4.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.531 -0.304 . . . . 0.77000000000000002 110.259 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.546 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -83.74 -32.77 9.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.128 0.489 . . . . 0.20999999999999999 110.115 179.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.462 ' O ' ' CE ' ' A' ' 19' ' ' LYS . . . 175.83 -156.76 22.34 Favored Glycine 0 C--O 1.225 -0.417 0 N-CA-C 111.077 -0.809 . . . . 0.20000000000000001 111.077 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 29' ' ' CYS . 18.4 t -95.58 -170.61 2.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.258 0.529 . . . . 1.01 109.953 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.66 ' SG ' ' HG ' ' A' ' 1' ' ' LEU . 51.2 t -143.76 -165.42 2.1 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.664 0.268 . . . . 1.1599999999999999 110.932 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.564 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 25.2 t80 -65.99 130.44 43.25 Favored 'General case' 0 N--CA 1.441 -0.893 0 CA-C-O 121.731 0.777 . . . . 0.88 112.5 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.57 -42.8 0.44 Allowed Glycine 0 N--CA 1.434 -1.437 0 CA-C-N 113.776 -1.556 . . . . 1.75 115.997 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.682 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER 179.08 -10.97 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.466 0.633 . . . . 0.69999999999999996 112.371 -176.057 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.551 ' O ' ' N ' ' A' ' 23' ' ' CYS . 85.9 mtm180 -65.63 158.99 25.8 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.838 0.352 . . . . 0.64000000000000001 111.574 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.414 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 9.7 m -100.97 138.52 37.9 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.657 -0.702 . . . . 0.68000000000000005 109.429 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.546 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.8 OUTLIER -91.47 126.12 36.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.145 0.498 . . . . 0.71999999999999997 109.795 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.626 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 4.5 m -117.75 143.76 45.94 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.893 0.854 . . . . 0.16 111.183 -178.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.833 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -134.81 173.16 12.01 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.049 -1.432 . . . . 0.12 107.236 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.806 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 42.6 m95 -89.31 140.56 28.65 Favored Pre-proline 0 C--N 1.307 -1.248 0 CA-C-O 121.577 0.703 . . . . 0.42999999999999999 112.157 -178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.588 ' O ' ' N ' ' A' ' 35' ' ' ASN . 29.8 Cg_endo -60.44 -16.75 43.77 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 125.078 3.852 . . . . 0.27000000000000002 116.781 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.806 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.4 -35.64 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 113.605 0.965 . . . . 0.32000000000000001 113.605 -177.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.595 ' ND2' ' CE3' ' A' ' 34' ' ' TRP . 12.1 p30 -158.59 20.59 0.22 Allowed 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.167 0.508 . . . . 1.8999999999999999 110.482 -177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.876 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--N 1.316 -0.869 0 CA-C-O 118.435 -0.793 . . . . 1.3200000000000001 110.827 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 110.362 -0.236 . . . . 1.6100000000000001 110.362 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.512 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 29.0 t80 -82.5 166.46 19.29 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.386 -0.598 . . . . 0.56000000000000005 109.386 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.604 ' O ' ' N ' ' A' ' 5' ' ' GLY . 92.5 m -145.63 136.92 24.92 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.489 -0.93 . . . . 0.98999999999999999 108.489 178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.5 mttm -40.91 83.29 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.533 0.52 . . . . 2.2000000000000002 111.449 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.645 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 131.44 -41.59 1.49 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.647 -0.706 . . . . 0.33000000000000002 112.357 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 3' ' ' CYS . . . -149.4 -126.01 1.43 Allowed Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.957 -0.457 . . . . 0.40000000000000002 111.957 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.9 m -135.24 167.09 21.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.129 0.49 . . . . 0.73999999999999999 110.899 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' SG ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -95.84 134.2 39.09 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.76 -0.655 . . . . 1.04 110.407 -179.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.61 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 38.0 m-70 -130.6 135.35 47.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.36 -0.836 . . . . 0.17000000000000001 109.461 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.488 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -74.54 135.47 42.15 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 120.738 -0.385 . . . . 0.48999999999999999 110.203 179.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.36 -43.99 1.59 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.016 -0.612 . . . . 0.28000000000000003 112.896 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.93 -129.8 1.59 Allowed Glycine 0 N--CA 1.439 -1.129 0 C-N-CA 120.728 -0.748 . . . . 0.17000000000000001 111.989 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.2 m -152.35 144.47 16.64 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.493 0.187 . . . . 0.19 111.037 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' O ' ' N ' ' A' ' 16' ' ' HIS . 29.1 Cg_exo -55.63 134.08 61.84 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.557 1.504 . . . . 0.22 109.235 178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 53.5 m -34.76 -32.67 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.277 0.473 . . . . 1.3999999999999999 112.277 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -69.51 -48.92 59.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.958 0.409 . . . . 0.40999999999999998 111.58 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.437 HD21 ' CE2' ' A' ' 32' ' ' TRP . 37.8 mt -73.47 149.22 42.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.623 1.342 . . . . 0.56000000000000005 114.623 -176.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.853 HG12 ' HB3' ' A' ' 36' ' ' ALA . 2.0 pp -99.91 138.56 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 112.94 -1.937 . . . . 0.14000000000000001 110.257 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.424 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 22.2 tptm -69.97 97.09 1.1 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.442 -0.344 . . . . 0.77000000000000002 110.599 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -73.81 -31.12 30.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.016 0.436 . . . . 0.20999999999999999 110.297 179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.71 -151.19 16.49 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.941 -0.647 . . . . 0.20000000000000001 111.912 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.5 p -96.68 178.11 5.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.71 0.291 . . . . 1.01 110.986 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.626 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 43.7 t -135.12 -163.87 1.44 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.226 -0.443 . . . . 1.1599999999999999 109.844 -179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.607 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 11.7 t80 -72.79 135.73 45.31 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-O 121.648 0.737 . . . . 0.88 112.326 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 68.86 -46.05 0.42 Allowed Glycine 0 N--CA 1.435 -1.375 0 CA-C-N 113.66 -1.609 . . . . 1.75 115.925 178.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.691 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -180.0 -5.56 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 117.038 0.419 . . . . 0.69999999999999996 111.727 -176.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.626 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 80.4 mtm180 -66.96 159.86 27.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.055 0.455 . . . . 0.64000000000000001 111.569 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.424 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 50.8 m -102.54 138.85 38.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.272 -0.876 . . . . 0.68000000000000005 109.144 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.477 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -91.97 126.21 36.97 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.357 -0.608 . . . . 0.71999999999999997 109.357 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.61 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 5.1 m -118.58 139.34 51.63 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.917 0.865 . . . . 0.16 111.47 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.803 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -135.04 173.17 12.03 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 113.963 -1.471 . . . . 0.12 107.331 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.792 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 45.6 m95 -86.34 139.58 34.08 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-O 121.485 0.66 . . . . 0.42999999999999999 112.076 -178.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.6 ' O ' ' N ' ' A' ' 35' ' ' ASN . 10.3 Cg_endo -54.04 -25.81 38.38 Favored 'Trans proline' 0 N--CA 1.484 0.957 0 C-N-CA 125.204 3.936 . . . . 0.27000000000000002 117.448 -176.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.792 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -23.14 -38.16 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 114.012 1.116 . . . . 0.32000000000000001 114.012 -177.037 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.647 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.3 OUTLIER -158.54 40.75 0.25 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.621 -0.511 . . . . 1.8999999999999999 109.621 -177.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.853 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.18 -0.914 . . . . 1.3200000000000001 110.825 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 36.5 tp . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 110.112 -0.329 . . . . 1.6100000000000001 110.112 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 34.9 t80 -79.94 162.82 24.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.46 0.647 . . . . 0.56000000000000005 110.197 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.64 ' O ' ' N ' ' A' ' 5' ' ' GLY . 76.8 m -150.18 137.69 19.8 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.745 -1.205 . . . . 0.98999999999999999 107.745 178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -34.02 78.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.927 0.714 . . . . 2.2000000000000002 112.927 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.75 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 134.55 -43.29 1.27 Allowed Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.712 -0.756 . . . . 0.33000000000000002 113.394 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.56 -136.71 2.51 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.662 -0.78 . . . . 0.40000000000000002 112.772 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -116.26 162.23 17.8 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.243 0.544 . . . . 0.73999999999999999 111.344 -179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -96.08 139.09 32.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.631 -0.713 . . . . 1.04 109.888 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.622 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 27.1 m-70 -134.02 132.77 40.46 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.916 -0.584 . . . . 0.17000000000000001 109.81 -178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.54 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.5 OUTLIER -73.01 132.94 44.02 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 116.303 -0.408 . . . . 0.48999999999999999 110.226 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.02 -48.16 0.98 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 121.129 -0.558 . . . . 0.28000000000000003 112.631 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.4 -139.74 4.02 Favored Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 111.423 -0.671 . . . . 0.17000000000000001 111.423 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 95.4 m -147.13 137.41 12.35 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.675 0.238 . . . . 0.19 111.158 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 17' ' ' LEU . 32.8 Cg_exo -52.54 133.22 48.57 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.833 1.689 . . . . 0.22 109.602 178.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.5 t -35.91 -34.19 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 O-C-N 123.328 0.393 . . . . 1.3999999999999999 111.779 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.494 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.8 OUTLIER -62.55 -48.62 78.7 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.235 0.54 . . . . 0.40999999999999998 110.386 -179.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.432 HD21 ' CE2' ' A' ' 32' ' ' TRP . 37.1 mt -77.32 155.32 32.07 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 122.637 1.208 . . . . 0.56000000000000005 114.088 -176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.891 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.8 pp -108.42 134.21 51.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-N 112.704 -2.043 . . . . 0.14000000000000001 110.005 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' A' ' 28' ' ' SER . 22.4 tptm -68.71 93.47 0.53 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.809 0.337 . . . . 0.77000000000000002 110.211 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -71.46 -28.67 32.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.41 0.624 . . . . 0.20999999999999999 109.863 179.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.31 -156.55 27.76 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.611 -0.996 . . . . 0.20000000000000001 110.611 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.47 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 14.1 t -94.47 -179.94 5.07 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 117.213 0.506 . . . . 1.01 109.692 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.631 ' HB3' ' C ' ' A' ' 27' ' ' ARG . 42.4 t -123.87 -164.86 1.28 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.197 -0.456 . . . . 1.1599999999999999 110.355 -179.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.621 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 34.4 t80 -73.58 133.1 43.45 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-O 121.613 0.72 . . . . 0.88 111.718 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 70.12 -43.48 0.53 Allowed Glycine 0 N--CA 1.436 -1.341 0 CA-C-N 114.157 -1.383 . . . . 1.75 115.841 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.708 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER 179.45 -13.11 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 117.734 0.767 . . . . 0.69999999999999996 112.684 -176.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.631 ' C ' ' HB3' ' A' ' 23' ' ' CYS . 79.8 mtm180 -64.8 166.29 9.21 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 110.072 -0.344 . . . . 0.64000000000000001 110.072 -179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.429 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . 58.8 m -105.58 141.24 37.38 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.911 -0.774 . . . . 0.68000000000000005 108.911 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' ' 22' ' ' SER . 0.9 OUTLIER -91.65 125.65 36.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.183 0.516 . . . . 0.71999999999999997 109.803 -179.47 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.622 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 4.4 m -120.03 138.6 53.42 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-O 121.934 0.873 . . . . 0.16 110.728 -178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.75 ' HB1' ' HA3' ' A' ' 5' ' ' GLY . . . -136.25 173.66 11.46 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.119 -1.401 . . . . 0.12 107.455 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.817 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 52.1 m95 -87.45 141.81 32.65 Favored Pre-proline 0 C--N 1.303 -1.431 0 CA-C-O 121.443 0.64 . . . . 0.42999999999999999 111.996 -178.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 35' ' ' ASN . 16.8 Cg_endo -57.56 -21.15 44.95 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 C-N-CA 125.179 3.919 . . . . 0.27000000000000002 117.565 -176.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.817 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.16 -35.91 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.65 0.981 . . . . 0.32000000000000001 113.65 -177.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.661 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -155.28 31.83 0.38 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.401 -0.592 . . . . 1.8999999999999999 109.401 -177.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.891 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 119.051 -0.5 . . . . 1.3200000000000001 110.121 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.652 HD23 ' SG ' ' A' ' 8' ' ' CYS . 19.4 tp . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 110.088 -0.338 . . . . 1.6100000000000001 110.088 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.502 ' CE1' ' O ' ' A' ' 3' ' ' CYS . 19.3 t80 -87.23 160.58 18.41 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.887 -0.412 . . . . 0.56000000000000005 109.887 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.835 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 94.8 m -136.64 144.19 43.9 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 109.027 -0.731 . . . . 0.98999999999999999 109.027 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -48.67 79.33 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.747 0.308 . . . . 2.2000000000000002 110.745 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.761 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 131.76 -28.34 3.56 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.626 -0.797 . . . . 0.33000000000000002 112.857 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.17 -121.33 0.64 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.923 -0.656 . . . . 0.40000000000000002 112.699 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.8 m -148.79 173.14 13.58 Favored 'General case' 0 C--N 1.319 -0.726 0 O-C-N 122.58 -0.365 . . . . 0.73999999999999999 110.844 -178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.835 ' SG ' ' SG ' ' A' ' 3' ' ' CYS . 86.8 m -93.53 143.16 26.56 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.974 -0.557 . . . . 1.04 111.027 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.658 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 37.3 m-70 -144.44 122.12 11.85 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.605 -0.725 . . . . 0.17000000000000001 109.401 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 26' ' ' PHE . 2.7 t80 -69.14 136.61 52.43 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 120.268 -0.573 . . . . 0.48999999999999999 109.863 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 107.42 -45.71 1.27 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 121.028 -0.606 . . . . 0.28000000000000003 112.037 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.74 -134.89 3.12 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 110.987 -0.845 . . . . 0.17000000000000001 110.987 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 92.4 m -148.05 142.77 16.85 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 120.572 0.225 . . . . 0.19 110.933 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 16' ' ' HIS . 51.8 Cg_exo -50.6 132.91 37.19 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.659 1.572 . . . . 0.22 109.804 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 2.0 p -36.16 -26.82 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.598 0.592 . . . . 1.3999999999999999 112.598 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -78.85 -45.51 20.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.085 0.469 . . . . 0.40999999999999998 111.526 -179.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.8 mt -74.29 143.2 45.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 122.341 1.067 . . . . 0.56000000000000005 113.861 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.834 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.9 pp -95.96 138.72 20.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.182 -1.826 . . . . 0.14000000000000001 110.504 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -72.43 100.38 2.68 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.178 -0.465 . . . . 0.77000000000000002 110.84 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.809 HG23 ' HB3' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -74.2 -36.41 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 110.169 -0.308 . . . . 0.20999999999999999 110.169 179.107 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.39 -161.3 28.64 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 121.062 -0.589 . . . . 0.20000000000000001 112.178 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -97.55 138.91 34.25 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.494 0.318 . . . . 1.01 110.721 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 98.5 m -97.97 -164.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.498 -0.319 . . . . 1.1599999999999999 110.857 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -52.89 109.24 0.39 Allowed 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.743 0.782 . . . . 0.88 109.342 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 62.63 -134.6 44.44 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 114.265 -1.334 . . . . 1.75 113.861 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.593 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -60.89 -8.39 3.09 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 114.4 1.259 . . . . 0.69999999999999996 114.4 -178.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HG2' ' HB2' ' A' ' 10' ' ' PHE . 68.7 mtm180 -78.51 153.0 31.7 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 113.34 0.867 . . . . 0.64000000000000001 113.34 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.4 m -105.43 140.81 37.98 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.669 -1.15 . . . . 0.68000000000000005 110.506 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.834 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -92.88 125.75 37.63 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.557 -0.905 . . . . 0.71999999999999997 108.557 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.658 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 4.3 m -118.27 137.38 53.09 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 121.804 0.811 . . . . 0.16 111.291 -177.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.834 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -133.98 171.92 13.54 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 114.398 -1.274 . . . . 0.12 108.014 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.768 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 37.1 m95 -88.74 139.31 29.43 Favored Pre-proline 0 C--N 1.308 -1.209 0 CA-C-O 121.446 0.641 . . . . 0.42999999999999999 112.073 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.602 ' O ' ' N ' ' A' ' 35' ' ' ASN . 12.3 Cg_endo -54.54 -20.95 22.55 Favored 'Trans proline' 0 N--CA 1.486 1.086 1 C-N-CA 125.339 4.026 . . . . 0.27000000000000002 117.663 -177.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.768 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -26.16 -34.91 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 113.614 0.968 . . . . 0.32000000000000001 113.614 -177.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.671 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.5 OUTLIER -158.23 37.76 0.25 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.848 -0.797 . . . . 1.8999999999999999 108.848 -178.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.803 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.081 -0.962 . . . . 1.3200000000000001 110.191 -178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 22.9 tp . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.684 0.278 . . . . 1.6100000000000001 110.927 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.563 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 28.1 t80 -85.04 165.16 17.76 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.148 -0.686 . . . . 0.56000000000000005 109.148 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.632 ' O ' ' N ' ' A' ' 5' ' ' GLY . 63.5 m -144.78 138.11 26.91 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 108.429 -0.952 . . . . 0.98999999999999999 108.429 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 4' ' ' LYS . 9.5 mtpm? -41.86 80.34 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.886 0.374 . . . . 2.2000000000000002 111.961 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.706 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 136.83 -37.81 1.82 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.713 -0.676 . . . . 0.33000000000000002 112.511 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.6 -119.63 0.66 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 121.383 -0.437 . . . . 0.40000000000000002 112.017 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.4 m -143.81 169.48 17.69 Favored 'General case' 0 C--N 1.319 -0.718 0 O-C-N 122.342 -0.505 . . . . 0.73999999999999999 110.769 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -95.07 134.37 37.85 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.421 0.629 . . . . 1.04 111.059 -178.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.706 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 42.4 m-70 -130.47 134.83 47.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.987 -1.006 . . . . 0.17000000000000001 109.582 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.526 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 0.9 OUTLIER -77.14 141.42 40.16 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.847 -0.341 . . . . 0.48999999999999999 110.757 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.66 -42.78 2.52 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.122 -0.561 . . . . 0.28000000000000003 112.784 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.97 -137.92 3.21 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.484 -0.865 . . . . 0.17000000000000001 112.169 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 96.6 m -153.62 141.98 14.15 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.363 -0.236 . . . . 0.19 110.363 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 17' ' ' LEU . 32.4 Cg_exo -50.33 131.75 32.6 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.259 1.306 . . . . 0.22 109.602 178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 13.6 m -36.3 -32.28 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.747 0 O-C-N 123.26 0.35 . . . . 1.3999999999999999 111.503 -179.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.488 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 0.6 OUTLIER -65.68 -48.31 72.52 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.445 0.64 . . . . 0.40999999999999998 110.618 179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' N ' ' O ' ' A' ' 14' ' ' PRO . 32.7 mt -74.27 153.28 39.45 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.993 1.109 . . . . 0.56000000000000005 113.993 -176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.831 HG12 ' HB3' ' A' ' 36' ' ' ALA . 1.7 pp -108.95 138.73 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 CA-C-N 113.037 -1.892 . . . . 0.14000000000000001 110.166 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -71.38 96.6 1.48 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.977 0.418 . . . . 0.77000000000000002 111.23 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.57 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -74.46 -33.84 34.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.32 0.581 . . . . 0.20999999999999999 110.411 179.074 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 179.34 -160.95 26.69 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.176 -0.769 . . . . 0.20000000000000001 111.176 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.4 p -91.64 -172.41 3.21 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.013 0.407 . . . . 1.01 110.229 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.636 ' HB3' ' CB ' ' A' ' 27' ' ' ARG . 41.4 t -140.04 -164.68 1.75 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.415 -0.587 . . . . 1.1599999999999999 109.415 -179.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.621 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 18.7 t80 -72.57 134.83 45.38 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 121.649 0.738 . . . . 0.88 112.067 -178.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 69.47 -46.26 0.51 Allowed Glycine 0 N--CA 1.434 -1.478 0 CA-C-N 113.843 -1.526 . . . . 1.75 115.698 178.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.706 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -179.29 -6.58 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 117.194 0.497 . . . . 0.69999999999999996 112.015 -176.286 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.636 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 81.8 mtm180 -66.35 159.58 26.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.05 0.453 . . . . 0.64000000000000001 111.694 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.51 138.11 40.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.458 -0.792 . . . . 0.68000000000000005 109.06 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.562 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -91.36 125.34 36.09 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.016 -0.735 . . . . 0.71999999999999997 109.016 179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.706 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 3.6 m -114.05 139.04 49.6 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.392 -0.822 . . . . 0.16 111.429 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.817 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -133.72 172.04 13.32 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 114.215 -1.357 . . . . 0.12 107.734 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.797 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 39.0 m95 -89.15 139.18 28.7 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-O 121.581 0.705 . . . . 0.42999999999999999 112.049 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.571 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 18.9 Cg_endo -56.77 -15.98 18.26 Favored 'Trans proline' 0 N--CA 1.486 1.074 0 C-N-CA 125.231 3.954 . . . . 0.27000000000000002 117.413 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.797 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -28.84 -34.23 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 119.301 0.955 . . . . 0.32000000000000001 112.787 -177.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.646 ' N ' ' HE3' ' A' ' 34' ' ' TRP . 0.6 OUTLIER -157.52 35.61 0.27 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.941 -0.763 . . . . 1.8999999999999999 108.941 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.831 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.571 -0.728 . . . . 1.3200000000000001 110.233 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.44 HD13 ' N ' ' A' ' 2' ' ' PHE . 0.9 OUTLIER . . . . . 0 N--CA 1.478 0.943 0 N-CA-C 109.794 -0.447 . . . . 1.6100000000000001 109.794 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 3' ' ' CYS . 22.8 t80 -77.67 162.31 27.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.156 0.503 . . . . 0.56000000000000005 110.503 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.613 ' O ' ' N ' ' A' ' 5' ' ' GLY . 64.5 m -142.25 140.22 32.2 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.807 -0.812 . . . . 0.98999999999999999 108.807 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -41.79 81.09 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.385 0.428 . . . . 2.2000000000000002 111.954 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.705 ' HA3' ' HB1' ' A' ' 31' ' ' ALA . . . 133.7 -35.08 2.31 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.004 -0.617 . . . . 0.33000000000000002 113.151 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.466 ' N ' ' HA ' ' A' ' 31' ' ' ALA . . . -158.57 -135.35 1.86 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.834 -0.698 . . . . 0.40000000000000002 112.413 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 30' ' ' CYS . 20.3 m -124.92 159.6 30.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.007 0.432 . . . . 0.73999999999999999 111.592 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' CB ' ' SG ' ' A' ' 3' ' ' CYS . 0.0 OUTLIER -96.11 138.46 33.69 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.816 -0.629 . . . . 1.04 110.12 -179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.57 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 40.4 m-70 -135.82 138.8 42.92 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.765 -0.652 . . . . 0.17000000000000001 109.463 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.566 ' HB2' ' HG2' ' A' ' 27' ' ' ARG . 1.4 t80 -72.18 133.25 45.03 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 120.621 -0.432 . . . . 0.48999999999999999 111.329 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.49 -45.36 1.4 Allowed Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.119 -0.562 . . . . 0.28000000000000003 113.679 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -175.65 -134.91 2.0 Favored Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.577 -0.82 . . . . 0.17000000000000001 112.1 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 83.9 m -149.77 139.62 13.39 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.741 0.305 . . . . 0.19 111.756 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 16' ' ' HIS . 52.6 Cg_exo -47.85 131.45 20.69 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.664 1.576 . . . . 0.22 109.565 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.2 m -36.97 -26.71 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.784 0 O-C-N 123.398 0.436 . . . . 1.3999999999999999 111.572 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.496 ' N ' ' O ' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -77.43 -48.86 16.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.049 0.452 . . . . 0.40999999999999998 111.177 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.444 HD21 ' CE2' ' A' ' 32' ' ' TRP . 19.8 mt -73.85 144.5 45.44 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 113.558 0.947 . . . . 0.56000000000000005 113.558 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.77 ' CD1' ' HB3' ' A' ' 31' ' ' ALA . 1.8 pp -95.86 136.37 27.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 113.393 -1.73 . . . . 0.14000000000000001 110.151 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.413 ' HE3' ' CB ' ' A' ' 28' ' ' SER . 20.7 tptm -68.38 103.06 1.53 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.391 -0.368 . . . . 0.77000000000000002 110.07 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -80.31 -33.87 14.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.986 0.422 . . . . 0.20999999999999999 110.326 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.05 -156.01 21.68 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.595 -0.729 . . . . 0.20000000000000001 111.52 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.4 p -92.81 170.25 9.84 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.935 0.368 . . . . 1.01 110.632 179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.579 ' HB3' ' C ' ' A' ' 27' ' ' ARG . 48.9 t -121.54 -164.49 1.14 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.122 -0.49 . . . . 1.1599999999999999 109.892 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.542 ' N ' ' SG ' ' A' ' 23' ' ' CYS . 44.1 t80 -77.54 136.59 38.32 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.61 0.719 . . . . 0.88 112.03 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.463 ' C ' ' CG ' ' A' ' 26' ' ' PHE . . . 71.61 -45.56 0.84 Allowed Glycine 0 N--CA 1.434 -1.464 0 CA-C-N 114.036 -1.438 . . . . 1.75 115.876 177.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.763 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 0.0 OUTLIER 179.54 -12.35 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.285 0.542 . . . . 0.69999999999999996 112.02 -175.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.579 ' C ' ' HB3' ' A' ' 23' ' ' CYS . 89.9 mtm180 -66.52 161.59 22.62 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.158 -0.474 . . . . 0.64000000000000001 111.915 -178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.413 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 16.3 m -101.09 139.05 37.31 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.365 -0.834 . . . . 0.68000000000000005 109.534 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.454 ' HB3' HG23 ' A' ' 20' ' ' VAL . 0.5 OUTLIER -92.85 126.01 37.73 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.511 -0.551 . . . . 0.71999999999999997 109.511 179.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.57 ' SG ' ' HD2' ' A' ' 9' ' ' HIS . 3.4 m -120.64 146.26 46.57 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 121.788 0.804 . . . . 0.16 111.368 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.77 ' HB3' ' CD1' ' A' ' 18' ' ' ILE . . . -135.54 173.48 11.67 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.206 -1.361 . . . . 0.12 107.679 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.76 ' HB2' ' NE1' ' A' ' 34' ' ' TRP . 35.8 m95 -88.27 138.17 30.62 Favored Pre-proline 0 C--N 1.307 -1.278 0 CA-C-O 121.696 0.76 . . . . 0.42999999999999999 112.389 -178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.619 ' HD2' ' CE3' ' A' ' 32' ' ' TRP . 28.2 Cg_endo -59.89 -12.78 19.8 Favored 'Trans proline' 0 N--CA 1.485 0.978 0 C-N-CA 125.101 3.867 . . . . 0.27000000000000002 116.935 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . 0.76 ' NE1' ' HB2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -27.92 -36.58 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 119.085 0.857 . . . . 0.32000000000000001 112.794 -177.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.563 ' ND2' ' CE3' ' A' ' 34' ' ' TRP . 12.8 p30 -159.09 29.38 0.21 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.684 0.754 . . . . 1.8999999999999999 109.667 -178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.656 ' HB3' HG12 ' A' ' 18' ' ' ILE . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-N 114.785 -1.098 . . . . 1.3200000000000001 110.064 -179.831 . . . . . . . . 1 1 . 1 stop_ save_